<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Methylphenidate</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Methylphenidate">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Methylphenidate</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Methylphenidate</b>, sold under the trade name <b>Ritalin</b> among others, is a stimulant medication used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.<span class="mw-ref" id="cite_ref-AHFS2018_1-2"><a href="#cite_note-AHFS2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is a first line medication for ADHD.<span class="mw-ref" id="cite_ref-AHFS2018_1-3"><a href="#cite_note-AHFS2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It may be taken by mouth or applied to the skin, and different formulations have varying durations of effect.<span class="mw-ref" id="cite_ref-AHFS2018_1-4"><a href="#cite_note-AHFS2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>




<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Methylphenidate</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Methylphenidate-2D-skeletal.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Methylphenidate-2D-skeletal.svg.png" data-file-width="1100" data-file-height="963" data-file-type="drawing" height="175" width="200"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Methylphenidate-enantiomers-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/Methylphenidate-enantiomers-3D-balls.png" data-file-width="1100" data-file-height="552" data-file-type="bitmap" height="113" width="225"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>ˌ</span><span>m</span><span>ɛ</span><span>θ</span><span>əl</span><span>ˈ</span><span>f</span><span>ɛ</span><span>n</span><span>ɪ</span><span>d</span><span>eɪ</span><span>t</span></span>,<span class="wrap"> </span>-<span style="border-bottom:1px dotted"><span>ˈ</span><span>f</span><span>iː</span></span>-/</span></span><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Ritalin, Concerta, <a href="#Names" title="Methylphenidate">others</a></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/methylphenidate-hydrochloride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/methylphenidate-hydrochloride.html'" tppabs="https://www.drugs.com/monograph/methylphenidate-hydrochloride.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a682188.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a682188.html'" tppabs="https://medlineplus.gov/druginfo/meds/a682188.html" class="external text external">a682188</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Methylphenidate&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Methylphenidate&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Methylphenidate&SearchType=BasicSearch" class="external text external">Methylphenidate</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B3<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>C (Risk not ruled out)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Dependence<br>liability</th><td>High<span class="mw-ref" id="cite_ref-AHFS2018_1-0"><a href="#cite_note-AHFS2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Addiction<br>liability</th><td>High<span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth, transdermal<span class="mw-ref" id="cite_ref-AHFS2018_1-1"><a href="#cite_note-AHFS2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td><abbr>CNS</abbr> stimulant</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>N06BA04<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N06BA04  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N06BA04'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N06BA04" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S8 (Controlled drug)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span>Schedule III<span> </span></li>
<li><small><abbr class="country-name">DE</abbr></small>:<span> </span>Anlage III (Special prescription form required)<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>Class B<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>Schedule II<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>Approx. 30% (range: 11–52%)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>10–33%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (80%) mostly CES1A1-mediated</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>2–3 hours<span class="mw-ref" id="cite_ref-pmid10628897_3-0"><a href="#cite_note-pmid10628897-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine (90%)</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">Methyl phenyl(piperidin-2-yl)acetate</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=113-45-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=113-45-1'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=113-45-1" class="external text external">113-45-1</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/4158  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/4158'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/4158" class="external text external">4158</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7236  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7236'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7236" class="external text external">7236</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00422  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00422'" tppabs="https://www.drugbank.ca/drugs/DB00422" class="external text external">DB00422</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.4015.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.4015.html'" tppabs="http://www.chemspider.com/Chemical-Structure.4015.html" class="external text external">4015</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=207ZZ9QZ49  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=207ZZ9QZ49'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=207ZZ9QZ49" class="external text external">207ZZ9QZ49</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D04999  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D04999'" tppabs="https://www.kegg.jp/entry/D04999" class="external text external">D04999</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6887  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6887'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6887" class="external text external">CHEBI:6887</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL796  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL796'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL796" class="external text external">ChEMBL796</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID5023299  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID5023299'" tppabs="https://comptox.epa.gov/dashboard/DTXSID5023299" class="external text external">DTXSID5023299</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.003.662  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.003.662'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.003.662" class="external text external">100.003.662</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>14</sub><span>H</span><sub>19</sub><span>N</span><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td>233.31<span>&nbsp;</span>g/mol</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28OC%29C%28C1CCCCN1%29C2%3DCC%3DCC%3DC2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28OC%29C%28C1CCCCN1%29C2%3DCC%3DCC%3DC2'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28OC%29C%28C1CCCCN1%29C2%3DCC%3DCC%3DC2" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>74<span>&nbsp;</span>°C (165<span>&nbsp;</span>°F) <span class="mw-ref" id="cite_ref-Pubchem_properties_4-0"><a href="#cite_note-Pubchem_properties-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Boiling point</th><td>136<span>&nbsp;</span>°C (277<span>&nbsp;</span>°F) <span class="mw-ref" id="cite_ref-Pubchem_properties_4-1"><a href="#cite_note-Pubchem_properties-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(OC)C(C1CCCCN1)C2=CC=CC=C2</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:DUGOZIWVEXMGBE-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464371569&page2=Methylphenidate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464371569&page2=Methylphenidate'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464371569&page2=Methylphenidate" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects of methylphenidate include difficulty sleeping, decreased appetite, anxiety, and weight loss.<span class="mw-ref" id="cite_ref-AHFS2018_1-5"><a href="#cite_note-AHFS2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> More serious side effects may include psychosis, allergic reactions, prolonged erections, substance abuse, and heart problems.<span class="mw-ref" id="cite_ref-AHFS2018_1-6"><a href="#cite_note-AHFS2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Methylphenidate is believed to work by blocking dopamine and norepinephrine reuptake by neurons.<span class="mw-ref" id="cite_ref-Arn2005_5-0"><a href="#cite_note-Arn2005-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-St4th_6-0"><a href="#cite_note-St4th-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Methylphenidate is a central nervous system (CNS) stimulant of the phenethylamine and <a href="Piperidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperidine" title="Piperidine">piperidine</a> classes.<span class="mw-ref" id="cite_ref-AHFS2018_1-7"><a href="#cite_note-AHFS2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


<p>Methylphenidate was first made in 1944 and was approved for medical use in the United States in 1955.<span class="mw-ref" id="cite_ref-AHFS2018_1-8"><a href="#cite_note-AHFS2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Lang2010_8-0"><a href="#cite_note-Lang2010-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> It was originally sold by Swiss company CIBA, now Novartis Corporation.<span class="mw-ref" id="cite_ref-Lang2010_8-1"><a href="#cite_note-Lang2010-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> It is estimated that in 2013, 2.4 billion doses of methylphenidate were taken worldwide.<span class="mw-ref" id="cite_ref-PJ2015_9-0"><a href="#cite_note-PJ2015-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> In 2017, it was the 47th-most commonly prescribed medication in the United States, with more than 16 million prescriptions.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-AHFS2018_1-9"><a href="#cite_note-AHFS2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Uses">Uses</h2></summary>
    
<p>Methylphenidate is most commonly used to treat ADHD and narcolepsy.<span class="mw-ref" id="cite_ref-drugbank_12-0"><a href="#cite_note-drugbank-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Attention_deficit_hyperactivity_disorder">Attention deficit hyperactivity disorder</h3></summary>
    
<p>Methylphenidate is used for the treatment of attention deficit hyperactivity disorder.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> The addition of behavioural modification therapy can have additional benefits on treatment outcome.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> The dosage may vary and is titrated to effect.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-Management_2011_pp._1007–1022_17-0"><a href="#cite_note-Management_2011_pp._1007–1022-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<p>The short-term benefits and cost effectiveness of methylphenidate are well established.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> A number of reviews have established the safety and effectiveness of the stimulants for individuals with ADHD over several years.<span class="mw-ref" id="cite_ref-Millichap_3_20-0"><a href="#cite_note-Millichap_3-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-Long-Term_Outcomes_Medications_21-0"><a href="#cite_note-Long-Term_Outcomes_Medications-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-Millichap_22-0"><a href="#cite_note-Millichap-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> A 2018 review found tentative evidence that it may cause both serious and non-serious adverse effects in children.<span class="mw-ref" id="cite_ref-Cochrane2018_23-0"><a href="#cite_note-Cochrane2018-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> The precise magnitude of improvements in ADHD symptoms and quality of life that are produced by methylphenidate treatment remains uncertain as of November 2015.<span class="mw-ref" id="cite_ref-pmid26599576_24-0"><a href="#cite_note-pmid26599576-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> The World Health Organization, however, did not add methylphenidate to the World Health Organization Essential Medicines List as they found the evidence for benefits versus harms to be unclear in ADHD.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>

<p>Approximately<span>&nbsp;</span>70% of those who use methylphenidate see improvements in ADHD symptoms.<span class="mw-ref" id="cite_ref-ADHD_26-0"><a href="#cite_note-ADHD-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-WebMds_Review_27-0"><a href="#cite_note-WebMds_Review-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> Children with ADHD who use stimulant medications generally have better relationships with peers and family members,<span class="mw-ref" id="cite_ref-Millichap_3_20-1"><a href="#cite_note-Millichap_3-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-ADHD_26-1"><a href="#cite_note-ADHD-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> perform better in school, are less distractible and impulsive, and have longer attention spans.<span class="mw-ref" id="cite_ref-Millichap_3_20-2"><a href="#cite_note-Millichap_3-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-ADHD_26-2"><a href="#cite_note-ADHD-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> People with ADHD have an increased risk of substance use disorders without treatment, and stimulant medications reduce this risk.<span class="mw-ref" id="cite_ref-esmadhd18307377_28-0"><a href="#cite_note-esmadhd18307377-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span><span class="mw-ref" id="cite_ref-dstadhd12509574_29-0"><a href="#cite_note-dstadhd12509574-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> Some studies suggest that since ADHD diagnosis is increasing significantly around the world, using the drug may cause more harm than good in some populations using methylphenidate as a "study drug".<span class="mw-ref" id="cite_ref-Abelman_68_30-0"><a href="#cite_note-Abelman_68-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> This applies to people who potentially may be experiencing a different issue and are misdiagnosed with ADHD.<span class="mw-ref" id="cite_ref-Abelman_68_30-1"><a href="#cite_note-Abelman_68-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> People in this category can then experience negative side-effects of the drug which worsen their condition, and make it harder for them to receive adequate care as providers around them may believe the drugs are sufficient and the problem lies with the user.<span class="mw-ref" id="cite_ref-Abelman_68_30-2"><a href="#cite_note-Abelman_68-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> Methylphenidate is not approved for children under six years of age.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Immediate release methylphenidate is used daily along with the longer-acting form to achieve full-day control of symptoms.<span class="mw-ref" id="cite_ref-Management_2011_pp._1007–1022_17-1"><a href="#cite_note-Management_2011_pp._1007–1022-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-Neinstein_2009_p._33-0"><a href="#cite_note-Neinstein_2009_p.-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>722</span></sup></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Narcolepsy">Narcolepsy</h3></summary>
    
<p>Narcolepsy, a chronic sleep disorder characterized by overwhelming daytime drowsiness and uncontrollable sleep, is treated primarily with stimulants. Methylphenidate is considered effective in increasing wakefulness, vigilance, and performance.<span class="mw-ref" id="cite_ref-pmid9484423_34-0"><a href="#cite_note-pmid9484423-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> Methylphenidate improves measures of somnolence on standardized tests, such as the Multiple Sleep Latency Test (MSLT), but performance does not improve to levels comparable to healthy people.<span class="mw-ref" id="cite_ref-pmid7701190_35-0"><a href="#cite_note-pmid7701190-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other_medical_uses">Other medical uses</h3></summary>
    
<p>Methylphenidate may also be prescribed for off-label use in treatment-resistant cases of bipolar disorder and major depressive disorder.<span class="mw-ref" id="cite_ref-pmid25312027_36-0"><a href="#cite_note-pmid25312027-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> It can also improve depression in several groups including stroke, cancer, and HIV-positive patients.<span class="mw-ref" id="cite_ref-pmid15079851_37-0"><a href="#cite_note-pmid15079851-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> However, the use of stimulants such as methylphenidate in cases of treatment-resistant depression is controversial.<span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Stimulants may have fewer side-effects than tricyclic antidepressants in the elderly and medically ill.<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> In individuals with terminal cancer, methylphenidate can be used to counteract opioid-induced somnolence, to increase the analgesic effects of opioids, to treat depression, and to improve cognitive function.<span class="mw-ref" id="cite_ref-pmid11773187_40-0"><a href="#cite_note-pmid11773187-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span>  A 2018 review found low quality evidence supporting its use to treat apathy as seen in Alzheimer's Disease in addition to slight benefits for cognition and cognitive performance.<span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Enhancing_performance">Enhancing performance</h3></summary>
    
<p>A 2015 review found that therapeutic doses of <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a> and methylphenidate result in modest improvements in cognition, including working memory, episodic memory, and inhibitory control, in normal healthy adults;<span class="mw-ref" id="cite_ref-Unambiguous_PFC_D1_A2_42-0"><a href="#cite_note-Unambiguous_PFC_D1_A2-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span><span class="mw-ref" id="cite_ref-Cognitive_and_motivational_effects_43-0"><a href="#cite_note-Cognitive_and_motivational_effects-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span> the cognition-enhancing effects of these drugs are known to occur through the indirect activation of both dopamine receptor D<sub>1</sub> and adrenoceptor α<sub>2</sub> in the prefrontal cortex.<span class="mw-ref" id="cite_ref-Unambiguous_PFC_D1_A2_42-1"><a href="#cite_note-Unambiguous_PFC_D1_A2-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> Methylphenidate and other ADHD stimulants also improve task saliency and increase arousal.<span class="mw-ref" id="cite_ref-Malenka_2009_44-0"><a href="#cite_note-Malenka_2009-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span><span class="mw-ref" id="cite_ref-Continuum_45-0"><a href="#cite_note-Continuum-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span>  Stimulants such as amphetamine and methylphenidate can improve performance on difficult and boring tasks,<span class="mw-ref" id="cite_ref-Malenka_2009_44-1"><a href="#cite_note-Malenka_2009-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span><span class="mw-ref" id="cite_ref-Continuum_45-1"><a href="#cite_note-Continuum-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span><span class="mw-ref" id="cite_ref-46"><a href="#cite_note-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> and are used by some students as a study and test-taking aid.<span class="mw-ref" id="cite_ref-Abelman_68_30-3"><a href="#cite_note-Abelman_68-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-47"><a href="#cite_note-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> Based upon studies of self-reported illicit stimulant use, performance-enhancing use rather than use as a recreational drug, is the primary reason that students use stimulants.<span class="mw-ref" id="cite_ref-pmid16999660_48-0"><a href="#cite_note-pmid16999660-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span></p>

<p>Excessive doses of methylphenidate, above the therapeutic range, can interfere with working memory and cognitive control.<span class="mw-ref" id="cite_ref-Malenka_2009_44-2"><a href="#cite_note-Malenka_2009-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span><span class="mw-ref" id="cite_ref-Continuum_45-2"><a href="#cite_note-Continuum-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span>  Like amphetamine and <a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">bupropion</a>, methylphenidate increases stamina and endurance in humans primarily through reuptake inhibition of dopamine in the central nervous system.<span class="mw-ref" id="cite_ref-Roelands_2013_49-0"><a href="#cite_note-Roelands_2013-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span>  Similar to the loss of cognitive enhancement when using large amounts, large doses of methylphenidate can induce side effects that impair athletic performance, such as rhabdomyolysis and hyperthermia.<span class="mw-ref" id="cite_ref-FDA_Daytrana_2015_50-0"><a href="#cite_note-FDA_Daytrana_2015-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> While literature suggests it might improve cognition, most authors agree that using the drug recreationally as a study aid when ADHD diagnosis is not present does not actually improve GPA.<span class="mw-ref" id="cite_ref-Abelman_68_30-4"><a href="#cite_note-Abelman_68-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> Moreover, it has been suggested that students who use the drug for studying may be self-medicating for potentially deeper underlying issues.<span class="mw-ref" id="cite_ref-Abelman_68_30-5"><a href="#cite_note-Abelman_68-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Methylphenidate is contraindicated for individuals using monoamine oxidase inhibitors (e.g., <a href="Phenelzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenelzine" title="Phenelzine">phenelzine</a>, and <a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">tranylcypromine</a>), or individuals with agitation, tics, glaucoma, or a hypersensitivity to any ingredients contained in methylphenidate pharmaceuticals.<span class="mw-ref" id="cite_ref-FDA_approved_package_insert_51-0"><a href="#cite_note-FDA_approved_package_insert-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></p>

<p>The US Food and Drug Administration (FDA) gives methylphenidate a pregnancy category of C, and women are advised to only use the drug if the benefits outweigh the potential risks.<span class="mw-ref" id="cite_ref-52"><a href="#cite_note-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> Not enough human studies have been conducted to conclusively demonstrate an effect of methylphenidate on fetal development.<span class="mw-ref" id="cite_ref-53"><a href="#cite_note-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> In 2018, a review concluded that it has not been teratogenic in rats and rabbits, and that it "is not a major human teratogen".<span class="mw-ref" id="cite_ref-54"><a href="#cite_note-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Rational_harm_assessment_of_drugs_radar_plot.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Rational_harm_assessment_of_drugs_radar_plot.svg.png" data-file-width="900" data-file-height="900" data-file-type="drawing" height="220" width="220"><div class="thumbcaption" style="text-align: left">Addiction experts in psychiatry, chemistry, pharmacology, forensic science, epidemiology, and the police and legal services engaged in delphic analysis regarding 20 popular recreational drugs. Methylphenidate was ranked 13th in dependence, 12th in physical harm, and 18th in social harm.<span class="mw-ref" id="cite_ref-55"><a href="#cite_note-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span></div></div></div>
<p>The most common adverse effects include appetite loss, dry mouth, anxiety/nervousness, nausea, and insomnia. Gastrointestinal adverse effects may include abdominal pain and weight loss. Nervous system adverse effects may include akathisia (agitation/restlessness), irritability, dyskinesia (tics), lethargy (drowsiness/fatigue), and dizziness. Cardiac adverse effects may include palpitations, changes in blood pressure and heart rate (typically mild), and tachycardia (rapid heart rate).<span class="mw-ref" id="cite_ref-Ritalin_Rx_info_56-0"><a href="#cite_note-Ritalin_Rx_info-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> Ophthalmologic adverse effects may include blurred vision and dry eyes, with less frequent reports of diplopia and mydriasis.<span class="mw-ref" id="cite_ref-57"><a href="#cite_note-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span></p>

<p>There is some evidence of mild reductions in height with prolonged treatment in children.<span class="mw-ref" id="cite_ref-pmid23294014_58-0"><a href="#cite_note-pmid23294014-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> This has been estimated at <span>1 centimetre (0.4</span><span>&nbsp;</span><span>in)</span> or less per year during the first three years with a total decrease of <span>3 centimetres (1.2</span><span>&nbsp;</span><span>in)</span> over 10 years.<span class="mw-ref" id="cite_ref-59"><a href="#cite_note-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span><span class="mw-ref" id="cite_ref-60"><a href="#cite_note-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span></p>

<p>Hypersensitivity (including skin rash, urticaria, and fever) is sometimes reported when using transdermal methylphenidate. The Daytrana patch has a much higher rate of skin reactions than oral methylphenidate.<span class="mw-ref" id="cite_ref-61"><a href="#cite_note-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span></p>

<p>Methylphenidate can worsen psychosis in people who are psychotic, and in very rare cases it has been associated with the emergence of new psychotic symptoms.<span class="mw-ref" id="cite_ref-pmid20571380_62-0"><a href="#cite_note-pmid20571380-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span> It should be used with extreme caution in people with bipolar disorder due to the potential induction of mania or hypomania.<span class="mw-ref" id="cite_ref-63"><a href="#cite_note-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> There have been very rare reports of suicidal ideation, but some authors claim that evidence does not support a link.<span class="mw-ref" id="cite_ref-pmid23294014_58-1"><a href="#cite_note-pmid23294014-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> Logorrhea is occasionally reported. Libido disorders, disorientation, and hallucinations are very rarely reported. Priapism is a very rare adverse event that can be potentially serious.<span class="mw-ref" id="cite_ref-FDA_64-0"><a href="#cite_note-FDA-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span></p>

<p>USFDA-commissioned studies from 2011 indicate that in children, young adults, and adults there is no association between serious adverse cardiovascular events (sudden death, heart attack, and stroke) and the medical use of methylphenidate or other ADHD stimulants.<span class="mw-ref" id="cite_ref-65"><a href="#cite_note-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span></p>

<p>Because some adverse effects may only emerge during chronic use of methylphenidate, a constant watch for adverse effects is recommended.<span class="mw-ref" id="cite_ref-66"><a href="#cite_note-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span></p>

<p>A 2018 Cochrane review found that methylphenidate might be associated with serious side effects such as heart problems, psychosis, and death; the certainty of the evidence was stated as very low and the actual risk might be higher.<span class="mw-ref" id="cite_ref-67"><a href="#cite_note-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Overdose">Overdose</h3></summary>
    
<p>The symptoms of a moderate acute overdose on methylphenidate primarily arise from central nervous system overstimulation; these symptoms include: vomiting, nausea, agitation, tremors, hyperreflexia, muscle twitching, euphoria, confusion, hallucinations, delirium, hyperthermia, sweating, <a href="Flushing_(physiology).htm" tppabs="https://ptable.com/wiki/compounds/A/Flushing_(physiology)" title="Flushing (physiology)">flushing</a>, headache, tachycardia, heart palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes.<span class="mw-ref" id="cite_ref-FDA_Daytrana_2015_50-1"><a href="#cite_note-FDA_Daytrana_2015-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-MPH_INCHEM_68-0"><a href="#cite_note-MPH_INCHEM-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> A severe overdose may involve symptoms such as hyperpyrexia, sympathomimetic toxidrome, convulsions, paranoia, stereotypy (a repetitive movement disorder), rapid muscle breakdown, coma, and circulatory collapse.<span class="mw-ref" id="cite_ref-FDA_Daytrana_2015_50-2"><a href="#cite_note-FDA_Daytrana_2015-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span><span class="mw-ref" id="cite_ref-MPH_INCHEM_68-1"><a href="#cite_note-MPH_INCHEM-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span><span class="mw-ref" id="cite_ref-ADHD_toxidrome_69-0"><a href="#cite_note-ADHD_toxidrome-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> A methylphenidate overdose is rarely fatal with appropriate care.<span class="mw-ref" id="cite_ref-ADHD_toxidrome_69-1"><a href="#cite_note-ADHD_toxidrome-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> Following injection of methylphenidate tablets into an artery, severe toxic reactions involving abscess formation and necrosis have been reported.<span class="mw-ref" id="cite_ref-pmid21984207_70-0"><a href="#cite_note-pmid21984207-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span></p>

<p>Treatment of a methylphenidate overdose typically involves the administration of benzodiazepines, with antipsychotics, α-adrenoceptor agonists and <a href="Propofol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propofol" title="Propofol">propofol</a> serving as second-line therapies.<span class="mw-ref" id="cite_ref-ADHD_toxidrome_69-2"><a href="#cite_note-ADHD_toxidrome-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Addiction_and_dependence">Addiction and dependence</h3></summary>
    
<span>
</span><table role="presentation" cellpadding="0" style="border-spacing:0; clear:right; float:right;">
<tbody><tr>
<td><div class="thumb tright">
<div class="thumbinner" style="width:402px; ">
<div style="clear: both; font-weight: bold; font-size: 106.4%; text-align: center; background-color: aliceblue;margin-bottom:3px;">ΔFosB accumulation from excessive drug use</div>
<div style="position:relative; width:400px; height:440px; overflow:hidden; border:solid #ccc 1px; background-color:white;">
<div style="left:0px; top:0px; width:400px; position:absolute"> <figure-inline><img src="../I/m/ΔFosB_accumulation.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/%CE%94FosB_accumulation.svg.png" data-file-width="400" data-file-height="440" data-file-type="drawing" height="440" width="400"></figure-inline>
</div> 
<div style="text-align:center; line-height:110%;">
<div style="background-color:transparent; color:black"></div>
</div>
</div>
<div class="thumbcaption" style="clear:left">Top: this depicts the initial effects of high dose exposure to an addictive drug on gene expression in the nucleus accumbens for various Fos family proteins (i.e., c-Fos, FosB, ΔFosB, Fra1, and Fra2).<br>Bottom: this illustrates the progressive increase in ΔFosB expression in the nucleus accumbens following repeated twice daily drug binges, where these phosphorylated (35–37<span>&nbsp;</span>kilodalton) ΔFosB isoforms persist in the D1-type medium spiny neurons of the nucleus accumbens for up to 2<span>&nbsp;</span>months.<span class="mw-ref" id="cite_ref-pmid11572966_71-0"><a href="#cite_note-pmid11572966-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span><span class="mw-ref" id="cite_ref-Nestler2_72-0"><a href="#cite_note-Nestler2-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span></div>
</div>
</div></td></tr>
</tbody></table>
<p>Methylphenidate is a stimulant with an addiction liability and dependence liability similar to <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a>. It has moderate liability among addictive drugs;<span class="mw-ref" id="cite_ref-pmid15014637_73-0"><a href="#cite_note-pmid15014637-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span><span class="mw-ref" id="cite_ref-MPH_-_addiction_74-0"><a href="#cite_note-MPH_-_addiction-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> accordingly, addiction and psychological dependence are possible and likely when methylphenidate is used at high doses as a recreational drug.<span class="mw-ref" id="cite_ref-MPH_-_addiction_74-1"><a href="#cite_note-MPH_-_addiction-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span><span class="mw-ref" id="cite_ref-Addiction_genetics_75-0"><a href="#cite_note-Addiction_genetics-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span>  When used above the medical dose range, stimulants are associated with the development of stimulant psychosis.<span class="mw-ref" id="cite_ref-76"><a href="#cite_note-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span> As with all addictive drugs, the overexpression of ΔFosB in D1-type medium spiny neurons in the nucleus accumbens is implicated in methylphenidate addiction.<span class="mw-ref" id="cite_ref-Addiction_genetics_75-1"><a href="#cite_note-Addiction_genetics-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span><span class="mw-ref" id="cite_ref-MPH_ΔFosB_77-0"><a href="#cite_note-MPH_ΔFosB-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span></p>

<p>Methylphenidate has shown some benefits as a replacement therapy for individuals who are addicted to and dependent upon <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a>.<span class="mw-ref" id="cite_ref-78"><a href="#cite_note-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> Methylphenidate and <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a> have been investigated as a chemical replacement for the treatment of cocaine addiction<span class="mw-ref" id="cite_ref-pmid9408812_79-0"><a href="#cite_note-pmid9408812-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span><span class="mw-ref" id="cite_ref-80"><a href="#cite_note-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span><span class="mw-ref" id="cite_ref-81"><a href="#cite_note-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span><span class="mw-ref" id="cite_ref-82"><a href="#cite_note-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span> in the same way that <a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">methadone</a> is used as a replacement drug for physical dependence upon <a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">heroin</a>. Its effectiveness in treatment of cocaine or psychostimulant addiction, or psychological dependence has not been proven and further research is needed.<span class="mw-ref" id="cite_ref-83"><a href="#cite_note-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Biomolecular_mechanisms">Biomolecular mechanisms</h4></summary>
    

<p>Methylphenidate has the potential to induce euphoria due to its pharmacodynamic effect (i.e., dopamine reuptake inhibition) in the brain's reward system.<span class="mw-ref" id="cite_ref-MPH_ΔFosB_77-1"><a href="#cite_note-MPH_ΔFosB-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span> At therapeutic doses, ADHD stimulants do not sufficiently activate the reward system, or the reward pathway in particular, to the extent necessary to cause persistent increases in ΔFosB gene expression in the D1-type medium spiny neurons of the nucleus accumbens;<span class="mw-ref" id="cite_ref-MPH_-_addiction_74-2"><a href="#cite_note-MPH_-_addiction-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span><span class="mw-ref" id="cite_ref-MPH_ΔFosB_77-2"><a href="#cite_note-MPH_ΔFosB-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span><span class="mw-ref" id="cite_ref-Cellular_basis_84-0"><a href="#cite_note-Cellular_basis-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> consequently, when taken as directed in doses that are commonly prescribed for the treatment of ADHD, methylphenidate use lacks the capacity to cause an addiction.<span class="mw-ref" id="cite_ref-MPH_-_addiction_74-3"><a href="#cite_note-MPH_-_addiction-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span><span class="mw-ref" id="cite_ref-MPH_ΔFosB_77-3"><a href="#cite_note-MPH_ΔFosB-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span><span class="mw-ref" id="cite_ref-Cellular_basis_84-1"><a href="#cite_note-Cellular_basis-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> However, when methylphenidate is used at sufficiently high recreational doses through a bioavailable route of administration (e.g., insufflation or intravenous administration), particularly for use of the drug as a euphoriant, ΔFosB accumulates in the nucleus accumbens.<span class="mw-ref" id="cite_ref-MPH_-_addiction_74-4"><a href="#cite_note-MPH_-_addiction-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span><span class="mw-ref" id="cite_ref-MPH_ΔFosB_77-4"><a href="#cite_note-MPH_ΔFosB-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span> Hence, like any other addictive drug, regular recreational use of methylphenidate at high doses eventually gives rise to ΔFosB overexpression in D1-type neurons which subsequently triggers a series of gene transcription-mediated signaling cascades that induce an addiction.<span class="mw-ref" id="cite_ref-MPH_ΔFosB_77-5"><a href="#cite_note-MPH_ΔFosB-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span><span class="mw-ref" id="cite_ref-Cellular_basis_84-2"><a href="#cite_note-Cellular_basis-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span><span class="mw-ref" id="cite_ref-85"><a href="#cite_note-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>Methylphenidate may inhibit the metabolism of vitamin K anticoagulants, certain anticonvulsants, and some antidepressants (tricyclic antidepressants, and selective serotonin reuptake inhibitors). Concomitant administration may require dose adjustments, possibly assisted by monitoring of plasma drug concentrations.<span class="mw-ref" id="cite_ref-concerta_monograph_86-0"><a href="#cite_note-concerta_monograph-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span> There are several case reports of methylphenidate inducing serotonin syndrome with concomitant administration of antidepressants.<span class="mw-ref" id="cite_ref-87"><a href="#cite_note-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span><span class="mw-ref" id="cite_ref-88"><a href="#cite_note-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span><span class="mw-ref" id="cite_ref-89"><a href="#cite_note-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span><span class="mw-ref" id="cite_ref-90"><a href="#cite_note-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span></p>

<p>When methylphenidate is coingested with <a href="Ethanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethanol" title="Ethanol">ethanol</a>, a metabolite called ethylphenidate is formed via hepatic transesterification,<span class="mw-ref" id="cite_ref-91"><a href="#cite_note-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span><span class="mw-ref" id="cite_ref-pmid10820132_92-0"><a href="#cite_note-pmid10820132-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span> not unlike the hepatic formation of <a href="Cocaethylene.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaethylene" title="Cocaethylene">cocaethylene</a> from <a href="Cocaine.htm#Metabolism_and_excretion" tppabs="https://ptable.com/wiki/compounds/A/Cocaine#Metabolism_and_excretion" title="Cocaine">cocaine</a> and ethanol. The reduced potency of ethylphenidate and its minor formation means it does not contribute to the pharmacological profile at therapeutic doses and even in overdose cases ethylphenidate concentrations remain negligible.<span class="mw-ref" id="cite_ref-pmid10440465_93-0"><a href="#cite_note-pmid10440465-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span><span class="mw-ref" id="cite_ref-pmid10820132_92-1"><a href="#cite_note-pmid10820132-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span></p>

<p>Coingestion of alcohol (ethanol) also increases the blood plasma levels of d-methylphenidate by up to 40%.<span class="mw-ref" id="cite_ref-pmid17339864_94-0"><a href="#cite_note-pmid17339864-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span></p>

<p>Liver toxicity from methylphenidate is extremely rare, but limited evidence suggests that intake of β-adrenergic agonists with methylphenidate may increase the risk of liver toxicity.<span class="mw-ref" id="cite_ref-95"><a href="#cite_note-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<table class="wikitable" style="float:right;margin-left:5px; text-align:center">
<caption>Binding profile<span class="mw-ref" id="cite_ref-pmid18480678_96-0"><a href="#cite_note-pmid18480678-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span><span class="mw-ref" id="cite_ref-pmid17218796_97-0"><a href="#cite_note-pmid17218796-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span><span class="mw-ref" id="cite_ref-pmid17201613_98-0"><a href="#cite_note-pmid17201613-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span></caption>
<tbody><tr>
<th>Neurotransmitter<br>transporter</th>
<th>Measure<br>(units)</th>
<th><abbr>dl-MPH</abbr></th>
<th><abbr>d-MPH</abbr></th>
<th><abbr>l-MPH</abbr></th></tr>
<tr> 
<td rowspan="2">DAT</td>
<td>K<sub>i</sub> (<abbr>nM</abbr>)</td>
<td>121</td>
<td>161</td>
<td>2250</td></tr>
<tr>
<td>IC<sub>50</sub> (<abbr>nM</abbr>)</td>
<td>20</td>
<td>23</td>
<td>1600</td></tr>
<tr> 
<td rowspan="2">NET</td>
<td>K<sub>i</sub> (nM)</td>
<td>788</td>
<td>206</td>
<td>&gt;10000</td></tr>
<tr> 
<td>IC<sub>50</sub> (nM)</td>
<td>51</td>
<td>39</td>
<td>980</td></tr>
<tr>
<td rowspan="2">SERT</td>
<td>K<sub>i</sub> (nM)</td>
<td>&gt;10000</td>
<td>&gt;10000</td>
<td>&gt;6700</td></tr>
<tr>
<td>IC<sub>50</sub> (nM)</td>
<td style="text-align:center;"><span>—</span></td>
<td>&gt;10000</td>
<td>&gt;10000</td></tr>
<tr>
<th>GPCR</th>
<th>Measure<br>(units)</th>
<th><abbr>dl-MPH</abbr></th>
<th><abbr>d-MPH</abbr></th>
<th><abbr>l-MPH</abbr></th></tr>
<tr>
<td rowspan="2">5-HT<sub>1A</sub></td>
<td>K<sub>i</sub> (<abbr>nM</abbr>)</td>
<td>5000</td>
<td>3400</td>
<td>&gt;10000</td></tr>
<tr>
<td>IC<sub>50</sub> (<abbr>nM</abbr>)</td>
<td>10000</td>
<td>6800</td>
<td>&gt;10000</td></tr>
<tr>
<td rowspan="2">5-HT<sub>2B</sub></td>
<td>K<sub>i</sub> (nM)</td>
<td>&gt;10000</td>
<td>4700</td>
<td>&gt;10000</td></tr>
<tr>
<td>IC<sub>50</sub> (nM)</td>
<td>&gt;10000</td>
<td>4900</td>
<td>&gt;10000</td></tr>
</tbody></table>

<p>Methylphenidate primarily acts as a norepinephrine–dopamine reuptake inhibitor (NDRI). It is a benzylpiperidine and <a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">phenethylamine</a> derivative which also shares part of its basic structure with catecholamines.</p>

<p>Methylphenidate is a psychostimulant and increases the activity of the central nervous system through inhibition on reuptake of the neurotransmitters norepinephrine and <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a>. As models of ADHD suggest, it is associated with functional impairments in some of the brain's neurotransmitter systems, particularly those involving dopamine in the mesocortical and mesolimbic pathways and norepinephrine in the prefrontal cortex and locus coeruleus.<span class="mw-ref" id="cite_ref-Malenka_2009_03_99-0"><a href="#cite_note-Malenka_2009_03-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span>
Psychostimulants like methylphenidate and amphetamine may be effective in treating ADHD because they increase neurotransmitter activity in these systems. When reuptake of those neurotransmitters is halted, its concentration and effects in the synapse increase and last longer, respectively. Therefore, methylphenidate is called a norepinephrine–dopamine reuptake inhibitor.<span class="mw-ref" id="cite_ref-pmid10440465_93-1"><a href="#cite_note-pmid10440465-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span> By increasing the effects of norepinephrine and dopamine, methylphenidate increased the activity of the central nervous system and produced effects such as increased alertness, combated fatigue, and improved attention.<span class="mw-ref" id="cite_ref-steele_100-0"><a href="#cite_note-steele-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span> 
<span class="mw-ref" id="cite_ref-Malenka_2009_03_99-1"><a href="#cite_note-Malenka_2009_03-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span></p>

<p>Methylphenidate is most active at modulating levels of dopamine (DA) and to a lesser extent norepinephrine.<span class="mw-ref" id="cite_ref-Heal_DJ,_Pierce_DM_2006_713–38_101-0"><a href="#cite_note-Heal_DJ,_Pierce_DM_2006_713–38-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span> Methylphenidate binds to and blocks dopamine transporters (DAT) and norepinephrine transporters.<span class="mw-ref" id="cite_ref-102"><a href="#cite_note-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span>  Variability exists between DAT blockade, and extracellular dopamine, leading to the hypothesis that methylphenidate amplifies basal dopamine activity, leading to nonresponse in those with low basal DA activity.<span class="mw-ref" id="cite_ref-103"><a href="#cite_note-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span>  On average, methylphenidate elicits a 3–4 times increase in dopamine and norepinephrine in the striatum and prefrontal cortex.<span class="mw-ref" id="cite_ref-104"><a href="#cite_note-104" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span> Magnetic resonance imaging (MRI) studies suggest that long-term treatment with ADHD stimulants (specifically, <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a> and methylphenidate) decreases abnormalities in brain structure and function found in subjects with ADHD.<span class="mw-ref" id="cite_ref-Neuroplasticity_1_105-0"><a href="#cite_note-Neuroplasticity_1-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span><span class="mw-ref" id="cite_ref-Neuroplasticity_2_106-0"><a href="#cite_note-Neuroplasticity_2-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span><span class="mw-ref" id="cite_ref-Neuroplasticity_3_107-0"><a href="#cite_note-Neuroplasticity_3-107" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span></p>

<p>Both <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a> and methylphenidate are predominantly dopaminergic drugs, yet their mechanisms of action are distinct. Methylphenidate acts as a norepinephrine–dopamine reuptake inhibitor, while amphetamine is both a releasing agent and reuptake inhibitor of dopamine and norepinephrine. Methylphenidate's mechanism of action in the release of dopamine and norepinephrine is fundamentally different from most other phenethylamine derivatives, as methylphenidate is thought to increase neuronal firing rate,<span class="mw-ref" id="cite_ref-pmid15303308_108-0"><a href="#cite_note-pmid15303308-108" style="counter-reset: mw-Ref 108;"><span class="mw-reflink-text">[108]</span></a></span><span class="mw-ref" id="cite_ref-109"><a href="#cite_note-109" style="counter-reset: mw-Ref 109;"><span class="mw-reflink-text">[109]</span></a></span><span class="mw-ref" id="cite_ref-110"><a href="#cite_note-110" style="counter-reset: mw-Ref 110;"><span class="mw-reflink-text">[110]</span></a></span><span class="mw-ref" id="cite_ref-111"><a href="#cite_note-111" style="counter-reset: mw-Ref 111;"><span class="mw-reflink-text">[111]</span></a></span> whereas <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a> reduces firing rate, but causes monoamine release by reversing the flow of the monoamines through monoamine transporters via a diverse set of mechanisms, including TAAR1 activation and modulation of VMAT2 function, among other mechanisms.<span class="mw-ref" id="cite_ref-Miller_112-0"><a href="#cite_note-Miller-112" style="counter-reset: mw-Ref 112;"><span class="mw-reflink-text">[112]</span></a></span><span class="mw-ref" id="cite_ref-E_Weihe_113-0"><a href="#cite_note-E_Weihe-113" style="counter-reset: mw-Ref 113;"><span class="mw-reflink-text">[113]</span></a></span><span class="mw-ref" id="cite_ref-Amphetamine_VMAT2_pH_gradient_114-0"><a href="#cite_note-Amphetamine_VMAT2_pH_gradient-114" style="counter-reset: mw-Ref 114;"><span class="mw-reflink-text">[114]</span></a></span> The difference in mechanism of action between methylphenidate and amphetamine results in methylphenidate inhibiting amphetamine's effects on monoamine transporters when they are co-administered.<span class="mw-ref" id="cite_ref-Miller_112-1"><a href="#cite_note-Miller-112" style="counter-reset: mw-Ref 112;"><span class="mw-reflink-text">[112]</span></a></span></p>

<p>Methylphenidate has both dopamine transporter and norepinephrine transporter binding affinity, with the dextromethylphenidate enantiomers displaying a prominent affinity for the norepinephrine transporter. Both the dextrorotary and levorotary enantiomers displayed receptor affinity for the serotonergic 5HT<sub>1A</sub> and 5HT<sub>2B</sub> subtypes, though direct binding to the serotonin transporter was not observed.<span class="mw-ref" id="cite_ref-pmid17201613_98-1"><a href="#cite_note-pmid17201613-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> A later study confirmed the d-threo-methylphenidate (dexmethylphenidate) binding to the 5HT<sub>1A</sub> receptor, but no significant activity on the 5HT<sub>2B</sub> receptor was found.<span class="mw-ref" id="cite_ref-115"><a href="#cite_note-115" style="counter-reset: mw-Ref 115;"><span class="mw-reflink-text">[115]</span></a></span></p>

<p>Methylphenidate may protect neurons from the neurotoxic effects of Parkinson's disease and <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a> abuse.<span class="mw-ref" id="cite_ref-Volz2008_116-0"><a href="#cite_note-Volz2008-116" style="counter-reset: mw-Ref 116;"><span class="mw-reflink-text">[116]</span></a></span>  The hypothesized mechanism of neuroprotection is through inhibition of methamphetamine-DAT interactions, and through reducing cytosolic dopamine, leading to decreased production of dopamine-related reactive oxygen species.<span class="mw-ref" id="cite_ref-Volz2008_116-1"><a href="#cite_note-Volz2008-116" style="counter-reset: mw-Ref 116;"><span class="mw-reflink-text">[116]</span></a></span></p>

<p>The dextrorotary enantiomers are significantly more potent than the levorotary enantiomers, and some medications therefore only contain dexmethylphenidate.<span class="mw-ref" id="cite_ref-Heal_DJ,_Pierce_DM_2006_713–38_101-1"><a href="#cite_note-Heal_DJ,_Pierce_DM_2006_713–38-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span> The studied maximized daily dosage of methyphenidate appears to be 144<span>&nbsp;</span>mg/day.<span class="mw-ref" id="cite_ref-Drugs.com_2018_117-0"><a href="#cite_note-Drugs.com_2018-117" style="counter-reset: mw-Ref 117;"><span class="mw-reflink-text">[117]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<div role="note" class="hatnote navigation-not-searchable">Further information: <a href="#Available_forms">§<span>&nbsp;</span>Available forms</a></div>
<p>Methylphenidate taken orally has a bioavailability of 11–52% with a duration of peak action around 2–4<span>&nbsp;</span>hours for instant release (i.e. Ritalin), 3–8<span>&nbsp;</span>hours for sustained release (i.e. Ritalin SR), and 8–12<span>&nbsp;</span>hours for extended release (i.e. Concerta). The half-life of methylphenidate is 2–3<span>&nbsp;</span>hours, depending on the individual. The peak plasma time is achieved at about 2<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-pmid10628897_3-1"><a href="#cite_note-pmid10628897-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Methylphenidate has a low plasma protein binding of 10-33% and a volume of distribution of 2.65L/kg.<span class="mw-ref" id="cite_ref-fda_118-0"><a href="#cite_note-fda-118" style="counter-reset: mw-Ref 118;"><span class="mw-reflink-text">[118]</span></a></span></p>

<p>Dextromethylphenidate is much more bioavailable than levomethylphenidate when administered orally, and is primarily responsible for the psychoactivity of racemic methylphenidate.<span class="mw-ref" id="cite_ref-pmid10628897_3-2"><a href="#cite_note-pmid10628897-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>Contrary to the expectation, taking methylphenidate with a meal speeds absorption.<span class="mw-ref" id="cite_ref-119"><a href="#cite_note-119" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span> The effects of a high fat meal on the observed C<sub>max</sub> differ between some extended release formulations, with combined IR/ER and OROS formulations showing reduced C<sub>max</sub> levels<span class="mw-ref" id="cite_ref-120"><a href="#cite_note-120" style="counter-reset: mw-Ref 120;"><span class="mw-reflink-text">[120]</span></a></span> while liquid-based extended release formulations showed increased C<sub>max</sub> levels when administered with a high fat meal.<span class="mw-ref" id="cite_ref-121"><a href="#cite_note-121" style="counter-reset: mw-Ref 121;"><span class="mw-reflink-text">[121]</span></a></span></p>

<p>Methylphenidate is metabolized into ritalinic acid by CES1A1, enzymes in the liver. Dextromethylphenidate is selectively metabolized at a slower rate than levomethylphenidate.<span class="mw-ref" id="cite_ref-pmid15082749_122-0"><a href="#cite_note-pmid15082749-122" style="counter-reset: mw-Ref 122;"><span class="mw-reflink-text">[122]</span></a></span> 97% of the metabolised drug is excreted in the urine, and between 1 and 3% is excreted in the faeces. A small amount, less than 1%, of the drug is excreted in the urine in its unchanged form.<span class="mw-ref" id="cite_ref-fda_118-1"><a href="#cite_note-fda-118" style="counter-reset: mw-Ref 118;"><span class="mw-reflink-text">[118]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    

<p>Four isomers of methylphenidate are possible, since the molecule has two chiral centers. One pair of threo isomers and one pair of erythro are distinguished, from which primarily d-threo-methylphenidate exhibits the pharmacologically desired effects.<span class="mw-ref" id="cite_ref-Heal_DJ,_Pierce_DM_2006_713–38_101-2"><a href="#cite_note-Heal_DJ,_Pierce_DM_2006_713–38-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span><span class="mw-ref" id="cite_ref-123"><a href="#cite_note-123" style="counter-reset: mw-Ref 123;"><span class="mw-reflink-text">[123]</span></a></span> The erythro diastereomers are <i>pressor</i> amines, a property not shared with the threo diastereomers. When the drug was first introduced it was sold as a 4:1 mixture of erythro:threo diastereomers, but it was later reformulated to contain only the threo diastereomers. "TMP" refers to a threo product that does not contain any erythro diastereomers, i.e. (±)-threo-methylphenidate. Since the threo isomers are energetically favored, it is easy to epimerize out any of the undesired erythro isomers. The drug that contains only dextrorotatory methylphenidate is sometimes called d-TMP, although this name is only rarely used and it is much more commonly referred to as dexmethylphenidate, d-MPH, or d-threo-methylphenidate. A review on the synthesis of enantiomerically pure (2<i>R</i>,2'<i>R</i>)-(+)-<i>threo</i>-methylphenidate hydrochloride has been published.<span class="mw-ref" id="cite_ref-Prashad_124-0"><a href="#cite_note-Prashad-124" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span></p>

<style data-mw-deduplicate="TemplateStyles:r923042769/mw-parser-output/.tmulti">.mw-parser-output .tmulti .thumbinner{display:flex;flex-direction:column}.mw-parser-output .tmulti .trow{display:flex;flex-direction:row;clear:left;flex-wrap:wrap;width:100%;box-sizing:border-box}.mw-parser-output .tmulti .tsingle{margin:1px;float:left}.mw-parser-output .tmulti .theader{clear:both;font-weight:bold;text-align:center;align-self:center;background-color:transparent;width:100%}.mw-parser-output .tmulti .thumbcaption{text-align:left;background-color:transparent}.mw-parser-output .tmulti .thumbcaption-center{text-align:center;background-color:transparent}.mw-parser-output .tmulti .text-align-left{text-align:left}.mw-parser-output .tmulti .text-align-right{text-align:right}.mw-parser-output .tmulti .text-align-center{text-align:center}@media all and (max-width:720px){.mw-parser-output .tmulti .thumbinner{width:100%!important;box-sizing:border-box;max-width:none!important;align-items:center}.mw-parser-output .tmulti .trow{justify-content:center}.mw-parser-output .tmulti .tsingle{float:none!important;max-width:100%!important;box-sizing:border-box;text-align:center}.mw-parser-output .tmulti .thumbcaption{text-align:center}}</style><div class="thumb tmulti tnone center"><div class="thumbinner" style="width:754px;max-width:754px"><div class="trow"><div class="theader" style="text-align:center;background-color:">Methylphenidate synthesis</div></div><div class="trow"><div class="tsingle" style="width:752px;max-width:752px"><div class="thumbimage"><figure-inline><img src="../I/m/Methylphenidate_axten.png" tppabs="https://ptable.com/wiki/compounds/I/m/Methylphenidate_axten.png" data-file-width="9762" data-file-height="1573" data-file-type="bitmap" height="121" width="750"></figure-inline></div><div class="thumbcaption">Method 1: Methylphenidate preparation elucidated by Axten <i>et al.</i> (1998)<span class="mw-ref" id="cite_ref-125"><a href="#cite_note-125" style="counter-reset: mw-Ref 125;"><span class="mw-reflink-text">[125]</span></a></span> via Bamford-Stevens reaction.</div></div></div><div class="trow"><div class="tsingle" style="width:752px;max-width:752px"><div class="thumbimage"><figure-inline><img src="../I/m/Methylphenidate_classic2.png" tppabs="https://ptable.com/wiki/compounds/I/m/Methylphenidate_classic2.png" data-file-width="12025" data-file-height="3516" data-file-type="bitmap" height="219" width="750"></figure-inline></div><div class="thumbcaption">Method 2: Classic methylphenidate synthesis<span class="mw-ref" id="cite_ref-erowid_126-0"><a href="#cite_note-erowid-126" style="counter-reset: mw-Ref 126;"><span class="mw-reflink-text">[126]</span></a></span></div></div></div><div class="trow"><div class="tsingle" style="width:752px;max-width:752px"><div class="thumbimage"><figure-inline><img src="../I/m/Synthesis_of_Methylphenidate.png" tppabs="https://ptable.com/wiki/compounds/I/m/Synthesis_of_Methylphenidate.png" data-file-width="1773" data-file-height="452" data-file-type="bitmap" height="191" width="750"></figure-inline></div><div class="thumbcaption">Method 3: Another synthesis route of methylphenidate which applies Darzens reaction to obtain aldehyde as an intermediate. This route is significant for its selectivity.</div></div></div></div></div>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Detection_in_biological_fluids">Detection in biological fluids</h3></summary>
    

<p>The concentration of methylphenidate or ritalinic acid, its major metabolite, may be quantified in plasma, serum or whole blood in order to monitor compliance in those receiving the drug therapeutically, to confirm the diagnosis in potential poisoning victims or to assist in the forensic investigation in a case of fatal overdosage.<span class="mw-ref" id="cite_ref-127"><a href="#cite_note-127" style="counter-reset: mw-Ref 127;"><span class="mw-reflink-text">[127]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    

<p>Methylphenidate was first made in 1944,<span class="mw-ref" id="cite_ref-128"><a href="#cite_note-128" style="counter-reset: mw-Ref 128;"><span class="mw-reflink-text">[128]</span></a></span> and was identified as a stimulant in 1954.<span class="mw-ref" id="cite_ref-129"><a href="#cite_note-129" style="counter-reset: mw-Ref 129;"><span class="mw-reflink-text">[129]</span></a></span></p>

<p>Methylphenidate was synthesized by Ciba (now Novartis) chemist Leandro Panizzon. He named the drug after his wife, nicknamed Rita, who used Ritalin to compensate for low blood pressure.<span class="mw-ref" id="cite_ref-130"><a href="#cite_note-130" style="counter-reset: mw-Ref 130;"><span class="mw-reflink-text">[130]</span></a></span></p>

<p>Originally it was marketed as a mixture of two racemates, 80% (±)-erythro and 20% (±)-threo. Subsequent studies of the racemates showed that the central stimulant activity is associated with the threo racemate and were focused on the separation and interconversion of the erythro isomer into the more active threo isomer.<span class="mw-ref" id="cite_ref-131"><a href="#cite_note-131" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span><span class="mw-ref" id="cite_ref-132"><a href="#cite_note-132" style="counter-reset: mw-Ref 132;"><span class="mw-reflink-text">[132]</span></a></span><span class="mw-ref" id="cite_ref-133"><a href="#cite_note-133" style="counter-reset: mw-Ref 133;"><span class="mw-reflink-text">[133]</span></a></span></p>

<p>Methylphenidate was first used to allay <a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">barbiturate</a>-induced coma, narcolepsy and depression.<span class="mw-ref" id="cite_ref-books.google.com_134-0"><a href="#cite_note-books.google.com-134" style="counter-reset: mw-Ref 134;"><span class="mw-reflink-text">[134]</span></a></span> It was later used to treat memory deficits in the elderly.<span class="mw-ref" id="cite_ref-135"><a href="#cite_note-135" style="counter-reset: mw-Ref 135;"><span class="mw-reflink-text">[135]</span></a></span> Beginning in the 1960s, it was used to treat children with ADHD based on earlier work starting with the studies by American psychiatrist Charles Bradley<span class="mw-ref" id="cite_ref-136"><a href="#cite_note-136" style="counter-reset: mw-Ref 136;"><span class="mw-reflink-text">[136]</span></a></span> on the use of psychostimulant drugs, such as Benzedrine, with then called "maladjusted children".<span class="mw-ref" id="cite_ref-137"><a href="#cite_note-137" style="counter-reset: mw-Ref 137;"><span class="mw-reflink-text">[137]</span></a></span> Production and prescription of methylphenidate rose significantly in the 1990s, especially in the United States, as the ADHD diagnosis came to be better understood and more generally accepted within the medical and mental health communities.<span class="mw-ref" id="cite_ref-138"><a href="#cite_note-138" style="counter-reset: mw-Ref 138;"><span class="mw-reflink-text">[138]</span></a></span></p>

<p>In 2000, ALZA Corporation received US FDA approval to market "Concerta", an extended-release form of methylphenidate.<span class="mw-ref" id="cite_ref-139"><a href="#cite_note-139" style="counter-reset: mw-Ref 139;"><span class="mw-reflink-text">[139]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Names">Names</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Ritalin_Methylphenidat.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Ritalin_Methylphenidat.jpg" data-file-width="1076" data-file-height="758" data-file-type="bitmap" height="155" width="220"><div class="thumbcaption" style="text-align: left">German "Ritalin" brand methylphenidate</div></div></div>
<p>Methylphenidate is produced in the United States, Switzerland, Canada, Mexico, Spain, Sweden, Pakistan, and India. It is also sold in the majority of countries worldwide (although in much lower volumes than in the United States).<span class="mw-ref" id="cite_ref-:0_140-0"><a href="#cite_note-:0-140" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>8–9</span></sup> Brand names for methylphenidate include Ritalin, Concerta,<span class="mw-ref" id="cite_ref-141"><a href="#cite_note-141" style="counter-reset: mw-Ref 141;"><span class="mw-reflink-text">[141]</span></a></span> Medikinet, Adaphen, Addwize, Artige, Attenta, Cognil, Equasym, Inspiral, Methylin, Penid, Phenida, Prohiper, and Tradea.<span class="mw-ref" id="cite_ref-:0_140-1"><a href="#cite_note-:0-140" style="counter-reset: mw-Ref 140;"><span class="mw-reflink-text">[140]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>8–9</span></sup> Generic forms are produced by numerous pharmaceutical companies throughout the world.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Methylphenidate_Formulations.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Methylphenidate_Formulations.jpg" data-file-width="1942" data-file-height="1878" data-file-type="bitmap" height="213" width="220"><div class="thumbcaption" style="text-align: left">Clockwise from top: Concerta 18<span>&nbsp;</span>mg, Medikinet 30<span>&nbsp;</span>mg, Methylphenidat TAD 10<span>&nbsp;</span>mg, Ritalin 10<span>&nbsp;</span>mg, Medikinet<span>&nbsp;</span>XL 30<span>&nbsp;</span>mg.</div></div></div>

<p>Methylphenidate is available in numerous forms, and a doctor will determine the appropriate formulation of the drug to prescribe based on the patient's history, the doctor's experiences treating other patients with methylphenidate products, and product pricing or availability. Currently available forms include a variety of tablets and capsules, an adhesive-based matrix transdermal system (transdermal patch), and an oral suspension (liquid syrup).</p>

<p>The dextrorotary enantiomer of methylphenidate, known as dexmethylphenidate, is sold as a generic and under the brand names Focalin and Attenade in both an immediate-release and an extended-release form. In some circumstances it may be prescribed instead of methylphenidate, however it has no significant advantages over methylphenidate at equipotent dosages and so it is sometimes considered to be an example of an evergreened drug.<span class="mw-ref" id="cite_ref-142"><a href="#cite_note-142" style="counter-reset: mw-Ref 142;"><span class="mw-reflink-text">[142]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Immediate-release">Immediate-release</h4></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:204px"><img src="../I/m/Structural_formula_for_Ritalin_product_series.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Structural_formula_for_Ritalin_product_series.jpg" data-file-width="202" data-file-height="85" data-file-type="bitmap" height="85" width="202"><div class="thumbcaption" style="text-align: left"> Structural formula for the substance among Ritalin tablet series. (Ritalin, Ritalin LA, Ritalin SR.)  The volume of distribution was 2.65±1.11 L/kg for d-methylphenidate and 1.80±0.91 L/kg for l-methylphenidate subsequent to swallow of Ritalin tablet.<span class="mw-ref" id="cite_ref-DailyMed_2017_143-0"><a href="#cite_note-DailyMed_2017-143" style="counter-reset: mw-Ref 143;"><span class="mw-reflink-text">[143]</span></a></span></div></div></div>
<p>Methylphenidate was originally available as an immediate-release racemic mixture formulation under the Novartis trademark name Ritalin, although a variety of generics are now available, some under other brand names. Generic brand names include Ritalina, Rilatine, Attenta, Medikinet, Metadate, Methylin, Penid, Tranquilyn, and Rubifen.</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Extended-release">Extended-release</h4></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:221px"><img src="../I/m/Structural_formula_for_Concerta.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Structural_formula_for_Concerta.jpg" data-file-width="219" data-file-height="120" data-file-type="bitmap" height="120" width="219"><div class="thumbcaption" style="text-align: left">Structural formula for the substance inside Concerta tablet. Following administration of CONCERTA®, plasma concentrations of the l-isomer were approximately 1/40 the plasma concentrations of the d-isomer.<span class="mw-ref" id="cite_ref-DailyMed_2018_144-0"><a href="#cite_note-DailyMed_2018-144" style="counter-reset: mw-Ref 144;"><span class="mw-reflink-text">[144]</span></a></span></div></div></div>

<p>Extended-release methylphenidate products include:</p>
<table border="1" class="wikitable" style="width:575px;">
<tbody><tr>
<th>Brand name(s)</th>
<th>Generic name(s)<span class="mw-ref" id="cite_ref-149"><a href="#cite_note-149" style="counter-reset: mw-Ref 1;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 1]</span></a></span></th>
<th>Duration</th>
<th>Dosage<br>form</th></tr>
<tr>
<td>Aptensio<span>&nbsp;</span>XR<span>&nbsp;</span>(US);<br>Biphentin<span>&nbsp;</span>(CA)</td>
<td style="background: #ffdddd; color: black; vertical-align: middle; text-align: center; " class="table-no2">Currently unavailable</td>
<td>12<span>&nbsp;</span>hours<span class="mw-ref" id="cite_ref-152"><a href="#cite_note-152" style="counter-reset: mw-Ref 2;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 2]</span></a></span></td>
<td style="text-align:center;"><abbr>XR</abbr><br>capsule</td></tr>
<tr>
<td>Concerta<span>&nbsp;</span>(US/CA);<br>Concerta<span>&nbsp;</span>XL<span>&nbsp;</span>(UK)</td>
<td>methylphenidate<span>&nbsp;</span>ER<span>&nbsp;</span>(US/CA);<span class="mw-ref" id="cite_ref-153"><a href="#cite_note-153" style="counter-reset: mw-Ref 3;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 3]</span></a></span><br>methylphenidate<span>&nbsp;</span>ER‑C<span>&nbsp;</span>(CA)<span class="mw-ref" id="cite_ref-154"><a href="#cite_note-154" style="counter-reset: mw-Ref 4;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 4]</span></a></span></td>
<td>12<span>&nbsp;</span>hours<span class="mw-ref" id="cite_ref-Moses_155-0"><a href="#cite_note-Moses-155" style="counter-reset: mw-Ref 151;"><span class="mw-reflink-text">[151]</span></a></span></td>
<td style="text-align:center;"><abbr>OROS</abbr><br>tablet</td></tr>
<tr>
<td>Quillivant<span>&nbsp;</span>XR<span>&nbsp;</span>(US)</td>
<td style="background: #ffdddd; color: black; vertical-align: middle; text-align: center; " class="table-no2">Currently unavailable</td>
<td>12<span>&nbsp;</span>hours<span class="mw-ref" id="cite_ref-Moses_155-1"><a href="#cite_note-Moses-155" style="counter-reset: mw-Ref 151;"><span class="mw-reflink-text">[151]</span></a></span></td>
<td style="text-align:center;">oral<br>suspension</td></tr>
<tr>
<td>Daytrana<span>&nbsp;</span>(US)</td>
<td style="background: #ffdddd; color: black; vertical-align: middle; text-align: center; " class="table-no2">Currently unavailable</td>
<td>11<span>&nbsp;</span>hours<span class="mw-ref" id="cite_ref-156"><a href="#cite_note-156" style="counter-reset: mw-Ref 152;"><span class="mw-reflink-text">[152]</span></a></span></td>
<td style="text-align:center;">transdermal<br>patch</td></tr>
<tr>
<td>Metadate<span>&nbsp;</span>CD<span>&nbsp;</span>(US);<br>Equasym<span>&nbsp;</span>XL<span>&nbsp;</span>(UK)</td>
<td>methylphenidate<span>&nbsp;</span>ER<span>&nbsp;</span>(US)<span class="mw-ref" id="cite_ref-157"><a href="#cite_note-157" style="counter-reset: mw-Ref 5;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 5]</span></a></span></td>
<td>8–10<span>&nbsp;</span>hours<span class="mw-ref" id="cite_ref-Moses_155-2"><a href="#cite_note-Moses-155" style="counter-reset: mw-Ref 151;"><span class="mw-reflink-text">[151]</span></a></span></td>
<td style="text-align:center;"><abbr>CD/XL</abbr><br>capsule</td></tr>
<tr>
<td>QuilliChew<span>&nbsp;</span>ER<span>&nbsp;</span>(US)</td>
<td style="background: #ffdddd; color: black; vertical-align: middle; text-align: center; " class="table-no2">Currently unavailable</td>
<td>8<span>&nbsp;</span>hours<span class="mw-ref" id="cite_ref-158"><a href="#cite_note-158" style="counter-reset: mw-Ref 153;"><span class="mw-reflink-text">[153]</span></a></span></td>
<td style="text-align:center;">chewable<br>tablet</td></tr>
<tr>
<td>Ritalin<span>&nbsp;</span>LA<span>&nbsp;</span>(US);<br>Medikinet<span>&nbsp;</span>XL<span>&nbsp;</span>(UK)</td>
<td>methylphenidate<span>&nbsp;</span>ER<span>&nbsp;</span>(US)<span class="mw-ref" id="cite_ref-159"><a href="#cite_note-159" style="counter-reset: mw-Ref 6;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 6]</span></a></span></td>
<td>8<span>&nbsp;</span>hours<span class="mw-ref" id="cite_ref-Moses_155-3"><a href="#cite_note-Moses-155" style="counter-reset: mw-Ref 151;"><span class="mw-reflink-text">[151]</span></a></span></td>
<td style="text-align:center;"><abbr>ER</abbr><br>capsule</td></tr>
<tr>
<td>Ritalin<span>&nbsp;</span>SR<span>&nbsp;</span>(US/CA/UK);<br>Rubifen<span>&nbsp;</span>SR<span>&nbsp;</span>(NZ)</td>
<td>Metadate<span>&nbsp;</span>ER<span>&nbsp;</span>(US);<span class="mw-ref" id="cite_ref-160"><a href="#cite_note-160" style="counter-reset: mw-Ref 7;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 7]</span></a></span><br>Methylin<span>&nbsp;</span>ER<span>&nbsp;</span>(US);<span class="mw-ref" id="cite_ref-161"><a href="#cite_note-161" style="counter-reset: mw-Ref 8;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 8]</span></a></span><br>methylphenidate<span>&nbsp;</span>SR<span>&nbsp;</span>(US/CA)<span class="mw-ref" id="cite_ref-162"><a href="#cite_note-162" style="counter-reset: mw-Ref 9;" data-mw-group="lower-alpha"><span class="mw-reflink-text">[lower-alpha 9]</span></a></span></td>
<td>5–8<span>&nbsp;</span>hours<span class="mw-ref" id="cite_ref-Moses_155-4"><a href="#cite_note-Moses-155" style="counter-reset: mw-Ref 151;"><span class="mw-reflink-text">[151]</span></a></span></td>
<td style="text-align:center;"><abbr>CR</abbr><br>tablet</td></tr>
<tr>
<td colspan="4"><div class="reflist " style=" list-style-type: lower-alpha;">
<div class="mw-references-wrap"><ol class="mw-references references" data-mw-group="lower-alpha"><li id="cite_note-149"> <span id="mw-reference-text-cite_note-149" class="mw-reference-text"><span class="mw-ref" id="cite_ref-145"><a href="#cite_note-145" style="counter-reset: mw-Ref 145;"><span class="mw-reflink-text">[145]</span></a></span><span class="mw-ref" id="cite_ref-146"><a href="#cite_note-146" style="counter-reset: mw-Ref 146;"><span class="mw-reflink-text">[146]</span></a></span><span class="mw-ref" id="cite_ref-147"><a href="#cite_note-147" style="counter-reset: mw-Ref 147;"><span class="mw-reflink-text">[147]</span></a></span><span class="mw-ref" id="cite_ref-usfda-drugdb_148-0"><a href="#cite_note-usfda-drugdb-148" style="counter-reset: mw-Ref 148;"><span class="mw-reflink-text">[148]</span></a></span></span></li><li id="cite_note-152"> <span id="mw-reference-text-cite_note-152" class="mw-reference-text"><span class="mw-ref" id="cite_ref-pmid19881943_150-0"><a href="#cite_note-pmid19881943-150" style="counter-reset: mw-Ref 149;"><span class="mw-reflink-text">[149]</span></a></span><span class="mw-ref" id="cite_ref-151"><a href="#cite_note-151" style="counter-reset: mw-Ref 150;"><span class="mw-reflink-text">[150]</span></a></span></span></li><li id="cite_note-153"> <span id="mw-reference-text-cite_note-153" class="mw-reference-text">US generic manufactured by Actavis; CA generics manufactured by Pharmascience and Apotex.</span></li><li id="cite_note-154"> <span id="mw-reference-text-cite_note-154" class="mw-reference-text">Manufactured by Teva.</span></li><li id="cite_note-157"> <span id="mw-reference-text-cite_note-157" class="mw-reference-text">Manufactured by Impax, Mallinckrodt, and Teva.</span></li><li id="cite_note-159"> <span id="mw-reference-text-cite_note-159" class="mw-reference-text">Manufactured by Barr and Mayne.</span></li><li id="cite_note-160"> <span id="mw-reference-text-cite_note-160" class="mw-reference-text">Manufactured by UCB.</span></li><li id="cite_note-161"> <span id="mw-reference-text-cite_note-161" class="mw-reference-text">Manufactured by Mallinckrodt.</span></li><li id="cite_note-162"> <span id="mw-reference-text-cite_note-162" class="mw-reference-text">US generics manufactured by County Line Pharmaceuticals and Abhai; CA generic manufactured by Apotex.</span></li></ol></div></div></td></tr>
</tbody></table>

<p>Concerta tablets are marked with the letters "ALZA" and followed by: "18", "27", "36", or "54", relating to the mg dosage strength. Approximately 22% of the dose is immediate release,<span class="mw-ref" id="cite_ref-163"><a href="#cite_note-163" style="counter-reset: mw-Ref 154;"><span class="mw-reflink-text">[154]</span></a></span> and the remaining 78% of the dose is released over 10–12<span>&nbsp;</span>hours post ingestion, with an initial increase over the first 6 to 7<span>&nbsp;</span>hours, and subsequent decline in released drug.<span class="mw-ref" id="cite_ref-164"><a href="#cite_note-164" style="counter-reset: mw-Ref 155;"><span class="mw-reflink-text">[155]</span></a></span></p>

<p>Ritalin<span>&nbsp;</span>LA capsules are marked with the letters "NVR" (abbrev.: Novartis) and followed by: "R20", "R30", or "R40", depending on the (mg) dosage strength. Ritalin<span>&nbsp;</span>LA<span class="mw-ref" id="cite_ref-Ritalin_Rx_info_56-1"><a href="#cite_note-Ritalin_Rx_info-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> provides two standard doses – half the total dose being released immediately and the other half released four hours later. In total, each capsule is effective for about eight hours.</p>

<p>Metadate<span>&nbsp;</span>CD capsules contain two types of beads; 30% are immediate release, and the other 70% are evenly sustained release.<span class="mw-ref" id="cite_ref-165"><a href="#cite_note-165" style="counter-reset: mw-Ref 156;"><span class="mw-reflink-text">[156]</span></a></span></p>

<p>Quillivant XR is an extended-release oral suspension (after reconstitution with water): 25<span>&nbsp;</span>mg per 5 mL (5<span>&nbsp;</span>mg per mL). It was designed and is patented and made by Pfizer. The medication comes in various sizes from 60ml to 180ml (after reconstitution). Each bottle is shipped with the medication in powder form containing roughly 20% instant-release and 80% extended-release methylphenidate, to which water must be added by the pharmacist in an amount corresponding with the total intended volume of the bottle. The bottle must be shaken vigorously for ten seconds prior to administration via included oral syringe to ensure proper ratio.<span class="mw-ref" id="cite_ref-166"><a href="#cite_note-166" style="counter-reset: mw-Ref 157;"><span class="mw-reflink-text">[157]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Skin_patch">Skin patch</h4></summary>
    

<p>A methylphenidate skin patch is sold under the brand name Daytrana in the United States. It was developed and marketed by Noven Pharmaceuticals and approved in the US in 2006. It is also referred to as methylphenidate transdermal system (MTS). It is approved as a once daily treatment in children — ages 6 to 17 — with ADHD. It is mainly prescribed as a second-line treatment when oral forms are not well tolerated or if people have difficulty with compliance. Noven's original FDA submission indicated that it should be used for 12 hours. When the FDA rejected the submission they requested evidence that a shorter time period was safe and effective, Noven provided such evidence and it was approved for a 9-hour period.<span class="mw-ref" id="cite_ref-167"><a href="#cite_note-167" style="counter-reset: mw-Ref 158;"><span class="mw-reflink-text">[158]</span></a></span></p>

<p>Orally administered methylphenidate is subject to first-pass metabolism, by which the levo-isomer is extensively metabolized. By circumventing this first-pass metabolism, the relative concentrations of l-threo-methylphenidate are much higher with transdermal administration (50-60% of those of dexmethylphenidate instead of about 14-27%).<span class="mw-ref" id="cite_ref-168"><a href="#cite_note-168" style="counter-reset: mw-Ref 159;"><span class="mw-reflink-text">[159]</span></a></span></p>

<p>A 39 nanograms/mL peak serum concentration of methylphenidate be has been found to occur between 7.5 and 10.5 hours after administration.<span class="mw-ref" id="cite_ref-insert_169-0"><a href="#cite_note-insert-169" style="counter-reset: mw-Ref 160;"><span class="mw-reflink-text">[160]</span></a></span> However the onset to peak effect is 2 hours and the clinical effects remain up to 2 hours after patch has been removed. The absorption is increased when the transdermal patch is applied onto inflamed skin or skin that has been exposed to heat. The absorption lasts for approximately 9 hours after application (onto normal, unexposed to heat and uninflamed skin). 90% of the medication is excreted in the urine as metabolites and unchanged drug.<span class="mw-ref" id="cite_ref-insert_169-1"><a href="#cite_note-insert-169" style="counter-reset: mw-Ref 160;"><span class="mw-reflink-text">[160]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cost">Cost</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Ritalin_Pill.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Ritalin_Pill.jpg" data-file-width="1148" data-file-height="1032" data-file-type="bitmap" height="198" width="220"><div class="thumbcaption" style="text-align: left">Ritalin 10 mg tablet</div></div></div>

<p>The most expensive brand-name extended-release tablets may retail for as much as $12.40 per defined daily dose, per a 2016 source.<span class="mw-ref" id="cite_ref-170"><a href="#cite_note-170" style="counter-reset: mw-Ref 161;"><span class="mw-reflink-text">[161]</span></a></span></p>

<p>There are two main reasons for this price difference:</p>

<ul><li>Generic formulations are less expensive than brand-name formulations.</li>
<li>Immediate-release tablets are less expensive than 8-hour extended-release tablets, which are much less expensive than 12-hour extended-release tablets.</li></ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Legal_status">Legal status</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:252px"><img src="../I/m/Ritalin.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Ritalin.jpg" data-file-width="2127" data-file-height="1108" data-file-type="bitmap" height="130" width="250"><div class="thumbcaption" style="text-align: left">Legal warning printed on Ritalin packaging</div></div></div>
<ul><li>Internationally, methylphenidate is a Schedule II drug under the Convention on Psychotropic Substances.<span class="mw-ref" id="cite_ref-171"><a href="#cite_note-171" style="counter-reset: mw-Ref 162;"><span class="mw-reflink-text">[162]</span></a></span></li>
<li>In the United States, methylphenidate is classified as a Schedule II controlled substance, the designation used for substances that have a recognized medical value but present a high potential for abuse.</li>
<li>In the United Kingdom, methylphenidate is a controlled 'Class B' substance. Possession without prescription carries a sentence up to 5 years or an unlimited fine, or both; supplying methylphenidate is 14 years or an unlimited fine, or both.<span class="mw-ref" id="cite_ref-ABC_172-0"><a href="#cite_note-ABC-172" style="counter-reset: mw-Ref 163;"><span class="mw-reflink-text">[163]</span></a></span></li>
<li>In Canada, methylphenidate is listed in Schedule III of the Controlled Drugs and Substances Act and is illegal to possess without a prescription, with unlawful possession punishable by up to three years imprisonment, or (via summary conviction) by up to one year imprisonment and/or fines of up to two thousand dollars. Unlawful possession for the purpose of trafficking is punishable by up to ten years imprisonment, or (via summary conviction) by up to eighteen months imprisonment.<span class="mw-ref" id="cite_ref-173"><a href="#cite_note-173" style="counter-reset: mw-Ref 164;"><span class="mw-reflink-text">[164]</span></a></span></li>
<li>In New Zealand, methylphenidate is a 'class B2 controlled substance'. Unlawful possession is punishable by six-month prison sentence and distribution by a 14-year sentence.</li>
<li>In Australia, methylphenidate is a 'Schedule 8' controlled substance.<span class="mw-ref" id="cite_ref-174"><a href="#cite_note-174" style="counter-reset: mw-Ref 165;"><span class="mw-reflink-text">[165]</span></a></span> Such drugs must be kept in a lockable safe until dispensed and possession without prescription is punishable by fines and imprisonment.</li>
<li>In Russia, methylphenidate is a List I controlled psychotropic substance without recognized medical value. The Constant Committee for Drug Control of the Russian Ministry of Health has put methylphenidate and its derivatives on the National List of Narcotics, Psychotropic Substances and Their Precursors and the Government banned methylphenidate for any use on 25 October 2014.<span class="mw-ref" id="cite_ref-175"><a href="#cite_note-175" style="counter-reset: mw-Ref 166;"><span class="mw-reflink-text">[166]</span></a></span></li>
<li>In Sweden, methylphenidate is a List II controlled substance with recognized medical value. Possession without a prescription is punishable by up to three years in prison.<span class="mw-ref" id="cite_ref-Narkotikastrafflag_176-0"><a href="#cite_note-Narkotikastrafflag-176" style="counter-reset: mw-Ref 167;"><span class="mw-reflink-text">[167]</span></a></span></li>
<li>In France, methylphenidate is covered by the "narcotics" schedule, prescription and distribution conditions are restricted with hospital-only prescription for the initial treatment and yearly consultations.<span class="mw-ref" id="cite_ref-pmid14678352_177-0"><a href="#cite_note-pmid14678352-177" style="counter-reset: mw-Ref 168;"><span class="mw-reflink-text">[168]</span></a></span></li>
<li>In India, methylphenidate is a schedule X drug and is controlled by the Drugs and Cosmetics Rule, 1945. It is dispensed only by physician's prescription.<span class="mw-ref" id="cite_ref-178"><a href="#cite_note-178" style="counter-reset: mw-Ref 169;"><span class="mw-reflink-text">[169]</span></a></span> Legally, 2 grams of methylphenidate are classified as a small quantity, and 50 grams as a large or commercial quantity.<span class="mw-ref" id="cite_ref-NCB_179-0"><a href="#cite_note-NCB-179" style="counter-reset: mw-Ref 170;"><span class="mw-reflink-text">[170]</span></a></span></li>
<li>In Hong Kong, methylphenidate is controlled under the schedule 1 of the Dangerous Drugs Ordinance (Cap. 134).<span class="mw-ref" id="cite_ref-180"><a href="#cite_note-180" style="counter-reset: mw-Ref 171;"><span class="mw-reflink-text">[171]</span></a></span></li></ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Controversy">Controversy</h3></summary>
    

<p>Methylphenidate has been the subject of controversy in relation to its use in the treatment of ADHD. The prescription of psychostimulant medication to children to reduce ADHD symptoms has been a major point of criticism.<span class="mw-ref" id="cite_ref-pmid17949504_181-0"><a href="#cite_note-pmid17949504-181" style="counter-reset: mw-Ref 172;"><span class="mw-reflink-text">[172]</span></a></span> The contention that methylphenidate acts as a gateway drug has been discredited by multiple sources,<span class="mw-ref" id="cite_ref-nih.gov-nida-29.htm_182-0"><a href="#cite_note-nih.gov-nida-29.htm-182" style="counter-reset: mw-Ref 173;"><span class="mw-reflink-text">[173]</span></a></span> according to which abuse is statistically very low and "stimulant therapy in childhood does not increase the risk for subsequent drug and alcohol abuse disorders later in life".<span class="mw-ref" id="cite_ref-drugabuse.gov-ADHDFacts_183-0"><a href="#cite_note-drugabuse.gov-ADHDFacts-183" style="counter-reset: mw-Ref 174;"><span class="mw-reflink-text">[174]</span></a></span> A study found that ADHD medication was not associated with increased risk of cigarette use, and in fact stimulant treatments such as Ritalin seemed to lower this risk.<span class="mw-ref" id="cite_ref-184"><a href="#cite_note-184" style="counter-reset: mw-Ref 175;"><span class="mw-reflink-text">[175]</span></a></span></p>

<p>Among countries with the highest rates of use of methylphenidate medication is Iceland,<span class="mw-ref" id="cite_ref-185"><a href="#cite_note-185" style="counter-reset: mw-Ref 176;"><span class="mw-reflink-text">[176]</span></a></span> where research shows that the drug was the most commonly abused substance among intravenous substance abusers.<span class="mw-ref" id="cite_ref-186"><a href="#cite_note-186" style="counter-reset: mw-Ref 177;"><span class="mw-reflink-text">[177]</span></a></span> The study involved 108 intravenous substance abusers and 88% of them had injected methylphenidate within the last 30 days and for 63% of them, methylphenidate was the most preferred substance.</p>

<p>Treatment of ADHD by way of methylphenidate has led to legal actions, including malpractice suits regarding informed consent, inadequate information on side effects, misdiagnosis, and coercive use of medications by school systems.<span class="mw-ref" id="cite_ref-187"><a href="#cite_note-187" style="counter-reset: mw-Ref 178;"><span class="mw-reflink-text">[178]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Methylphenidate may have benefit as a treatment of apathy in patients with Alzheimer's disease.<span class="mw-ref" id="cite_ref-188"><a href="#cite_note-188" style="counter-reset: mw-Ref 179;"><span class="mw-reflink-text">[179]</span></a></span> It may be useful in losing weight.<span class="mw-ref" id="cite_ref-pmid14981214_189-0"><a href="#cite_note-pmid14981214-189" style="counter-reset: mw-Ref 180;"><span class="mw-reflink-text">[180]</span></a></span></p>

<p>Methylphenidate may provide possible protection from methamphetamine induced dopamine neuron damage and possible protection from Parkinson's disease.<span class="mw-ref" id="cite_ref-Volz2008_116-2"><a href="#cite_note-Volz2008-116" style="counter-reset: mw-Ref 116;"><span class="mw-reflink-text">[116]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-AHFS2018-1"> <span id="mw-reference-text-cite_note-AHFS2018-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/methylphenidate-hydrochloride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/methylphenidate-hydrochloride.html'" tppabs="https://www.drugs.com/monograph/methylphenidate-hydrochloride.html" class="external text external">"Methylphenidate Hydrochloride Monograph for Professionals"</a>. <i>Drugs.com</i>. AHFS. <a href="javascript:if(confirm('https://web.archive.org/web/20181219182550/https://www.drugs.com/monograph/methylphenidate-hydrochloride.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20181219182550/https://www.drugs.com/monograph/methylphenidate-hydrochloride.html'" tppabs="https://web.archive.org/web/20181219182550/https://www.drugs.com/monograph/methylphenidate-hydrochloride.html" class="external text external">Archived</a> from the original on 19 December 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">19 December</span> 2018</span>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite id="CITEREFBonewit-WestHuntApplegate2012" class="citation book cs1">Bonewit-West K, Hunt SA, Applegate E (2012). <a href="javascript:if(confirm('https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571'" tppabs="https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571" class="external text external"><i>Today's Medical Assistant: Clinical and Administrative Procedures</i></a>. Elsevier Health Sciences. p.<span>&nbsp;</span>571. ISBN<span>&nbsp;</span><bdi>9781455701506</bdi>.</cite></span></li><li id="cite_note-pmid10628897-3"> <span id="mw-reference-text-cite_note-pmid10628897-3" class="mw-reference-text"><cite id="CITEREFKimkoCrossAbernethy1999" class="citation journal cs1">Kimko HC, Cross JT, Abernethy DR (December 1999). "Pharmacokinetics and clinical effectiveness of methylphenidate". <i>Clinical Pharmacokinetics</i>. <b>37</b> (6): 457–70. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-199937060-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-199937060-00002'" tppabs="https://doi.org/10.2165%2F00003088-199937060-00002" class="external text external">10.2165/00003088-199937060-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10628897  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10628897'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10628897" class="external text external">10628897</a>.</cite></span></li><li id="cite_note-Pubchem_properties-4"> <span id="mw-reference-text-cite_note-Pubchem_properties-4" class="mw-reference-text"><cite class="citation encyclopaedia cs1"><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4158  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4158#x27'" tppabs="https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4158#x27" class="external text external">"Chemical and Physical Properties"</a>. <i>Methylphenidate</i>. <i>Pubchem Compound</i>. National Center for Biotechnology Information.</cite></span></li><li id="cite_note-Arn2005-5"> <span id="mw-reference-text-cite_note-Arn2005-5" class="mw-reference-text"><cite id="CITEREFArnstenLi2005" class="citation journal cs1">Arnsten AF, Li BM (2005). "Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions". <i>Biological Psychiatry</i>. <b>57</b> (11): 1377–84. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.biopsych.2004.08.019  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.biopsych.2004.08.019'" tppabs="https://doi.org/10.1016%2Fj.biopsych.2004.08.019" class="external text external">10.1016/j.biopsych.2004.08.019</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15950011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15950011'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15950011" class="external text external">15950011</a>.</cite></span></li><li id="cite_note-St4th-6"> <span id="mw-reference-text-cite_note-St4th-6" class="mw-reference-text"><cite id="CITEREFStahl2013" class="citation book cs1">Stahl, Stephen M. (11 April 2013). <i>Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications</i> (4th ed.). Cambridge University Press. ISBN<span>&nbsp;</span><bdi>978-1107686465</bdi>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFPreedy2016" class="citation book cs1">Preedy, Victor R. (2016). <a href="javascript:if(confirm('https://books.google.com/books?id=Yu9eBwAAQBAJ&pg=PA651  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Yu9eBwAAQBAJ&pg=PA651'" tppabs="https://books.google.com/books?id=Yu9eBwAAQBAJ&pg=PA651" class="external text external"><i>Neuropathology of Drug Addictions and Substance Misuse Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions</i></a>. Academic Press. p.<span>&nbsp;</span>651. ISBN<span>&nbsp;</span><bdi>9780128006771</bdi>.</cite></span></li><li id="cite_note-Lang2010-8"> <span id="mw-reference-text-cite_note-Lang2010-8" class="mw-reference-text"><cite id="CITEREFLangeReichlLangeTucha2010" class="citation journal cs1">Lange KW, Reichl S, Lange KM, Tucha L, Tucha O (2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907" class="external text external">"The history of attention deficit hyperactivity disorder"</a>. <i>ADHD Attention Deficit and Hyperactivity Disorders</i>. <b>2</b> (4): 241–55. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs12402-010-0045-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs12402-010-0045-8'" tppabs="https://doi.org/10.1007%2Fs12402-010-0045-8" class="external text external">10.1007/s12402-010-0045-8</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907" class="external text external">3000907</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21258430  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21258430'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21258430" class="external text external">21258430</a>.</cite></span></li><li id="cite_note-PJ2015-9"> <span id="mw-reference-text-cite_note-PJ2015-9" class="mw-reference-text"><cite id="CITEREFMarch_2015" class="citation journal cs1">March 2015, The Pharmaceutical Journal6. <a href="javascript:if(confirm('https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/narcotics-monitoring-board-reports-66-increase-in-global-consumption-of-methylphenidate/20068042.article?firstPass=false  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/narcotics-monitoring-board-reports-66-increase-in-global-consumption-of-methylphenidate/20068042.article?firstPass=false'" tppabs="https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/narcotics-monitoring-board-reports-66-increase-in-global-consumption-of-methylphenidate/20068042.article?firstPass=false" class="external text external">"Narcotics monitoring board reports 66% increase in global consumption of methylphenidate"</a>. <i>Pharmaceutical Journal</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20181219230236/https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/narcotics-monitoring-board-reports-66-increase-in-global-consumption-of-methylphenidate/20068042.article?firstPass=false  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20181219230236/https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/narcotics-monitoring-board-reports-66-increase-in-global-consumption-of-methylphenidate/20068042.article?firstPass=false'" tppabs="https://web.archive.org/web/20181219230236/https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/narcotics-monitoring-board-reports-66-increase-in-global-consumption-of-methylphenidate/20068042.article?firstPass=false" class="external text external">Archived</a> from the original on 19 December 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">19 December</span> 2018</span>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/Methylphenidate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/Methylphenidate'" tppabs="https://clincalc.com/DrugStats/Drugs/Methylphenidate" class="external text external">"Methylphenidate - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-drugbank-12"> <span id="mw-reference-text-cite_note-drugbank-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00422  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00422'" tppabs="https://www.drugbank.ca/drugs/DB00422" class="external text external">"Methylphenidate"</a>. <i>www.drugbank.ca</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20190131040915/https://www.drugbank.ca/drugs/DB00422  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20190131040915/https://www.drugbank.ca/drugs/DB00422'" tppabs="https://web.archive.org/web/20190131040915/https://www.drugbank.ca/drugs/DB00422" class="external text external">Archived</a> from the original on 31 January 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">30 January</span> 2019</span>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFFoneNutt2005" class="citation journal cs1">Fone KC, Nutt DJ (2005). "Stimulants: use and abuse in the treatment of ADD". <i>Current Opinion in Pharmacology</i>. <b>5</b> (1): 87–93. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.coph.2004.10.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.coph.2004.10.001'" tppabs="https://doi.org/10.1016%2Fj.coph.2004.10.001" class="external text external">10.1016/j.coph.2004.10.001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15661631  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15661631'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15661631" class="external text external">15661631</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFCappPearlConlon2005" class="citation journal cs1">Capp PK, Pearl PL, Conlon C (2005). "Methylphenidate HCl: therapy for attention deficit hyperactivity disorder". <i>Expert Rev Neurother</i>. <b>5</b> (3): 325–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2F14737175.5.3.325  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2F14737175.5.3.325'" tppabs="https://doi.org/10.1586%2F14737175.5.3.325" class="external text external">10.1586/14737175.5.3.325</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15938665  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15938665'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15938665" class="external text external">15938665</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFGreenfieldHechman2005" class="citation journal cs1">Greenfield B, Hechman L (2005). "Treatment of attention deficit hyperactivity disorder in adults". <i>Expert Rev Neurother</i>. <b>5</b> (1): 107–21. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2F14737175.5.1.107  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2F14737175.5.1.107'" tppabs="https://doi.org/10.1586%2F14737175.5.1.107" class="external text external">10.1586/14737175.5.1.107</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15853481  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15853481'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15853481" class="external text external">15853481</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFStevensonWolraich1989" class="citation journal cs1">Stevenson RD, Wolraich ML (1989). "Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder". <i>Pediatr. Clin. North Am</i>. <b>36</b> (5): 1183–97. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0031-3955%2816%2936764-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0031-3955%2816%2936764-5'" tppabs="https://doi.org/10.1016%2FS0031-3955%2816%2936764-5" class="external text external">10.1016/S0031-3955(16)36764-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2677938  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2677938'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2677938" class="external text external">2677938</a>.</cite></span></li><li id="cite_note-Management_2011_pp._1007–1022-17"> <span id="mw-reference-text-cite_note-Management_2011_pp._1007–1022-17" class="mw-reference-text"><cite id="CITEREFManagement2011" class="citation journal cs1">Management (1 November 2011). <a href="javascript:if(confirm('https://pediatrics.aappublications.org/content/128/5/1007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pediatrics.aappublications.org/content/128/5/1007'" tppabs="https://pediatrics.aappublications.org/content/128/5/1007" class="external text external">"ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents"</a>. <i>Pediatrics</i>. <b>128</b> (5): 1007–1022. doi:<a href="javascript:if(confirm('https://doi.org/10.1542%2Fpeds.2011-2654  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1542%2Fpeds.2011-2654'" tppabs="https://doi.org/10.1542%2Fpeds.2011-2654" class="external text external">10.1542/peds.2011-2654</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0031-4005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0031-4005'" tppabs="https://www.worldcat.org/issn/0031-4005" class="external text external">0031-4005</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500647  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500647'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500647" class="external text external">4500647</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22003063  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22003063'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22003063" class="external text external">22003063</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20190516150428/https://pediatrics.aappublications.org/content/128/5/1007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20190516150428/https://pediatrics.aappublications.org/content/128/5/1007'" tppabs="https://web.archive.org/web/20190516150428/https://pediatrics.aappublications.org/content/128/5/1007" class="external text external">Archived</a> from the original on 16 May 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">17 May</span> 2019</span>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite id="CITEREFGilmoreMilne2001" class="citation journal cs1">Gilmore A, Milne R (2001). "Methylphenidate in children with hyperactivity: review and cost-utility analysis". <i>Pharmacoepidemiol Drug Saf</i>. <b>10</b> (2): 85–94. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fpds.564  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fpds.564'" tppabs="https://doi.org/10.1002%2Fpds.564" class="external text external">10.1002/pds.564</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11499858  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11499858'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11499858" class="external text external">11499858</a>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFMottLeachJohnson2004" class="citation journal cs1">Mott TF, Leach L, Johnson L (2004). <a href="javascript:if(confirm('https://web.archive.org/web/20110713105514/http://www.jfponline.com/Pages.asp?AID=1753  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110713105514/http://www.jfponline.com/Pages.asp?AID=1753'" tppabs="https://web.archive.org/web/20110713105514/http://www.jfponline.com/Pages.asp?AID=1753" class="external text external">"Clinical inquiries. Is methylphenidate useful for treating adolescents with ADHD?"</a>. <i>The Journal of Family Practice</i>. <b>53</b> (8): 659–61. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15298843  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15298843'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15298843" class="external text external">15298843</a>. Archived from <a href="javascript:if(confirm('http://www.jfponline.com/Pages.asp?AID=1753  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.jfponline.com/Pages.asp?AID=1753'" tppabs="http://www.jfponline.com/Pages.asp?AID=1753" class="external text external">the original</a> on 13 July 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">30 April</span> 2009</span>.</cite></span></li><li id="cite_note-Millichap_3-20"> <span id="mw-reference-text-cite_note-Millichap_3-20" class="mw-reference-text"><cite id="CITEREFMillichap2010" class="citation book cs1">Millichap JG (2010). "Chapter 3: Medications for ADHD".  In Millichap, JG (ed.). <i>Attention Deficit Hyperactivity Disorder Handbook: A Physician's Guide to ADHD</i> (2nd ed.). New York: Springer. pp.<span>&nbsp;</span>111–113. ISBN<span>&nbsp;</span><bdi>9781441913968</bdi>.</cite></span></li><li id="cite_note-Long-Term_Outcomes_Medications-21"> <span id="mw-reference-text-cite_note-Long-Term_Outcomes_Medications-21" class="mw-reference-text"><cite id="CITEREFHuangTsai2011" class="citation journal cs1">Huang YS, Tsai MH (July 2011). "Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge". <i>CNS Drugs</i>. <b>25</b> (7): 539–554. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F11589380-000000000-00000  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F11589380-000000000-00000'" tppabs="https://doi.org/10.2165%2F11589380-000000000-00000" class="external text external">10.2165/11589380-000000000-00000</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21699268  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21699268'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21699268" class="external text external">21699268</a>.</cite></span></li><li id="cite_note-Millichap-22"> <span id="mw-reference-text-cite_note-Millichap-22" class="mw-reference-text"><cite class="citation book cs1">Millichap JG (2010). "Chapter 3: Medications for ADHD".  In Millichap, JG (ed.). <i>Attention Deficit Hyperactivity Disorder Handbook: A Physician's Guide to ADHD</i> (2nd ed.). New York: Springer. pp.<span>&nbsp;</span>121–123. ISBN<span>&nbsp;</span><bdi>9781441913968</bdi>.</cite></span></li><li id="cite_note-Cochrane2018-23"> <span id="mw-reference-text-cite_note-Cochrane2018-23" class="mw-reference-text"><cite id="CITEREFStorebøPedersenRamstadKielsholm2018" class="citation journal cs1">Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB,  et al. (2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554" class="external text external">"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies"</a>. <i>Cochrane Database Syst Rev</i> (Systematic Review). <b>5</b>: CD012069. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD012069.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD012069.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD012069.pub2" class="external text external">10.1002/14651858.CD012069.pub2</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554" class="external text external">6494554</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29744873  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29744873'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29744873" class="external text external">29744873</a>. <q>Our findings suggest that methylphenidate may be associated with a number of serious adverse events as well as a large number of non-serious adverse events in children. Concerning adverse events associated with the treatment, our systematic review of randomised clinical trials (RCTs) demonstrated no increase in serious adverse events, but a high proportion of participants suffered a range of non‐serious adverse events.</q></cite></span></li><li id="cite_note-pmid26599576-24"> <span id="mw-reference-text-cite_note-pmid26599576-24" class="mw-reference-text"><cite id="CITEREFStorebøRamstadKroghNilausen2015" class="citation journal cs1">Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C (November 2015). <a href="javascript:if(confirm('https://findresearcher.sdu.dk:8443/ws/files/129083195/Methylphenidate_for_children_and_adolescents_with_attention_deficit_hyperactivity_disorder_ADHD_.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://findresearcher.sdu.dk:8443/ws/files/129083195/Methylphenidate_for_children_and_adolescents_with_attention_deficit_hyperactivity_disorder_ADHD_.pdf'" tppabs="https://findresearcher.sdu.dk:8443/ws/files/129083195/Methylphenidate_for_children_and_adolescents_with_attention_deficit_hyperactivity_disorder_ADHD_.pdf" class="external text external">"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)"</a> <span class="cs1-format">(PDF)</span>. <i>Cochrane Database Syst Rev</i>. <b>11</b> (11): CD009885. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD009885.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD009885.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD009885.pub2" class="external text external">10.1002/14651858.CD009885.pub2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26599576  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26599576'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26599576" class="external text external">26599576</a>. <q>the low quality of the underpinning evidence means that we cannot be certain of the magnitude of the effects.</q></cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://list.essentialmeds.org/recommendations/1200  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://list.essentialmeds.org/recommendations/1200'" tppabs="https://list.essentialmeds.org/recommendations/1200" class="external text external">"eEML - Electronic Essential Medicines List"</a>. <i>list.essentialmeds.org</i><span class="reference-accessdate">. Retrieved <span class="nowrap">26 March</span> 2020</span>.</cite></span></li><li id="cite_note-ADHD-26"> <span id="mw-reference-text-cite_note-ADHD-26" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.webmd.com/add-adhd/childhood-adhd/stimulants-for-attention-deficit-hyperactivity-disorder  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.webmd.com/add-adhd/childhood-adhd/stimulants-for-attention-deficit-hyperactivity-disorder'" tppabs="http://www.webmd.com/add-adhd/childhood-adhd/stimulants-for-attention-deficit-hyperactivity-disorder" class="external text external">"Stimulants for Attention Deficit Hyperactivity Disorder"</a>. <i>WebMD</i>. Healthwise. 12 April 2010. <a href="javascript:if(confirm('https://web.archive.org/web/20131113004717/http://www.webmd.com/add-adhd/childhood-adhd/stimulants-for-attention-deficit-hyperactivity-disorder  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20131113004717/http://www.webmd.com/add-adhd/childhood-adhd/stimulants-for-attention-deficit-hyperactivity-disorder'" tppabs="https://web.archive.org/web/20131113004717/http://www.webmd.com/add-adhd/childhood-adhd/stimulants-for-attention-deficit-hyperactivity-disorder" class="external text external">Archived</a> from the original on 13 November 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">12 November</span> 2013</span>.</cite></span></li><li id="cite_note-WebMds_Review-27"> <span id="mw-reference-text-cite_note-WebMds_Review-27" class="mw-reference-text"><cite id="CITEREFGreenhillPliszkaDulcanBernet2002" class="citation journal cs1">Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S (February 2002). "Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults". <i>J. Am. Acad. Child Adolesc. Psychiatry</i>. <b>41</b> (2 Suppl): 26S–49S. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004583-200202001-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004583-200202001-00003'" tppabs="https://doi.org/10.1097%2F00004583-200202001-00003" class="external text external">10.1097/00004583-200202001-00003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11833633  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11833633'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11833633" class="external text external">11833633</a>.</cite></span></li><li id="cite_note-esmadhd18307377-28"> <span id="mw-reference-text-cite_note-esmadhd18307377-28" class="mw-reference-text"><cite id="CITEREFFaraoneWilens2007" class="citation journal cs1">Faraone SV, Wilens TE (2007). "Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion". <i>J Clin Psychiatry</i>. 68 Suppl 11 (11): 15–22. doi:<a href="javascript:if(confirm('https://doi.org/10.4088%2Fjcp.1107e28  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4088%2Fjcp.1107e28'" tppabs="https://doi.org/10.4088%2Fjcp.1107e28" class="external text external">10.4088/jcp.1107e28</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18307377  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18307377'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18307377" class="external text external">18307377</a>.</cite></span></li><li id="cite_note-dstadhd12509574-29"> <span id="mw-reference-text-cite_note-dstadhd12509574-29" class="mw-reference-text"><cite id="CITEREFWilensFaraoneBiedermanGunawardene2003" class="citation journal cs1">Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003). "Does Stimulant Therapy of Attention-Deficit/Hyperactivity Disorder Beget Later Substance Abuse? A Meta-analytic Review of the Literature". <i>Pediatrics</i>. <b>111</b> (1): 179–85. CiteSeerX<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.507.874  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.507.874'" tppabs="https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.507.874" class="external text external">10.1.1.507.874</a></span>. doi:<a href="javascript:if(confirm('https://doi.org/10.1542%2Fpeds.111.1.179  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1542%2Fpeds.111.1.179'" tppabs="https://doi.org/10.1542%2Fpeds.111.1.179" class="external text external">10.1542/peds.111.1.179</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12509574  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12509574'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12509574" class="external text external">12509574</a>.</cite></span></li><li id="cite_note-Abelman_68-30"> <span id="mw-reference-text-cite_note-Abelman_68-30" class="mw-reference-text"><cite id="CITEREFAbelman2017" class="citation journal cs1">Abelman DD (October 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639593'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639593" class="external text external">"Mitigating risks of students use of study drugs through understanding motivations for use and applying harm reduction theory: a literature review"</a>. <i>Harm Reduction Journal</i>. <b>14</b> (1): 68. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2Fs12954-017-0194-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2Fs12954-017-0194-6'" tppabs="https://doi.org/10.1186%2Fs12954-017-0194-6" class="external text external">10.1186/s12954-017-0194-6</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639593'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639593" class="external text external">5639593</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28985738  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28985738'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28985738" class="external text external">28985738</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFVitiello2001" class="citation journal cs1">Vitiello B (October 2001). <a href="javascript:if(confirm('https://semanticscholar.org/paper/7b921a206155401fc089da016b94d96ceba389a3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://semanticscholar.org/paper/7b921a206155401fc089da016b94d96ceba389a3'" tppabs="https://semanticscholar.org/paper/7b921a206155401fc089da016b94d96ceba389a3" class="external text external">"Psychopharmacology for young children: clinical needs and research opportunities"</a>. <i>Pediatrics</i>. <b>108</b> (4): 983–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1542%2Fpeds.108.4.983  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1542%2Fpeds.108.4.983'" tppabs="https://doi.org/10.1542%2Fpeds.108.4.983" class="external text external">10.1542/peds.108.4.983</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11581454  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11581454'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11581454" class="external text external">11581454</a>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite id="CITEREFHermensRoweGordonWilliams2006" class="citation journal cs1">Hermens DF, Rowe DL, Gordon E, Williams LM (2006). "Integrative neuroscience approach to predict ADHD stimulant response". <i>Expert Review of Neurotherapeutics</i>. <b>6</b> (5): 753–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2F14737175.6.5.753  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2F14737175.6.5.753'" tppabs="https://doi.org/10.1586%2F14737175.6.5.753" class="external text external">10.1586/14737175.6.5.753</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16734523  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16734523'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16734523" class="external text external">16734523</a>.</cite></span></li><li id="cite_note-Neinstein_2009_p.-33"> <span id="mw-reference-text-cite_note-Neinstein_2009_p.-33" class="mw-reference-text"><cite id="CITEREFNeinstein2009" class="citation book cs1">Neinstein L (2009). <i>Handbook of adolescent health care</i>. Philadelphia: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins. ISBN<span>&nbsp;</span><bdi>978-0-7817-9020-8</bdi>. OCLC<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/oclc/226304727  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/oclc/226304727'" tppabs="https://www.worldcat.org/oclc/226304727" class="external text external">226304727</a>.</cite></span></li><li id="cite_note-pmid9484423-34"> <span id="mw-reference-text-cite_note-pmid9484423-34" class="mw-reference-text"><cite id="CITEREFFry1998" class="citation journal cs1">Fry JM (February 1998). "Treatment modalities for narcolepsy". <i>Neurology</i>. <b>50</b> (2 Suppl 1): S43-8. doi:<a href="javascript:if(confirm('https://doi.org/10.1212%2FWNL.50.2_Suppl_1.S43  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1212%2FWNL.50.2_Suppl_1.S43'" tppabs="https://doi.org/10.1212%2FWNL.50.2_Suppl_1.S43" class="external text external">10.1212/WNL.50.2_Suppl_1.S43</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9484423  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9484423'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9484423" class="external text external">9484423</a>.</cite></span></li><li id="cite_note-pmid7701190-35"> <span id="mw-reference-text-cite_note-pmid7701190-35" class="mw-reference-text"><cite id="CITEREFMitler1994" class="citation journal cs1">Mitler MM (December 1994). <a href="javascript:if(confirm('https://doi.org/10.1093/sleep/17.suppl_8.S103  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/sleep/17.suppl_8.S103'" tppabs="https://doi.org/10.1093/sleep/17.suppl_8.S103" class="external text external">"Evaluation of treatment with stimulants in narcolepsy"</a>. <i>Sleep</i>. <b>17</b> (8 Suppl): S103-6. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fsleep%2F17.suppl_8.S103  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fsleep%2F17.suppl_8.S103'" tppabs="https://doi.org/10.1093%2Fsleep%2F17.suppl_8.S103" class="external text external">10.1093/sleep/17.suppl_8.S103</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7701190  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7701190'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7701190" class="external text external">7701190</a>.</cite></span></li><li id="cite_note-pmid25312027-36"> <span id="mw-reference-text-cite_note-pmid25312027-36" class="mw-reference-text"><cite id="CITEREFDell'OssoDobreaCremaschiArici2014" class="citation journal cs1">Dell'Osso B, Dobrea C, Cremaschi L, Arici C, Altamura AC (December 2014). "Wake-promoting pharmacotherapy for psychiatric disorders". <i>Curr Psychiatry Rep</i>. <b>16</b> (12): 524. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs11920-014-0524-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs11920-014-0524-2'" tppabs="https://doi.org/10.1007%2Fs11920-014-0524-2" class="external text external">10.1007/s11920-014-0524-2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25312027  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25312027'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25312027" class="external text external">25312027</a>.</cite></span></li><li id="cite_note-pmid15079851-37"> <span id="mw-reference-text-cite_note-pmid15079851-37" class="mw-reference-text"><cite id="CITEREFLeonardMcCartanWhiteKing2004" class="citation journal cs1">Leonard BE, McCartan D, White J, King DJ (2004). "Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects". <i>Hum Psychopharmacol</i>. <b>19</b> (3): 151–80. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fhup.579  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fhup.579'" tppabs="https://doi.org/10.1002%2Fhup.579" class="external text external">10.1002/hup.579</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15079851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15079851'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15079851" class="external text external">15079851</a>.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite id="CITEREFKrausBurch1992" class="citation journal cs1">Kraus MF, Burch EA (1992). "Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review". <i>South. Med. J</i>. <b>85</b> (10): 985–91. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00007611-199210000-00012  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00007611-199210000-00012'" tppabs="https://doi.org/10.1097%2F00007611-199210000-00012" class="external text external">10.1097/00007611-199210000-00012</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1411740  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1411740'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1411740" class="external text external">1411740</a>.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFSatelNelson1989" class="citation journal cs1">Satel SL, Nelson JC (1989). "Stimulants in the treatment of depression: a critical overview". <i>J Clin Psychiatry</i>. <b>50</b> (7): 241–9. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2567730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2567730'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2567730" class="external text external">2567730</a>.</cite></span></li><li id="cite_note-pmid11773187-40"> <span id="mw-reference-text-cite_note-pmid11773187-40" class="mw-reference-text"><cite id="CITEREFRozansDreisbachLertoraKahn2002" class="citation journal cs1">Rozans M, Dreisbach A, Lertora JJ, Kahn MJ (2002). "Palliative uses of methylphenidate in patients with cancer: a review". <i>J. Clin. Oncol</i>. <b>20</b> (1): 335–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1200%2FJCO.20.1.335  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1200%2FJCO.20.1.335'" tppabs="https://doi.org/10.1200%2FJCO.20.1.335" class="external text external">10.1200/JCO.20.1.335</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11773187  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11773187'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11773187" class="external text external">11773187</a>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite id="CITEREFRuthirakuhanHerrmannAbrahamChan2018" class="citation journal cs1">Ruthirakuhan, Myuri T.; Herrmann, Nathan; Abraham, Eleenor H.; Chan, Sarah; Lanctôt, Krista L. (4 May 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pubmed/29727467  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pubmed/29727467'" tppabs="https://www.ncbi.nlm.nih.gov/pubmed/29727467" class="external text external">"Pharmacological interventions for apathy in Alzheimer's disease"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>5</b>: CD012197. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD012197.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD012197.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD012197.pub2" class="external text external">10.1002/14651858.CD012197.pub2</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1469-493X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1469-493X'" tppabs="https://www.worldcat.org/issn/1469-493X" class="external text external">1469-493X</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494556  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494556'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494556" class="external text external">6494556</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29727467  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29727467'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29727467" class="external text external">29727467</a>.</cite></span></li><li id="cite_note-Unambiguous_PFC_D1_A2-42"> <span id="mw-reference-text-cite_note-Unambiguous_PFC_D1_A2-42" class="mw-reference-text"><cite id="CITEREFSpencerDevilbissBerridge2015" class="citation journal cs1">Spencer RC, Devilbiss DM, Berridge CW (June 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377121  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377121'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377121" class="external text external">"The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex"</a>. <i>Biol. Psychiatry</i>. <b>77</b> (11): 940–950. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.biopsych.2014.09.013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.biopsych.2014.09.013'" tppabs="https://doi.org/10.1016%2Fj.biopsych.2014.09.013" class="external text external">10.1016/j.biopsych.2014.09.013</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377121  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377121'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377121" class="external text external">4377121</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25499957  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25499957'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25499957" class="external text external">25499957</a>. <q>The procognitive actions of psychostimulants are only associated with low doses. Surprisingly, despite nearly 80 years of clinical use, the neurobiology of the procognitive actions of psychostimulants has only recently been systematically investigated. Findings from this research unambiguously demonstrate that the cognition-enhancing effects of psychostimulants involve the preferential elevation of catecholamines in the PFC and the subsequent activation of norepinephrine α2 and dopamine D1 receptors.<span>&nbsp;</span>... This differential modulation of PFC-dependent processes across dose appears to be associated with the differential involvement of noradrenergic α2 versus α1 receptors. Collectively, this evidence indicates that at low, clinically relevant doses, psychostimulants are devoid of the behavioral and neurochemical actions that define this class of drugs and instead act largely as cognitive enhancers (improving PFC-dependent function). This information has potentially important clinical implications as well as relevance for public health policy regarding the widespread clinical use of psychostimulants and for the development of novel pharmacologic treatments for attention-deficit/hyperactivity disorder and other conditions associated with PFC dysregulation.</q></cite></span></li><li id="cite_note-Cognitive_and_motivational_effects-43"> <span id="mw-reference-text-cite_note-Cognitive_and_motivational_effects-43" class="mw-reference-text"><cite id="CITEREFIlievaHookFarah2015" class="citation journal cs1">Ilieva IP, Hook CJ, Farah MJ (January 2015). <a href="javascript:if(confirm('https://repository.upenn.edu/neuroethics_pubs/130  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://repository.upenn.edu/neuroethics_pubs/130'" tppabs="https://repository.upenn.edu/neuroethics_pubs/130" class="external text external">"Prescription Stimulants' Effects on Healthy Inhibitory Control, Working Memory, and Episodic Memory: A Meta-analysis"</a>. <i>J. Cogn. Neurosci</i>. <b>27</b> (6): 1069–1089. doi:<a href="javascript:if(confirm('https://doi.org/10.1162%2Fjocn_a_00776  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1162%2Fjocn_a_00776'" tppabs="https://doi.org/10.1162%2Fjocn_a_00776" class="external text external">10.1162/jocn_a_00776</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25591060  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25591060'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25591060" class="external text external">25591060</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20180919111616/https://repository.upenn.edu/neuroethics_pubs/130/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20180919111616/https://repository.upenn.edu/neuroethics_pubs/130/'" tppabs="https://web.archive.org/web/20180919111616/https://repository.upenn.edu/neuroethics_pubs/130/" class="external text external">Archived</a> from the original on 19 September 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">14 November</span> 2018</span>. <q>Specifically, in a set of experiments limited to high-quality designs, we found significant enhancement of several cognitive abilities.<span>&nbsp;</span>... The results of this meta-analysis<span>&nbsp;</span>... do confirm the reality of cognitive enhancing effects for normal healthy adults in general, while also indicating that these effects are modest in size.</q></cite></span></li><li id="cite_note-Malenka_2009-44"> <span id="mw-reference-text-cite_note-Malenka_2009-44" class="mw-reference-text"><cite id="CITEREFMalenkaNestlerHyman2009" class="citation book cs1">Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 13: Higher Cognitive Function and Behavioral Control".  In Sydor A, Brown RY (eds.). <i>Molecular Neuropharmacology: A Foundation for Clinical Neuroscience</i> (2nd ed.). New York: McGraw-Hill Medical. p.<span>&nbsp;</span>318. ISBN<span>&nbsp;</span><bdi>9780071481274</bdi>. <q>Therapeutic (relatively low) doses of psychostimulants, such as methylphenidate and amphetamine, improve performance on working memory tasks both in normal subjects and those with ADHD. Positron emission tomography (PET) demonstrates that methylphenidate decreases regional cerebral blood flow in the doroslateral prefrontal cortex and posterior parietal cortex while improving performance of a spatial working memory task. This suggests that cortical networks that normally process spatial working memory become more efficient in response to the drug.<span>&nbsp;</span>... [It] is now believed that dopamine and norepinephrine, but not serotonin, produce the beneficial effects of stimulants on working memory. At abused (relatively high) doses, stimulants can interfere with working memory and cognitive control<span>&nbsp;</span>... stimulants act not only on working memory function, but also on general levels of arousal and, within the nucleus accumbens, improve the saliency of tasks. Thus, stimulants improve performance on effortful but tedious tasks<span>&nbsp;</span>... through indirect stimulation of dopamine and norepinephrine receptors.</q></cite></span></li><li id="cite_note-Continuum-45"> <span id="mw-reference-text-cite_note-Continuum-45" class="mw-reference-text"><cite id="CITEREFWoodSageShumanAnagnostaras2014" class="citation journal cs1">Wood S, Sage JR, Shuman T, Anagnostaras SG (January 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880463  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880463'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880463" class="external text external">"Psychostimulants and cognition: a continuum of behavioral and cognitive activation"</a>. <i>Pharmacol. Rev</i>. <b>66</b> (1): 193–221. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fpr.112.007054  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fpr.112.007054'" tppabs="https://doi.org/10.1124%2Fpr.112.007054" class="external text external">10.1124/pr.112.007054</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880463  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880463'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880463" class="external text external">3880463</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24344115  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24344115'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24344115" class="external text external">24344115</a>.</cite></span></li><li id="cite_note-46"> <span id="mw-reference-text-cite_note-46" class="mw-reference-text"><cite id="CITEREFAgayYechiamCarmelLevkovitz2010" class="citation journal cs1">Agay N, Yechiam E, Carmel Z, Levkovitz Y (2010). "Non-specific effects of Methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adult". <i>Psychopharmacology</i>. <b>210</b> (4): 511–519. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00213-010-1853-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00213-010-1853-4'" tppabs="https://doi.org/10.1007%2Fs00213-010-1853-4" class="external text external">10.1007/s00213-010-1853-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20424828  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20424828'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20424828" class="external text external">20424828</a>.</cite></span></li><li id="cite_note-47"> <span id="mw-reference-text-cite_note-47" class="mw-reference-text"><cite id="CITEREFTwohey2006" class="citation web cs1">Twohey M (26 March 2006). <a href="javascript:if(confirm('https://web.archive.org/web/20070815200239/http://www.jsonline.com/story/index.aspx?id=410902  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070815200239/http://www.jsonline.com/story/index.aspx?id=410902'" tppabs="https://web.archive.org/web/20070815200239/http://www.jsonline.com/story/index.aspx?id=410902" class="external text external">"Pills become an addictive study aid"</a>. <i>JS Online</i>. Archived from <a href="javascript:if(confirm('http://www.jsonline.com/story/index.aspx?id=410902  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.jsonline.com/story/index.aspx?id=410902'" tppabs="http://www.jsonline.com/story/index.aspx?id=410902" class="external text external">the original</a> on 15 August 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">2 December</span> 2007</span>.</cite></span></li><li id="cite_note-pmid16999660-48"> <span id="mw-reference-text-cite_note-pmid16999660-48" class="mw-reference-text"><cite id="CITEREFTeterMcCabeLaGrangeCranford2006" class="citation journal cs1">Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ (October 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794223  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794223'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794223" class="external text external">"Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration"</a>. <i>Pharmacotherapy</i>. <b>26</b> (10): 1501–1510. doi:<a href="javascript:if(confirm('https://doi.org/10.1592%2Fphco.26.10.1501  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1592%2Fphco.26.10.1501'" tppabs="https://doi.org/10.1592%2Fphco.26.10.1501" class="external text external">10.1592/phco.26.10.1501</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794223  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794223'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794223" class="external text external">1794223</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16999660  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16999660'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16999660" class="external text external">16999660</a>.</cite></span></li><li id="cite_note-Roelands_2013-49"> <span id="mw-reference-text-cite_note-Roelands_2013-49" class="mw-reference-text"><cite id="CITEREFRoelandsde_KoningFosterHettinga2013" class="citation journal cs1">Roelands B, de Koning J, Foster C, Hettinga F, Meeusen R (May 2013). "Neurophysiological determinants of theoretical concepts and mechanisms involved in pacing". <i>Sports Med</i>. <b>43</b> (5): 301–311. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40279-013-0030-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40279-013-0030-4'" tppabs="https://doi.org/10.1007%2Fs40279-013-0030-4" class="external text external">10.1007/s40279-013-0030-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23456493  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23456493'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23456493" class="external text external">23456493</a>.</cite></span></li><li id="cite_note-FDA_Daytrana_2015-50"> <span id="mw-reference-text-cite_note-FDA_Daytrana_2015-50" class="mw-reference-text"><cite id="CITEREFNoven_Pharmaceuticals,_Inc.2015" class="citation web cs1">Noven Pharmaceuticals, Inc. (17 April 2015). <a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021514s022lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021514s022lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021514s022lbl.pdf" class="external text external">"Daytrana Prescribing Information"</a> <span class="cs1-format">(PDF)</span>. United States Food and Drug Administration. pp.<span>&nbsp;</span>1–33. <a href="javascript:if(confirm('https://web.archive.org/web/20150623073946/http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021514s022lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150623073946/http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021514s022lbl.pdf'" tppabs="https://web.archive.org/web/20150623073946/http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021514s022lbl.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 23 June 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">23 June</span> 2015</span>.</cite></span></li><li id="cite_note-FDA_approved_package_insert-51"> <span id="mw-reference-text-cite_note-FDA_approved_package_insert-51" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021514s017lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021514s017lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021514s017lbl.pdf" class="external text external">"DAYTRANA"</a> <span class="cs1-format">(PDF)</span>. <i>United States Food and Drug Administration</i>. Noven Pharmaceuticals, Inc. October 2013. <a href="javascript:if(confirm('https://web.archive.org/web/20140714205415/http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021514s017lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140714205415/http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021514s017lbl.pdf'" tppabs="https://web.archive.org/web/20140714205415/http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021514s017lbl.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 14 July 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">13 June</span> 2014</span>.</cite></span></li><li id="cite_note-52"> <span id="mw-reference-text-cite_note-52" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20180102005138/https://www.drugs.com/pregnancy/methylphenidate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20180102005138/https://www.drugs.com/pregnancy/methylphenidate.html'" tppabs="https://web.archive.org/web/20180102005138/https://www.drugs.com/pregnancy/methylphenidate.html" class="external text external">"Methylphenidate: Use During Pregnancy and Breastfeeding"</a>. <i>Drugs.com</i>. Archived from <a href="javascript:if(confirm('https://www.drugs.com/pregnancy/methylphenidate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/methylphenidate.html'" tppabs="https://www.drugs.com/pregnancy/methylphenidate.html" class="external text external">the original</a> on 2 January 2018.</cite></span></li><li id="cite_note-53"> <span id="mw-reference-text-cite_note-53" class="mw-reference-text"><cite id="CITEREFHumphreysGarcia-BournissenItoKoren2007" class="citation journal cs1">Humphreys C, Garcia-Bournissen F, Ito S, Koren G (2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1949295  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1949295'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1949295" class="external text external">"Exposure to attention deficit hyperactivity disorder medications during pregnancy"</a>. <i>Canadian Family Physician</i>. <b>53</b> (7): 1153–5. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1949295  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1949295'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1949295" class="external text external">1949295</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17872810  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17872810'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17872810" class="external text external">17872810</a>.</cite></span></li><li id="cite_note-54"> <span id="mw-reference-text-cite_note-54" class="mw-reference-text"><cite id="CITEREFOrnoy2018" class="citation journal cs1">Ornoy, Asher (6 February 2018). "Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation". <i>Pharmaceutical Research</i>. <b>35</b> (3): 46. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs11095-017-2323-z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs11095-017-2323-z'" tppabs="https://doi.org/10.1007%2Fs11095-017-2323-z" class="external text external">10.1007/s11095-017-2323-z</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29411149  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29411149'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29411149" class="external text external">29411149</a>.</cite></span></li><li id="cite_note-55"> <span id="mw-reference-text-cite_note-55" class="mw-reference-text"><cite id="CITEREFNuttKingSaulsburyBlakemore2007" class="citation journal cs1">Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). "Development of a rational scale to assess the harm of drugs of potential misuse". <i>Lancet</i>. <b>369</b> (9566): 1047–53. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2807%2960464-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2807%2960464-4'" tppabs="https://doi.org/10.1016%2FS0140-6736%2807%2960464-4" class="external text external">10.1016/S0140-6736(07)60464-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17382831  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17382831'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17382831" class="external text external">17382831</a>.</cite></span></li><li id="cite_note-Ritalin_Rx_info-56"> <span id="mw-reference-text-cite_note-Ritalin_Rx_info-56" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20110720004745/http://www.pharma.us.novartis.com/product/pi/pdf/ritalin_la.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110720004745/http://www.pharma.us.novartis.com/product/pi/pdf/ritalin_la.pdf'" tppabs="https://web.archive.org/web/20110720004745/http://www.pharma.us.novartis.com/product/pi/pdf/ritalin_la.pdf" class="external text external">"Ritalin<span>&nbsp;</span>LA® (methylphenidate hydrochloride) extended-release capsules"</a> <span class="cs1-format">(PDF)</span>. Novartis. Archived from <a href="javascript:if(confirm('http://www.pharma.us.novartis.com/product/pi/pdf/ritalin_la.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pharma.us.novartis.com/product/pi/pdf/ritalin_la.pdf'" tppabs="http://www.pharma.us.novartis.com/product/pi/pdf/ritalin_la.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 20 July 2011.</cite></span></li><li id="cite_note-57"> <span id="mw-reference-text-cite_note-57" class="mw-reference-text"><cite id="CITEREFJaanus1992" class="citation journal cs1">Jaanus SD (1992). "Ocular side effects of selected systemic drugs". <i>Optometry Clinics</i>. <b>2</b> (4): 73–96. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1363080  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1363080'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1363080" class="external text external">1363080</a>.</cite></span></li><li id="cite_note-pmid23294014-58"> <span id="mw-reference-text-cite_note-pmid23294014-58" class="mw-reference-text"><cite id="CITEREFCorteseHoltmannBanaschewskiBuitelaar2013" class="citation journal cs1">Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M,  et al. (March 2013). "Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents". <i>Journal of Child Psychology and Psychiatry, and Allied Disciplines</i>. <b>54</b> (3): 227–46. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fjcpp.12036  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fjcpp.12036'" tppabs="https://doi.org/10.1111%2Fjcpp.12036" class="external text external">10.1111/jcpp.12036</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23294014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23294014'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23294014" class="external text external">23294014</a>.</cite></span></li><li id="cite_note-59"> <span id="mw-reference-text-cite_note-59" class="mw-reference-text"><cite id="CITEREFPoulton2005" class="citation journal cs1">Poulton A (August 2005). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720538  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720538'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720538" class="external text external">"Growth on stimulant medication; clarifying the confusion: a review"</a>. <i>Archives of Disease in Childhood</i>. <b>90</b> (8): 801–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fadc.2004.056952  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fadc.2004.056952'" tppabs="https://doi.org/10.1136%2Fadc.2004.056952" class="external text external">10.1136/adc.2004.056952</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720538  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720538'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720538" class="external text external">1720538</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16040876  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16040876'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16040876" class="external text external">16040876</a>.</cite></span></li><li id="cite_note-60"> <span id="mw-reference-text-cite_note-60" class="mw-reference-text"><cite id="CITEREFHinshawArnold2015" class="citation journal cs1">Hinshaw SP, Arnold LE (January 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280855  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280855'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280855" class="external text external">"ADHD, Multimodal Treatment, and Longitudinal Outcome: Evidence, Paradox, and Challenge"</a>. <i>Wiley Interdisciplinary Reviews. Cognitive Science</i>. <b>6</b> (1): 39–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fwcs.1324  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fwcs.1324'" tppabs="https://doi.org/10.1002%2Fwcs.1324" class="external text external">10.1002/wcs.1324</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280855  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280855'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280855" class="external text external">4280855</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25558298  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25558298'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25558298" class="external text external">25558298</a>.</cite></span></li><li id="cite_note-61"> <span id="mw-reference-text-cite_note-61" class="mw-reference-text"><cite id="CITEREFFindlingDinh2014" class="citation journal cs1">Findling RL, Dinh S (March 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933749  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933749'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933749" class="external text external">"Transdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS)"</a>. <i>CNS Drugs</i>. <b>28</b> (3): 217–28. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40263-014-0141-y  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40263-014-0141-y'" tppabs="https://doi.org/10.1007%2Fs40263-014-0141-y" class="external text external">10.1007/s40263-014-0141-y</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933749  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933749'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933749" class="external text external">3933749</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24532028  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24532028'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24532028" class="external text external">24532028</a>.</cite></span></li><li id="cite_note-pmid20571380-62"> <span id="mw-reference-text-cite_note-pmid20571380-62" class="mw-reference-text"><cite id="CITEREFKraemerUekermannWiltfangKis2010" class="citation journal cs1">Kraemer M, Uekermann J, Wiltfang J, Kis B (July 2010). "Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature". <i>Clinical Neuropharmacology</i>. <b>33</b> (4): 204–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FWNF.0b013e3181e29174  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FWNF.0b013e3181e29174'" tppabs="https://doi.org/10.1097%2FWNF.0b013e3181e29174" class="external text external">10.1097/WNF.0b013e3181e29174</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20571380  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20571380'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20571380" class="external text external">20571380</a>.</cite></span></li><li id="cite_note-63"> <span id="mw-reference-text-cite_note-63" class="mw-reference-text"><cite id="CITEREFWingoGhaemi2008" class="citation journal cs1">Wingo AP, Ghaemi SN (2008). "Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder patients". <i>Psychopharmacology Bulletin</i>. <b>41</b> (4): 37–47. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19015628  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19015628'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19015628" class="external text external">19015628</a>.</cite></span></li><li id="cite_note-FDA-64"> <span id="mw-reference-text-cite_note-FDA-64" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm378876.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm378876.htm'" tppabs="https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm378876.htm" class="external text external">"Methylphenidate ADHD Medications: Drug Safety Communication – Risk of Long-lasting Erections"</a>. <i>U.S. Food and Drug Administration</i>. 17 December 2013. <a href="javascript:if(confirm('https://web.archive.org/web/20131217225515/https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm378876.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20131217225515/https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm378876.htm'" tppabs="https://web.archive.org/web/20131217225515/https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm378876.htm" class="external text external">Archived</a> from the original on 17 December 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">17 December</span> 2013</span>.</cite></span></li><li id="cite_note-65"> <span id="mw-reference-text-cite_note-65" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/Drugs/DrugSafety/ucm277770.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/DrugSafety/ucm277770.htm'" tppabs="https://www.fda.gov/Drugs/DrugSafety/ucm277770.htm" class="external text external">"FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults"</a>. <i>United States Food and Drug Administration</i>. 20 December 2011. <a href="javascript:if(confirm('https://web.archive.org/web/20131030042927/https://www.fda.gov/Drugs/DrugSafety/ucm277770.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20131030042927/https://www.fda.gov/Drugs/DrugSafety/ucm277770.htm'" tppabs="https://web.archive.org/web/20131030042927/https://www.fda.gov/Drugs/DrugSafety/ucm277770.htm" class="external text external">Archived</a> from the original on 30 October 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">4 November</span> 2013</span>.</cite><br>• <cite id="CITEREFCooperHabelSoxChan2011" class="citation journal cs1">Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA (November 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943074  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943074'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943074" class="external text external">"ADHD drugs and serious cardiovascular events in children and young adults"</a>. <i>N. Engl. J. Med</i>. <b>365</b> (20): 1896–1904. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa1110212  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa1110212'" tppabs="https://doi.org/10.1056%2FNEJMoa1110212" class="external text external">10.1056/NEJMoa1110212</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943074  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943074'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943074" class="external text external">4943074</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22043968  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22043968'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22043968" class="external text external">22043968</a>.</cite><br>• <cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/Drugs/DrugSafety/ucm279858.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/DrugSafety/ucm279858.htm'" tppabs="https://www.fda.gov/Drugs/DrugSafety/ucm279858.htm" class="external text external">"FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults"</a>. <i>United States Food and Drug Administration</i>. 15 December 2011. <a href="javascript:if(confirm('https://web.archive.org/web/20131030064843/https://www.fda.gov/Drugs/DrugSafety/ucm279858.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20131030064843/https://www.fda.gov/Drugs/DrugSafety/ucm279858.htm'" tppabs="https://web.archive.org/web/20131030064843/https://www.fda.gov/Drugs/DrugSafety/ucm279858.htm" class="external text external">Archived</a> from the original on 30 October 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">4 November</span> 2013</span>.</cite><br>• <cite id="CITEREFHabelCooperSoxChan2011" class="citation journal cs1">Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV (December 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350308  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350308'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350308" class="external text external">"ADHD medications and risk of serious cardiovascular events in young and middle-aged adults"</a>. <i>JAMA</i>. <b>306</b> (24): 2673–2683. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.2011.1830  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.2011.1830'" tppabs="https://doi.org/10.1001%2Fjama.2011.1830" class="external text external">10.1001/jama.2011.1830</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350308  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350308'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350308" class="external text external">3350308</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22161946  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22161946'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22161946" class="external text external">22161946</a>.</cite></span></li><li id="cite_note-66"> <span id="mw-reference-text-cite_note-66" class="mw-reference-text"><cite id="CITEREFGordon1999" class="citation journal cs1">Gordon N (1999). "Attention deficit hyperactivity disorder: possible causes and treatment". <i>International Journal of Clinical Practice</i>. <b>53</b> (7): 524–8. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10692738  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10692738'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10692738" class="external text external">10692738</a>.</cite></span></li><li id="cite_note-67"> <span id="mw-reference-text-cite_note-67" class="mw-reference-text"><cite class="citation journal cs1">Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB,  et al. (May 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554" class="external text external">"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>5</b>: CD012069. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD012069.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD012069.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD012069.pub2" class="external text external">10.1002/14651858.CD012069.pub2</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554" class="external text external">6494554</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29744873  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29744873'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29744873" class="external text external">29744873</a>.</cite></span></li><li id="cite_note-MPH_INCHEM-68"> <span id="mw-reference-text-cite_note-MPH_INCHEM-68" class="mw-reference-text"><cite id="CITEREFHeedesAilakis" class="citation web cs1">Heedes G, Ailakis J. <a href="javascript:if(confirm('http://www.inchem.org/documents/pims/pharm/pim344.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.inchem.org/documents/pims/pharm/pim344.htm'" tppabs="http://www.inchem.org/documents/pims/pharm/pim344.htm" class="external text external">"Methylphenidate hydrochloride (PIM 344)"</a>. <i>INCHEM</i>. International Programme on Chemical Safety. <a href="javascript:if(confirm('https://web.archive.org/web/20150623102325/http://www.inchem.org/documents/pims/pharm/pim344.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150623102325/http://www.inchem.org/documents/pims/pharm/pim344.htm'" tppabs="https://web.archive.org/web/20150623102325/http://www.inchem.org/documents/pims/pharm/pim344.htm" class="external text external">Archived</a> from the original on 23 June 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">23 June</span> 2015</span>.</cite></span></li><li id="cite_note-ADHD_toxidrome-69"> <span id="mw-reference-text-cite_note-ADHD_toxidrome-69" class="mw-reference-text"><cite id="CITEREFSpillerHaysAleguas2013" class="citation journal cs1">Spiller HA, Hays HL, Aleguas A (June 2013). "Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management". <i>CNS Drugs</i>. <b>27</b> (7): 531–543. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40263-013-0084-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40263-013-0084-8'" tppabs="https://doi.org/10.1007%2Fs40263-013-0084-8" class="external text external">10.1007/s40263-013-0084-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23757186  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23757186'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23757186" class="external text external">23757186</a>. <q>The management of amphetamine, dextroamphetamine, and methylphenidate overdose is largely supportive, with a focus on interruption of the sympathomimetic syndrome with judicious use of benzodiazepines. In cases where agitation, delirium, and movement disorders are unresponsive to benzodiazepines, second-line therapies include antipsychotics such as ziprasidone or haloperidol, central alpha-adrenoreceptor agonists such as dexmedetomidine, or propofol.<span>&nbsp;</span>... However, fatalities are rare with appropriate care</q></cite></span></li><li id="cite_note-pmid21984207-70"> <span id="mw-reference-text-cite_note-pmid21984207-70" class="mw-reference-text"><cite id="CITEREFBruggisserBodmerLiechti2011" class="citation journal cs1">Bruggisser M, Bodmer M, Liechti ME (2011). <a href="javascript:if(confirm('https://doi.org/10.4414/smw.2011.13267  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4414/smw.2011.13267'" tppabs="https://doi.org/10.4414/smw.2011.13267" class="external text external">"Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets"</a>. <i>Swiss Med Wkly</i>. <b>141</b>: w13267. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.4414%2Fsmw.2011.13267  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4414%2Fsmw.2011.13267'" tppabs="https://doi.org/10.4414%2Fsmw.2011.13267" class="external text external">10.4414/smw.2011.13267</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21984207  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21984207'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21984207" class="external text external">21984207</a>.</cite></span></li><li id="cite_note-pmid11572966-71"> <span id="mw-reference-text-cite_note-pmid11572966-71" class="mw-reference-text"><cite id="CITEREFNestlerBarrotSelf2001" class="citation journal cs1">Nestler EJ, Barrot M, Self DW (September 2001). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC58680  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC58680'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC58680" class="external text external">"DeltaFosB: a sustained molecular switch for addiction"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>98</b> (20): 11042–6. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2001PNAS...9811042N  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2001PNAS...9811042N'" tppabs="https://ui.adsabs.harvard.edu/abs/2001PNAS...9811042N" class="external text external">2001PNAS...9811042N</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.191352698  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.191352698'" tppabs="https://doi.org/10.1073%2Fpnas.191352698" class="external text external">10.1073/pnas.191352698</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC58680  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC58680'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC58680" class="external text external">58680</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11572966  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11572966'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11572966" class="external text external">11572966</a>. <q>Although the ΔFosB signal is relatively long-lived, it is not permanent. ΔFosB degrades gradually and can no longer be detected in brain after 1–2 months of drug withdrawal<span>&nbsp;</span>... Indeed, ΔFosB is the longest-lived adaptation known to occur in adult brain, not only in response to drugs of abuse, but to any other perturbation (that doesn't involve lesions) as well.</q></cite></span></li><li id="cite_note-Nestler2-72"> <span id="mw-reference-text-cite_note-Nestler2-72" class="mw-reference-text"><cite id="CITEREFNestler2012" class="citation journal cs1">Nestler EJ (December 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569166  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569166'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569166" class="external text external">"Transcriptional mechanisms of drug addiction"</a>. <i>Clinical Psychopharmacology and Neuroscience</i>. <b>10</b> (3): 136–43. doi:<a href="javascript:if(confirm('https://doi.org/10.9758%2Fcpn.2012.10.3.136  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.9758%2Fcpn.2012.10.3.136'" tppabs="https://doi.org/10.9758%2Fcpn.2012.10.3.136" class="external text external">10.9758/cpn.2012.10.3.136</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569166  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569166'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569166" class="external text external">3569166</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23430970  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23430970'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23430970" class="external text external">23430970</a>. <q>The 35–37 kD ΔFosB isoforms accumulate with chronic drug exposure due to their extraordinarily long half-lives.<span>&nbsp;</span>... As a result of its stability, the ΔFosB protein persists in neurons for at least several weeks after cessation of drug exposure.<span>&nbsp;</span>... ΔFosB overexpression in nucleus accumbens induces NFκB</q></cite></span></li><li id="cite_note-pmid15014637-73"> <span id="mw-reference-text-cite_note-pmid15014637-73" class="mw-reference-text"><cite id="CITEREFMortonStockton2000" class="citation journal cs1">Morton WA, Stockton GG (2000). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181133  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181133'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181133" class="external text external">"Methylphenidate Abuse and Psychiatric Side Effects"</a>. <i>Prim Care Companion J Clin Psychiatry</i>. <b>2</b> (5): 159–164. doi:<a href="javascript:if(confirm('https://doi.org/10.4088%2FPCC.v02n0502  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4088%2FPCC.v02n0502'" tppabs="https://doi.org/10.4088%2FPCC.v02n0502" class="external text external">10.4088/PCC.v02n0502</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181133  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181133'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181133" class="external text external">181133</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15014637  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15014637'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15014637" class="external text external">15014637</a>.</cite></span></li><li id="cite_note-MPH_-_addiction-74"> <span id="mw-reference-text-cite_note-MPH_-_addiction-74" class="mw-reference-text"><cite class="citation book cs1">Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 15: Reinforcement and Addictive Disorders".  In Sydor A, Brown RY (eds.). <i>Molecular Neuropharmacology: A Foundation for Clinical Neuroscience</i> (2nd ed.). New York: McGraw-Hill Medical. p.<span>&nbsp;</span>368. ISBN<span>&nbsp;</span><bdi>9780071481274</bdi>. <q>Cocaine, [amphetamine], and methamphetamine are the major psychostimulants of abuse. The related drug methylphenidate is also abused, although it is far less potent. These drugs elicit similar initial subjective effects<span>&nbsp;</span>; differences generally reflect the route of administration and other pharmacokinetic factors. Such agents also have important therapeutic uses; cocaine, for example, is used as a local anesthetic (Chapter 2), and amphetamines and methylphenidate are used in low doses to treat attention deficit hyperactivity disorder and in higher doses to treat narcolepsy (Chapter 12). Despite their clinical uses, these drugs are strongly reinforcing, and their long-term use at high doses is linked with potential addiction, especially when they are rapidly administered or when high-potency forms are given.</q></cite></span></li><li id="cite_note-Addiction_genetics-75"> <span id="mw-reference-text-cite_note-Addiction_genetics-75" class="mw-reference-text"><cite id="CITEREFSteinerVan_Waes2013" class="citation journal cs1">Steiner H, Van Waes V (January 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525776  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525776'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525776" class="external text external">"Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants"</a>. <i>Prog. Neurobiol</i>. <b>100</b>: 60–80. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.pneurobio.2012.10.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.pneurobio.2012.10.001'" tppabs="https://doi.org/10.1016%2Fj.pneurobio.2012.10.001" class="external text external">10.1016/j.pneurobio.2012.10.001</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525776  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525776'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525776" class="external text external">3525776</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23085425  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23085425'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23085425" class="external text external">23085425</a>.</cite></span></li><li id="cite_note-76"> <span id="mw-reference-text-cite_note-76" class="mw-reference-text"><cite id="CITEREFAugerGoodmanSilberKrahn2005" class="citation journal cs1">Auger RR, Goodman SH, Silber MH, Krahn LE, Pankratz VS, Slocumb NL (2005). <a href="javascript:if(confirm('https://doi.org/10.1093/sleep/28.6.667  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/sleep/28.6.667'" tppabs="https://doi.org/10.1093/sleep/28.6.667" class="external text external">"Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study"</a>. <i>Sleep</i>. <b>28</b> (6): 667–72. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fsleep%2F28.6.667  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fsleep%2F28.6.667'" tppabs="https://doi.org/10.1093%2Fsleep%2F28.6.667" class="external text external">10.1093/sleep/28.6.667</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16477952  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16477952'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16477952" class="external text external">16477952</a>.</cite></span></li><li id="cite_note-MPH_ΔFosB-77"> <span id="mw-reference-text-cite_note-MPH_ΔFosB-77" class="mw-reference-text"><cite id="CITEREFKimTeylanBaronSands2009" class="citation journal cs1">Kim Y, Teylan MA, Baron M, Sands A, Nairn AC, Greengard P (2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650365  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650365'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650365" class="external text external">"Methylphenidate-induced dendritic spine formation and DeltaFosB expression in nucleus accumbens"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>106</b> (8): 2915–20. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2009PNAS..106.2915K  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2009PNAS..106.2915K'" tppabs="https://ui.adsabs.harvard.edu/abs/2009PNAS..106.2915K" class="external text external">2009PNAS..106.2915K</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.0813179106  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.0813179106'" tppabs="https://doi.org/10.1073%2Fpnas.0813179106" class="external text external">10.1073/pnas.0813179106</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650365  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650365'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650365" class="external text external">2650365</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19202072  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19202072'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19202072" class="external text external">19202072</a>. <q>Despite decades of clinical use of methylphenidate for ADHD, concerns have been raised that long-term treatment of children with this medication may result in subsequent drug abuse and addiction. However, meta analysis of available data suggests that treatment of ADHD with stimulant drugs may have a significant protective effect, reducing the risk for addictive substance use (36, 37). Studies with juvenile rats have also indicated that repeated exposure to methylphenidate does not necessarily lead to enhanced drug-seeking behavior in adulthood (38). However, the recent increase of methylphenidate use as a cognitive enhancer by the general public has again raised concerns because of its potential for abuse and addiction (3, 6–10). Thus, although oral administration of clinical doses of methylphenidate is not associated with euphoria or with abuse problems, nontherapeutic use of high doses or i.v. administration may lead to addiction (39, 40).</q></cite></span></li><li id="cite_note-78"> <span id="mw-reference-text-cite_note-78" class="mw-reference-text"><cite id="CITEREFElkashefVocciHansonWhite2008" class="citation journal cs1">Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J (2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597382  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597382'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597382" class="external text external">"Pharmacotherapy of methamphetamine addiction: an update"</a>. <i>Substance Abuse</i>. <b>29</b> (3): 31–49. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F08897070802218554  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F08897070802218554'" tppabs="https://doi.org/10.1080%2F08897070802218554" class="external text external">10.1080/08897070802218554</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597382  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597382'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597382" class="external text external">2597382</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19042205  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19042205'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19042205" class="external text external">19042205</a>.</cite></span></li><li id="cite_note-pmid9408812-79"> <span id="mw-reference-text-cite_note-pmid9408812-79" class="mw-reference-text"><cite id="CITEREFGrabowskiRoacheSchmitzRhoades1997" class="citation journal cs1">Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A (December 1997). "Replacement medication for cocaine dependence: methylphenidate". <i>Journal of Clinical Psychopharmacology</i>. <b>17</b> (6): 485–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004714-199712000-00008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004714-199712000-00008'" tppabs="https://doi.org/10.1097%2F00004714-199712000-00008" class="external text external">10.1097/00004714-199712000-00008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9408812  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9408812'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9408812" class="external text external">9408812</a>.</cite></span></li><li id="cite_note-80"> <span id="mw-reference-text-cite_note-80" class="mw-reference-text"><cite id="CITEREFGorelickGardnerXi2004" class="citation journal cs1">Gorelick DA, Gardner EL, Xi ZX (2004). <a href="javascript:if(confirm('https://zenodo.org/record/1236415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/1236415'" tppabs="https://zenodo.org/record/1236415" class="external text external">"Agents in development for the management of cocaine abuse"</a>. <i>Drugs</i>. <b>64</b> (14): 1547–73. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200464140-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200464140-00004'" tppabs="https://doi.org/10.2165%2F00003495-200464140-00004" class="external text external">10.2165/00003495-200464140-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15233592  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15233592'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15233592" class="external text external">15233592</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20190701002920/https://zenodo.org/record/1236415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20190701002920/https://zenodo.org/record/1236415'" tppabs="https://web.archive.org/web/20190701002920/https://zenodo.org/record/1236415" class="external text external">Archived</a> from the original on 1 July 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2019</span>.</cite></span></li><li id="cite_note-81"> <span id="mw-reference-text-cite_note-81" class="mw-reference-text"><cite id="CITEREFKarilaGorelickWeinsteinNoble2008" class="citation journal cs1">Karila L, Gorelick D, Weinstein A, Noble F, Benyamina A, Coscas S,  et al. (May 2008). <a href="javascript:if(confirm('https://doi.org/10.1017/S1461145707008097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1017/S1461145707008097'" tppabs="https://doi.org/10.1017/S1461145707008097" class="external text external">"New treatments for cocaine dependence: a focused review"</a>. <i>The International Journal of Neuropsychopharmacology</i>. <b>11</b> (3): 425–38. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1017%2FS1461145707008097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1017%2FS1461145707008097'" tppabs="https://doi.org/10.1017%2FS1461145707008097" class="external text external">10.1017/S1461145707008097</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17927843  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17927843'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17927843" class="external text external">17927843</a>.</cite></span></li><li id="cite_note-82"> <span id="mw-reference-text-cite_note-82" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20101215101803/http://drugabuse.gov/PDF/InfoFacts/Understanding08.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20101215101803/http://drugabuse.gov/PDF/InfoFacts/Understanding08.pdf'" tppabs="https://web.archive.org/web/20101215101803/http://drugabuse.gov/PDF/InfoFacts/Understanding08.pdf" class="external text external">"NIDA InfoFacts: Understanding Drug Abuse and Addiction"</a> <span class="cs1-format">(PDF)</span>. 2008. Archived from <a href="javascript:if(confirm('http://www.drugabuse.gov/PDF/InfoFacts/Understanding08.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.drugabuse.gov/PDF/InfoFacts/Understanding08.pdf'" tppabs="http://www.drugabuse.gov/PDF/InfoFacts/Understanding08.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 15 December 2010.</cite></span></li><li id="cite_note-83"> <span id="mw-reference-text-cite_note-83" class="mw-reference-text"><cite id="CITEREFShearer2008" class="citation journal cs1">Shearer J (May 2008). "The principles of agonist pharmacotherapy for psychostimulant dependence". <i>Drug and Alcohol Review</i>. <b>27</b> (3): 301–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F09595230801927372  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F09595230801927372'" tppabs="https://doi.org/10.1080%2F09595230801927372" class="external text external">10.1080/09595230801927372</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18368612  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18368612'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18368612" class="external text external">18368612</a>.</cite></span></li><li id="cite_note-Cellular_basis-84"> <span id="mw-reference-text-cite_note-Cellular_basis-84" class="mw-reference-text"><cite id="CITEREFNestler2013" class="citation journal cs1">Nestler EJ (December 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898681  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898681'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898681" class="external text external">"Cellular basis of memory for addiction"</a>. <i>Dialogues in Clinical Neuroscience</i>. <b>15</b> (4): 431–43. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898681  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898681'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898681" class="external text external">3898681</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24459410  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24459410'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24459410" class="external text external">24459410</a>. <q><em>Despite the importance of numerous psychosocial factors, at its core, drug addiction involves a biological process</em>: the ability of repeated exposure to a drug of abuse to induce changes in a vulnerable brain that drive the compulsive seeking and taking of drugs, and loss of control over drug use, that define a state of addiction.<span>&nbsp;</span>... A large body of literature has demonstrated that such ΔFosB induction in D1-type NAc neurons increases an animal's sensitivity to drug as well as natural rewards and promotes drug self-administration, presumably through a process of positive reinforcement<span>&nbsp;</span>... Another ΔFosB target is cFos: as ΔFosB accumulates with repeated drug exposure it represses c-Fos and contributes to the molecular switch whereby ΔFosB is selectively induced in the chronic drug-treated state.<sup>41</sup>.<span>&nbsp;</span>... Moreover, there is increasing evidence that, despite a range of genetic risks for addiction across the population, exposure to sufficiently high doses of a drug for long periods of time can transform someone who has relatively lower genetic loading into an addict.4</q></cite></span></li><li id="cite_note-85"> <span id="mw-reference-text-cite_note-85" class="mw-reference-text"><cite id="CITEREFRuffle2014" class="citation journal cs1">Ruffle JK (November 2014). "Molecular neurobiology of addiction: what's all the (Δ)FosB about?". <i>The American Journal of Drug and Alcohol Abuse</i>. <b>40</b> (6): 428–37. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F00952990.2014.933840  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F00952990.2014.933840'" tppabs="https://doi.org/10.3109%2F00952990.2014.933840" class="external text external">10.3109/00952990.2014.933840</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25083822  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25083822'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25083822" class="external text external">25083822</a>. <q><br>The strong correlation between chronic drug exposure and ΔFosB provides novel opportunities for targeted therapies in addiction (118), and suggests methods to analyze their efficacy (119). Over the past two decades, research has progressed from identifying ΔFosB induction to investigating its subsequent action (38). It is likely that ΔFosB research will now progress into a new era – the use of ΔFosB as a biomarker.<span>&nbsp;</span>...<br>Conclusions<br><span>&nbsp;</span> <span>&nbsp;</span> <span>&nbsp;</span>ΔFosB is an essential transcription factor implicated in the molecular and behavioral pathways of addiction following repeated drug exposure. The formation of ΔFosB in multiple brain regions, and the molecular pathway leading to the formation of AP-1 complexes is well understood. The establishment of a functional purpose for ΔFosB has allowed further determination as to some of the key aspects of its molecular cascades, involving effectors such as GluR2 (87,88), Cdk5 (93) and NFkB (100). Moreover, many of these molecular changes identified are now directly linked to the structural, physiological and behavioral changes observed following chronic drug exposure (60,95,97,102). New frontiers of research investigating the molecular roles of ΔFosB have been opened by epigenetic studies, and recent advances have illustrated the role of ΔFosB acting on DNA and histones, truly as a <i>molecular switch</i> (34). As a consequence of our improved understanding of ΔFosB in addiction, it is possible to evaluate the addictive potential of current medications (119), as well as use it as a biomarker for assessing the efficacy of therapeutic interventions (121,122,124). Some of these proposed interventions have limitations (125) or are in their infancy (75). However, it is hoped that some of these preliminary findings may lead to innovative treatments, which are much needed in addiction.</q></cite><br><b>•</b> <cite id="CITEREFBilińskiWojtyłaKapka-SkrzypczakChwedorowicz2012" class="citation journal cs1">Biliński P, Wojtyła A, Kapka-Skrzypczak L, Chwedorowicz R, Cyranka M, Studziński T (2012). "Epigenetic regulation in drug addiction". <i>Annals of Agricultural and Environmental Medicine</i>. <b>19</b> (3): 491–6. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23020045  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23020045'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23020045" class="external text external">23020045</a>. <q>For these reasons, ΔFosB is considered a primary and causative transcription factor in creating new neural connections in the reward centre, prefrontal cortex, and other regions of the limbic system. This is reflected in the increased, stable and long-lasting level of sensitivity to cocaine and other drugs, and tendency to relapse even after long periods of abstinence. These newly constructed networks function very efficiently via new pathways as soon as drugs of abuse are further taken<span>&nbsp;</span>... In this way, the induction of CDK5 gene expression occurs together with suppression of the G9A gene coding for dimethyltransferase acting on the histone H3. A feedback mechanism can be observed in the regulation of these 2 crucial factors that determine the adaptive epigenetic response to cocaine. This depends on ΔFosB inhibiting G9a gene expression, i.e. H3K9me2 synthesis which in turn inhibits transcription factors for ΔFosB. For this reason, the observed hyper-expression of G9a, which ensures high levels of the dimethylated form of histone H3, eliminates the neuronal structural and plasticity effects caused by cocaine by means of this feedback which blocks ΔFosB transcription</q></cite><br><b>•</b> <cite id="CITEREFRobisonNestler2011" class="citation journal cs1">Robison AJ, Nestler EJ (October 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277" class="external text external">"Transcriptional and epigenetic mechanisms of addiction"</a>. <i>Nature Reviews. Neuroscience</i>. <b>12</b> (11): 623–37. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrn3111  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrn3111'" tppabs="https://doi.org/10.1038%2Fnrn3111" class="external text external">10.1038/nrn3111</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277" class="external text external">3272277</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21989194  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21989194'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21989194" class="external text external">21989194</a>. <q>ΔFosB has been linked directly to several addiction-related behaviors<span>&nbsp;</span>...  Importantly, genetic or viral overexpression of ΔJunD, a dominant negative mutant of JunD which antagonizes ΔFosB- and other AP-1-mediated transcriptional activity, in the NAc or OFC blocks these key effects of drug exposure<sup>14,22–24</sup>. This indicates that ΔFosB is both necessary and sufficient for many of the changes wrought in the brain by chronic drug exposure. ΔFosB is also induced in D1-type NAc MSNs by chronic consumption of several natural rewards, including sucrose, high fat food, sex, wheel running, where it promotes that consumption<sup>14,26–30</sup>. This implicates ΔFosB in the regulation of natural rewards under normal conditions and perhaps during pathological addictive-like states.</q></cite></span></li><li id="cite_note-concerta_monograph-86"> <span id="mw-reference-text-cite_note-concerta_monograph-86" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.janssenmd.com/pdf/concerta/CONCERTA_PI.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.janssenmd.com/pdf/concerta/CONCERTA_PI.pdf'" tppabs="https://www.janssenmd.com/pdf/concerta/CONCERTA_PI.pdf" class="external text external">"Concerta product monograph"</a> <span class="cs1-format">(PDF)</span>. Janssen Pharmaceuticals. <a href="javascript:if(confirm('https://web.archive.org/web/20170128153821/https://www.janssenmd.com/pdf/concerta/CONCERTA_PI.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170128153821/https://www.janssenmd.com/pdf/concerta/CONCERTA_PI.pdf'" tppabs="https://web.archive.org/web/20170128153821/https://www.janssenmd.com/pdf/concerta/CONCERTA_PI.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 28 January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">4 December</span> 2016</span>.</cite></span></li><li id="cite_note-87"> <span id="mw-reference-text-cite_note-87" class="mw-reference-text"><cite id="CITEREFIshiiTatsuzawaYoshinoNomura2008" class="citation journal cs1">Ishii M, Tatsuzawa Y, Yoshino A, Nomura S (April 2008). "Serotonin syndrome induced by augmentation of SSRI with methylphenidate". <i>Psychiatry and Clinical Neurosciences</i>. <b>62</b> (2): 246. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1440-1819.2008.01767.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1440-1819.2008.01767.x'" tppabs="https://doi.org/10.1111%2Fj.1440-1819.2008.01767.x" class="external text external">10.1111/j.1440-1819.2008.01767.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18412855  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18412855'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18412855" class="external text external">18412855</a>.</cite></span></li><li id="cite_note-88"> <span id="mw-reference-text-cite_note-88" class="mw-reference-text"><cite id="CITEREFTürkoğlu2015" class="citation journal cs1">Türkoğlu S (2015). "Serotonin syndrome with sertraline and methylphenidate in an adolescent". <i>Clinical Neuropharmacology</i>. <b>38</b> (2): 65–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FWNF.0000000000000075  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FWNF.0000000000000075'" tppabs="https://doi.org/10.1097%2FWNF.0000000000000075" class="external text external">10.1097/WNF.0000000000000075</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25768857  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25768857'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25768857" class="external text external">25768857</a>.</cite></span></li><li id="cite_note-89"> <span id="mw-reference-text-cite_note-89" class="mw-reference-text"><cite id="CITEREFParkJung2010" class="citation journal cs1">Park YM, Jung YK (May 2010). "Manic switch and serotonin syndrome induced by augmentation of paroxetine with methylphenidate in a patient with major depression". <i>Progress in Neuro-Psychopharmacology &amp; Biological Psychiatry</i>. <b>34</b> (4): 719–20. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.pnpbp.2010.03.016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.pnpbp.2010.03.016'" tppabs="https://doi.org/10.1016%2Fj.pnpbp.2010.03.016" class="external text external">10.1016/j.pnpbp.2010.03.016</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20298736  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20298736'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20298736" class="external text external">20298736</a>.</cite></span></li><li id="cite_note-90"> <span id="mw-reference-text-cite_note-90" class="mw-reference-text"><cite id="CITEREFBodnerLynchLewisKahn1995" class="citation journal cs1">Bodner RA, Lynch T, Lewis L, Kahn D (February 1995). "Serotonin syndrome". <i>Neurology</i>. <b>45</b> (2): 219–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1212%2Fwnl.45.2.219  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1212%2Fwnl.45.2.219'" tppabs="https://doi.org/10.1212%2Fwnl.45.2.219" class="external text external">10.1212/wnl.45.2.219</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7854515  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7854515'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7854515" class="external text external">7854515</a>.</cite></span></li><li id="cite_note-91"> <span id="mw-reference-text-cite_note-91" class="mw-reference-text"><cite id="CITEREFPatrickGonzálezStraughnMarkowitz2005" class="citation journal cs1">Patrick KS, González MA, Straughn AB, Markowitz JS (2005). "New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder". <i>Expert Opinion on Drug Delivery</i>. <b>2</b> (1): 121–43. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F17425247.2.1.121  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F17425247.2.1.121'" tppabs="https://doi.org/10.1517%2F17425247.2.1.121" class="external text external">10.1517/17425247.2.1.121</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16296740  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16296740'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16296740" class="external text external">16296740</a>.</cite></span></li><li id="cite_note-pmid10820132-92"> <span id="mw-reference-text-cite_note-pmid10820132-92" class="mw-reference-text"><cite id="CITEREFMarkowitzDeVaneBoultonNahas2000" class="citation journal cs1">Markowitz JS, DeVane CL, Boulton DW, Nahas Z, Risch SC, Diamond F, Patrick KS (2000). "Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol". <i>Drug Metabolism and Disposition</i>. <b>28</b> (6): 620–4. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10820132  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10820132'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10820132" class="external text external">10820132</a>.</cite></span></li><li id="cite_note-pmid10440465-93"> <span id="mw-reference-text-cite_note-pmid10440465-93" class="mw-reference-text"><cite id="CITEREFMarkowitzLoganDiamondPatrick1999" class="citation journal cs1">Markowitz JS, Logan BK, Diamond F, Patrick KS (1999). "Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion". <i>Journal of Clinical Psychopharmacology</i>. <b>19</b> (4): 362–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004714-199908000-00013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004714-199908000-00013'" tppabs="https://doi.org/10.1097%2F00004714-199908000-00013" class="external text external">10.1097/00004714-199908000-00013</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10440465  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10440465'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10440465" class="external text external">10440465</a>.</cite></span></li><li id="cite_note-pmid17339864-94"> <span id="mw-reference-text-cite_note-pmid17339864-94" class="mw-reference-text"><cite id="CITEREFPatrickStraughnMinhinnettYeatts2007" class="citation journal cs1">Patrick KS, Straughn AB, Minhinnett RR, Yeatts SD, Herrin AE, DeVane CL, Malcolm R, Janis GC, Markowitz JS (March 2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188424  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188424'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188424" class="external text external">"Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics"</a>. <i>Clinical Pharmacology and Therapeutics</i>. <b>81</b> (3): 346–53. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.clpt.6100082  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.clpt.6100082'" tppabs="https://doi.org/10.1038%2Fsj.clpt.6100082" class="external text external">10.1038/sj.clpt.6100082</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188424  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188424'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188424" class="external text external">3188424</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17339864  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17339864'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17339864" class="external text external">17339864</a>.</cite></span></li><li id="cite_note-95"> <span id="mw-reference-text-cite_note-95" class="mw-reference-text"><cite id="CITEREFRobertsDeMottJames1997" class="citation journal cs1">Roberts SM, DeMott RP, James RC (1997). "Adrenergic modulation of hepatotoxicity". <i>Drug Metab. Rev</i>. <b>29</b> (1–2): 329–53. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F03602539709037587  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F03602539709037587'" tppabs="https://doi.org/10.3109%2F03602539709037587" class="external text external">10.3109/03602539709037587</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9187524  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9187524'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9187524" class="external text external">9187524</a>.</cite></span></li><li id="cite_note-pmid18480678-96"> <span id="mw-reference-text-cite_note-pmid18480678-96" class="mw-reference-text"><cite id="CITEREFMarkowitzPatrick2008" class="citation journal cs1">Markowitz JS, Patrick KS (June 2008). "Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?". <i>Journal of Clinical Psychopharmacology</i>. <b>28</b> (3 Suppl 2): S54-61. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FJCP.0b013e3181733560  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FJCP.0b013e3181733560'" tppabs="https://doi.org/10.1097%2FJCP.0b013e3181733560" class="external text external">10.1097/JCP.0b013e3181733560</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18480678  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18480678'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18480678" class="external text external">18480678</a>.</cite></span></li><li id="cite_note-pmid17218796-97"> <span id="mw-reference-text-cite_note-pmid17218796-97" class="mw-reference-text"><cite id="CITEREFWilliardMiddaughZhuPatrick2007" class="citation journal cs1">Williard RL, Middaugh LD, Zhu HJ, Patrick KS (February 2007). "Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity". <i>Behavioural Pharmacology</i>. <b>18</b> (1): 39–51. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2Ffbp.0b013e3280143226  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2Ffbp.0b013e3280143226'" tppabs="https://doi.org/10.1097%2Ffbp.0b013e3280143226" class="external text external">10.1097/fbp.0b013e3280143226</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17218796  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17218796'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17218796" class="external text external">17218796</a>.</cite></span></li><li id="cite_note-pmid17201613-98"> <span id="mw-reference-text-cite_note-pmid17201613-98" class="mw-reference-text"><cite id="CITEREFMarkowitzDeVanePestreichPatrick2006" class="citation journal cs1">Markowitz JS, DeVane CL, Pestreich LK, Patrick KS, Muniz R (December 2006). <a href="javascript:if(confirm('https://semanticscholar.org/paper/adb71af0b909e4a96f605266ca1a77df368985ad  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://semanticscholar.org/paper/adb71af0b909e4a96f605266ca1a77df368985ad'" tppabs="https://semanticscholar.org/paper/adb71af0b909e4a96f605266ca1a77df368985ad" class="external text external">"A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study"</a>. <i>Journal of Child and Adolescent Psychopharmacology</i>. <b>16</b> (6): 687–98. doi:<a href="javascript:if(confirm('https://doi.org/10.1089%2Fcap.2006.16.687  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1089%2Fcap.2006.16.687'" tppabs="https://doi.org/10.1089%2Fcap.2006.16.687" class="external text external">10.1089/cap.2006.16.687</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17201613  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17201613'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17201613" class="external text external">17201613</a>.</cite></span></li><li id="cite_note-Malenka_2009_03-99"> <span id="mw-reference-text-cite_note-Malenka_2009_03-99" class="mw-reference-text"><cite class="citation book cs1">Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 6: Widely Projecting Systems: Monoamines, Acetylcholine, and Orexin".  In Sydor A, Brown RY (eds.). <i>Molecular Neuropharmacology: A Foundation for Clinical Neuroscience</i> (2nd ed.). New York: McGraw-Hill Medical. pp.<span>&nbsp;</span>154–157. ISBN<span>&nbsp;</span><bdi>9780071481274</bdi>.</cite></span></li><li id="cite_note-steele-100"> <span id="mw-reference-text-cite_note-steele-100" class="mw-reference-text"><cite id="CITEREFSteeleWeissSwansonWang2006" class="citation journal cs1">Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE (2006). <a href="javascript:if(confirm('http://webarchive.nationalarchives.gov.uk/20111215210932/http%3A//www.cjcp.ca/CJCP_05%2D012_e50%2Dr101628  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://webarchive.nationalarchives.gov.uk/20111215210932/http%3A//www.cjcp.ca/CJCP_05%2D012_e50%2Dr101628'" tppabs="http://webarchive.nationalarchives.gov.uk/20111215210932/http%3A//www.cjcp.ca/CJCP_05%2D012_e50%2Dr101628" class="external text external">"A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder"</a>. <i>Can J Clin Pharmacol</i>. <b>13</b> (1): e50–62. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16456216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16456216'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16456216" class="external text external">16456216</a>. Archived from <a href="javascript:if(confirm('http://www.cjcp.ca/pdf/CJCP_05-012_e50.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cjcp.ca/pdf/CJCP_05-012_e50.pdf'" tppabs="http://www.cjcp.ca/pdf/CJCP_05-012_e50.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 15 December 2011.</cite></span></li><li id="cite_note-Heal_DJ,_Pierce_DM_2006_713–38-101"> <span id="mw-reference-text-cite_note-Heal_DJ,_Pierce_DM_2006_713–38-101" class="mw-reference-text"><cite id="CITEREFHealPierce2006" class="citation journal cs1">Heal DJ, Pierce DM (2006). "Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system". <i>CNS Drugs</i>. <b>20</b> (9): 713–38. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00023210-200620090-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00023210-200620090-00002'" tppabs="https://doi.org/10.2165%2F00023210-200620090-00002" class="external text external">10.2165/00023210-200620090-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16953648  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16953648'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16953648" class="external text external">16953648</a>.</cite></span></li><li id="cite_note-102"> <span id="mw-reference-text-cite_note-102" class="mw-reference-text"><cite id="CITEREFIversen2006" class="citation journal cs1">Iversen L (January 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760736  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760736'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760736" class="external text external">"Neurotransmitter transporters and their impact on the development of psychopharmacology"</a>. <i>British Journal of Pharmacology</i>. 147 Suppl 1 (Suppl 1): S82-8. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.bjp.0706428  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.bjp.0706428'" tppabs="https://doi.org/10.1038%2Fsj.bjp.0706428" class="external text external">10.1038/sj.bjp.0706428</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760736  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760736'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760736" class="external text external">1760736</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16402124  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16402124'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16402124" class="external text external">16402124</a>.</cite></span></li><li id="cite_note-103"> <span id="mw-reference-text-cite_note-103" class="mw-reference-text"><cite id="CITEREFVolkowFowlerWangDing2002" class="citation journal cs1">Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ (1 January 2002). "Mechanism of action of methylphenidate: insights from PET imaging studies". <i>Journal of Attention Disorders</i>. 6 Suppl 1: S31-43. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F070674370200601s05  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F070674370200601s05'" tppabs="https://doi.org/10.1177%2F070674370200601s05" class="external text external">10.1177/070674370200601s05</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12685517  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12685517'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12685517" class="external text external">12685517</a>.</cite></span></li><li id="cite_note-104"> <span id="mw-reference-text-cite_note-104" class="mw-reference-text"><cite id="CITEREFHodgkinsShawCoghillHechtman2012" class="citation journal cs1">Hodgkins P, Shaw M, Coghill D, Hechtman L (September 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432777  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432777'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432777" class="external text external">"Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options"</a>. <i>European Child &amp; Adolescent Psychiatry</i>. <b>21</b> (9): 477–92. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00787-012-0286-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00787-012-0286-5'" tppabs="https://doi.org/10.1007%2Fs00787-012-0286-5" class="external text external">10.1007/s00787-012-0286-5</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432777  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432777'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432777" class="external text external">3432777</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22763750  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22763750'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22763750" class="external text external">22763750</a>.</cite></span></li><li id="cite_note-Neuroplasticity_1-105"> <span id="mw-reference-text-cite_note-Neuroplasticity_1-105" class="mw-reference-text"><cite id="CITEREFHartRaduaNakaoMataix-Cols2013" class="citation journal cs1">Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K (February 2013). <a href="javascript:if(confirm('https://doi.org/10.1001/jamapsychiatry.2013.277  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/jamapsychiatry.2013.277'" tppabs="https://doi.org/10.1001/jamapsychiatry.2013.277" class="external text external">"Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects"</a>. <i>JAMA Psychiatry</i>. <b>70</b> (2): 185–98. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Fjamapsychiatry.2013.277  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjamapsychiatry.2013.277'" tppabs="https://doi.org/10.1001%2Fjamapsychiatry.2013.277" class="external text external">10.1001/jamapsychiatry.2013.277</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23247506  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23247506'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23247506" class="external text external">23247506</a>.</cite></span></li><li id="cite_note-Neuroplasticity_2-106"> <span id="mw-reference-text-cite_note-Neuroplasticity_2-106" class="mw-reference-text"><cite id="CITEREFSpencerBrownSeidmanValera2013" class="citation journal cs1">Spencer TJ, Brown A, Seidman LJ, Valera EM, Makris N, Lomedico A,  et al. (September 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801446  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801446'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801446" class="external text external">"Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies"</a>. <i>The Journal of Clinical Psychiatry</i>. <b>74</b> (9): 902–17. doi:<a href="javascript:if(confirm('https://doi.org/10.4088%2FJCP.12r08287  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4088%2FJCP.12r08287'" tppabs="https://doi.org/10.4088%2FJCP.12r08287" class="external text external">10.4088/JCP.12r08287</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801446  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801446'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801446" class="external text external">3801446</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24107764  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24107764'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24107764" class="external text external">24107764</a>.</cite></span></li><li id="cite_note-Neuroplasticity_3-107"> <span id="mw-reference-text-cite_note-Neuroplasticity_3-107" class="mw-reference-text"><cite id="CITEREFFrodlSkokauskas2012" class="citation journal cs1">Frodl T, Skokauskas N (February 2012). "Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects". <i>Acta Psychiatrica Scandinavica</i>. <b>125</b> (2): 114–26. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1600-0447.2011.01786.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1600-0447.2011.01786.x'" tppabs="https://doi.org/10.1111%2Fj.1600-0447.2011.01786.x" class="external text external">10.1111/j.1600-0447.2011.01786.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22118249  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22118249'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22118249" class="external text external">22118249</a>. <q>Basal ganglia regions like the right globus pallidus, the right putamen, and the nucleus caudatus are structurally affected in children with ADHD. These changes and alterations in limbic regions like ACC and amygdala are more pronounced in non-treated populations and seem to diminish over time from child to adulthood. Treatment seems to have positive effects on brain structure.</q></cite></span></li><li id="cite_note-pmid15303308-108"> <span id="mw-reference-text-cite_note-pmid15303308-108" class="mw-reference-text"><cite id="CITEREFViggianoValloneSadile2004" class="citation journal cs1">Viggiano D, Vallone D, Sadile A (2004). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565441  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565441'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565441" class="external text external">"Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling"</a>. <i>Neural Plasticity</i>. <b>11</b> (1–2): 102, 106–107. doi:<a href="javascript:if(confirm('https://doi.org/10.1155%2FNP.2004.97  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1155%2FNP.2004.97'" tppabs="https://doi.org/10.1155%2FNP.2004.97" class="external text external">10.1155/NP.2004.97</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565441  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565441'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565441" class="external text external">2565441</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15303308  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15303308'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15303308" class="external text external">15303308</a>.</cite></span></li><li id="cite_note-109"> <span id="mw-reference-text-cite_note-109" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.rxlist.com/focalin-xr-drug.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rxlist.com/focalin-xr-drug.htm#description'" tppabs="https://www.rxlist.com/focalin-xr-drug.htm#description" class="external text external">"Focalin XR"</a>. <i>RxList</i>.</cite></span></li><li id="cite_note-110"> <span id="mw-reference-text-cite_note-110" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20110714203029/http://www.pharma.us.novartis.com/product/pi/pdf/focalinXR.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110714203029/http://www.pharma.us.novartis.com/product/pi/pdf/focalinXR.pdf'" tppabs="https://web.archive.org/web/20110714203029/http://www.pharma.us.novartis.com/product/pi/pdf/focalinXR.pdf" class="external text external">"Focalin XR – Full Prescribing Information"</a> <span class="cs1-format">(PDF)</span>. Novartis. Archived from <a href="javascript:if(confirm('http://www.pharma.us.novartis.com/product/pi/pdf/focalinXR.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pharma.us.novartis.com/product/pi/pdf/focalinXR.pdf'" tppabs="http://www.pharma.us.novartis.com/product/pi/pdf/focalinXR.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 14 July 2011.</cite></span></li><li id="cite_note-111"> <span id="mw-reference-text-cite_note-111" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20171017010139/http://www.medicines.org.uk/emc/medicine/8380  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20171017010139/http://www.medicines.org.uk/emc/medicine/8380'" tppabs="https://web.archive.org/web/20171017010139/http://www.medicines.org.uk/emc/medicine/8380" class="external text external">"Concerta XL 18 mg – 54 mg prolonged release tablets"</a>. <i>eMC</i>. Archived from <a href="javascript:if(confirm('http://www.medicines.org.uk/emc/medicine/8380  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medicines.org.uk/emc/medicine/8380'" tppabs="http://www.medicines.org.uk/emc/medicine/8380" class="external text external">the original</a> on 17 October 2017.</cite></span></li><li id="cite_note-Miller-112"> <span id="mw-reference-text-cite_note-Miller-112" class="mw-reference-text"><cite id="CITEREFMiller2011" class="citation journal cs1">Miller GM (January 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101" class="external text external">"The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity"</a>. <i>Journal of Neurochemistry</i>. <b>116</b> (2): 164–76. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1471-4159.2010.07109.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1471-4159.2010.07109.x'" tppabs="https://doi.org/10.1111%2Fj.1471-4159.2010.07109.x" class="external text external">10.1111/j.1471-4159.2010.07109.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005101" class="external text external">3005101</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21073468  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21073468'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21073468" class="external text external">21073468</a>.</cite></span></li><li id="cite_note-E_Weihe-113"> <span id="mw-reference-text-cite_note-E_Weihe-113" class="mw-reference-text"><cite id="CITEREFEidenWeihe2011" class="citation journal cs1">Eiden LE, Weihe E (January 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183197  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183197'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183197" class="external text external">"VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse"</a>. <i>Ann. N. Y. Acad. Sci</i>. <b>1216</b> (1): 86–98. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2011NYASA1216...86E  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2011NYASA1216...86E'" tppabs="https://ui.adsabs.harvard.edu/abs/2011NYASA1216...86E" class="external text external">2011NYASA1216...86E</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1749-6632.2010.05906.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1749-6632.2010.05906.x'" tppabs="https://doi.org/10.1111%2Fj.1749-6632.2010.05906.x" class="external text external">10.1111/j.1749-6632.2010.05906.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183197  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183197'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183197" class="external text external">4183197</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21272013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21272013'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21272013" class="external text external">21272013</a>. <q>VMAT2 is the CNS vesicular transporter for not only the biogenic amines DA, NE, EPI, 5-HT, and HIS, but likely also for the trace amines TYR, PEA, and thyronamine (THYR)<span>&nbsp;</span>... AMPH release of DA from synapses requires both an action at VMAT2 to release DA to the cytoplasm and a concerted release of DA from the cytoplasm via “reverse transport” through DAT.</q></cite></span></li><li id="cite_note-Amphetamine_VMAT2_pH_gradient-114"> <span id="mw-reference-text-cite_note-Amphetamine_VMAT2_pH_gradient-114" class="mw-reference-text"><cite id="CITEREFSulzerCraggRice2016" class="citation journal cs1">Sulzer D, Cragg SJ, Rice ME (August 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850498  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850498'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850498" class="external text external">"Striatal dopamine neurotransmission: regulation of release and uptake"</a>. <i>Basal Ganglia</i>. <b>6</b> (3): 123–148. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.baga.2016.02.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.baga.2016.02.001'" tppabs="https://doi.org/10.1016%2Fj.baga.2016.02.001" class="external text external">10.1016/j.baga.2016.02.001</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850498  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850498'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850498" class="external text external">4850498</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27141430  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27141430'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27141430" class="external text external">27141430</a>. <q>Despite the challenges in determining synaptic vesicle pH, the proton gradient across the vesicle membrane is of fundamental importance for its function. Exposure of isolated catecholamine vesicles to protonophores collapses the pH gradient and rapidly redistributes transmitter from inside to outside the vesicle.<span>&nbsp;</span>... Amphetamine and its derivatives like methamphetamine are weak base compounds that are the only widely used class of drugs known to elicit transmitter release by a non-exocytic mechanism. As substrates for both DAT and VMAT, amphetamines can be taken up to the cytosol and then sequestered in vesicles, where they act to collapse the vesicular pH gradient.</q></cite></span></li><li id="cite_note-115"> <span id="mw-reference-text-cite_note-115" class="mw-reference-text"><cite id="CITEREFMarkowitzDeVaneRamamoorthyZhu2009" class="citation journal cs1">Markowitz JS, DeVane CL, Ramamoorthy S, Zhu HJ (February 2009). "The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor". <i>Die Pharmazie</i>. <b>64</b> (2): 123–5. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19322953  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19322953'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19322953" class="external text external">19322953</a>.</cite></span></li><li id="cite_note-Volz2008-116"> <span id="mw-reference-text-cite_note-Volz2008-116" class="mw-reference-text"><cite id="CITEREFVolz2008" class="citation journal cs1">Volz TJ (December 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701286  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701286'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701286" class="external text external">"Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate"</a>. <i>Current Neuropharmacology</i>. <b>6</b> (4): 379–85. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F157015908787386041  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F157015908787386041'" tppabs="https://doi.org/10.2174%2F157015908787386041" class="external text external">10.2174/157015908787386041</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701286  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701286'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701286" class="external text external">2701286</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19587858  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19587858'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19587858" class="external text external">19587858</a>.</cite></span></li><li id="cite_note-Drugs.com_2018-117"> <span id="mw-reference-text-cite_note-Drugs.com_2018-117" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pro/concerta.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pro/concerta.html'" tppabs="https://www.drugs.com/pro/concerta.html" class="external text external">"Concerta"</a>. <i>Drugs.com</i>. 1 October 2018. <a href="javascript:if(confirm('https://web.archive.org/web/20180929171112/https://www.drugs.com/pro/concerta.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20180929171112/https://www.drugs.com/pro/concerta.html'" tppabs="https://web.archive.org/web/20180929171112/https://www.drugs.com/pro/concerta.html" class="external text external">Archived</a> from the original on 29 September 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">11 March</span> 2019</span>.</cite></span></li><li id="cite_note-fda-118"> <span id="mw-reference-text-cite_note-fda-118" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021284s020lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021284s020lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021284s020lbl.pdf" class="external text external">"FDA"</a> <span class="cs1-format">(PDF)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20170210141542/http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021284s020lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170210141542/http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021284s020lbl.pdf'" tppabs="https://web.archive.org/web/20170210141542/http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021284s020lbl.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 10 February 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">30 January</span> 2019</span>.</cite></span></li><li id="cite_note-119"> <span id="mw-reference-text-cite_note-119" class="mw-reference-text"><cite id="CITEREFChanSwansonSoldinThiessen1983" class="citation journal cs1">Chan YP, Swanson JM, Soldin SS, Thiessen JJ, Macleod SM, Logan W (1983). "Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid". <i>Pediatrics</i>. <b>72</b> (1): 56–59. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6866592  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6866592'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6866592" class="external text external">6866592</a>.</cite></span></li><li id="cite_note-120"> <span id="mw-reference-text-cite_note-120" class="mw-reference-text"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205489s000lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205489s000lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205489s000lbl.pdf" class="external free external">https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205489s000lbl.pdf</a></span></li><li id="cite_note-121"> <span id="mw-reference-text-cite_note-121" class="mw-reference-text"><a href="javascript:if(confirm('https://www.trispharma.com/generic/Quillivant_XR_08_2018_FINAL_for_Website_Jan_22_2019.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.trispharma.com/generic/Quillivant_XR_08_2018_FINAL_for_Website_Jan_22_2019.pdf#page15'" tppabs="https://www.trispharma.com/generic/Quillivant_XR_08_2018_FINAL_for_Website_Jan_22_2019.pdf#page15" class="external free external">https://www.trispharma.com/generic/Quillivant_XR_08_2018_FINAL_for_Website_Jan_22_2019.pdf#page15</a></span></li><li id="cite_note-pmid15082749-122"> <span id="mw-reference-text-cite_note-pmid15082749-122" class="mw-reference-text"><cite id="CITEREFSunMurrySanghaniDavis2004" class="citation journal cs1">Sun Z, Murry DJ, Sanghani SP, Davis WI, Kedishvili NY, Zou Q,  et al. (August 2004). "Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A1". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>310</b> (2): 469–76. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fjpet.104.067116  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fjpet.104.067116'" tppabs="https://doi.org/10.1124%2Fjpet.104.067116" class="external text external">10.1124/jpet.104.067116</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15082749  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15082749'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15082749" class="external text external">15082749</a>.</cite></span></li><li id="cite_note-123"> <span id="mw-reference-text-cite_note-123" class="mw-reference-text"><cite id="CITEREFFroimowitzPatrickCody1995" class="citation journal cs1">Froimowitz M, Patrick KS, Cody V (October 1995). "Conformational analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT". <i>Pharmaceutical Research</i>. <b>12</b> (10): 1430–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1023%2FA%3A1016262815984  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1023%2FA%3A1016262815984'" tppabs="https://doi.org/10.1023%2FA%3A1016262815984" class="external text external">10.1023/A:1016262815984</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8584475  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8584475'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8584475" class="external text external">8584475</a>.</cite></span></li><li id="cite_note-Prashad-124"> <span id="mw-reference-text-cite_note-Prashad-124" class="mw-reference-text"><cite id="CITEREFPrashad2001" class="citation journal cs1">Prashad M (2001). "Approaches to the Preparation of Enantiomerically Pure (2R,2′R)-(+)-threo-Methylphenidate Hydrochloride". <i>Adv. Synth. Catal</i>. <b>343</b> (5): 379–92. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F1615-4169%28200107%29343%3A5%3C379%3A%3AAID-ADSC379%3E3.0.CO%3B2-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F1615-4169%28200107%29343%3A5%3C379%3A%3AAID-ADSC379%3E3.0.CO%3B2-4'" tppabs="https://doi.org/10.1002%2F1615-4169%28200107%29343%3A5%3C379%3A%3AAID-ADSC379%3E3.0.CO%3B2-4" class="external text external">10.1002/1615-4169(200107)343:5<span>&lt;</span>379::AID-ADSC379<span>&gt;</span>3.0.CO;2-4</a>.</cite></span></li><li id="cite_note-125"> <span id="mw-reference-text-cite_note-125" class="mw-reference-text"><cite id="CITEREFAxtenKrimKungWinkler1998" class="citation journal cs1">Axten JM, Krim L, Kung HF, Winkler JD (1998). "A Stereoselective Synthesis ofdl-threo-Methylphenidate: Preparation and Biological Evaluation of Novel Analogues". <i>The Journal of Organic Chemistry</i>. <b>63</b> (26): 9628–9629. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjo982214t  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjo982214t'" tppabs="https://doi.org/10.1021%2Fjo982214t" class="external text external">10.1021/jo982214t</a>.</cite></span></li><li id="cite_note-erowid-126"> <span id="mw-reference-text-cite_note-erowid-126" class="mw-reference-text"><cite id="CITEREFSingh2000" class="citation journal cs1">Singh S (March 2000). "Chemistry, design, and structure-activity relationship of cocaine antagonists". <i>Chemical Reviews</i>. <b>100</b> (3): 925–1024. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fcr9700538  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fcr9700538'" tppabs="https://doi.org/10.1021%2Fcr9700538" class="external text external">10.1021/cr9700538</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11749256  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11749256'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11749256" class="external text external">11749256</a>.</cite></span></li><li id="cite_note-127"> <span id="mw-reference-text-cite_note-127" class="mw-reference-text">R. Baselt, <i>Disposition of Toxic Drugs and Chemicals in Man</i>, 9th edition, Biomedical Publications, Seal Beach, CA, 2011, pp. 1091–93.</span></li><li id="cite_note-128"> <span id="mw-reference-text-cite_note-128" class="mw-reference-text"><cite id="CITEREFPanizzon_L1944" class="citation journal cs1">Panizzon L (1944). "La preparazione di piridile piperidil-arilacetonitrili e di alcuni prodotti di trasformazione (Parte Ia)". <i>Helvetica Chimica Acta</i>. <b>27</b>: 1748–56. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fhlca.194402701222  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fhlca.194402701222'" tppabs="https://doi.org/10.1002%2Fhlca.194402701222" class="external text external">10.1002/hlca.194402701222</a>.</cite></span></li><li id="cite_note-129"> <span id="mw-reference-text-cite_note-129" class="mw-reference-text"><cite id="CITEREFMeierGrossTripod1954" class="citation journal cs1">Meier R, Gross F, Tripod J (May 1954). "[Ritalin, a new synthetic compound with specific analeptic components]". <i>Klinische Wochenschrift</i>. <b>32</b> (19–20): 445–50. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2FBF01466968  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2FBF01466968'" tppabs="https://doi.org/10.1007%2FBF01466968" class="external text external">10.1007/BF01466968</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/13164273  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/13164273'" tppabs="https://pubmed.ncbi.nlm.nih.gov/13164273" class="external text external">13164273</a>.</cite></span></li><li id="cite_note-130"> <span id="mw-reference-text-cite_note-130" class="mw-reference-text"><cite id="CITEREFMyers2007" class="citation book cs1">Myers RL (1 January 2007). <a href="javascript:if(confirm('https://books.google.com/books?id=a4DuGVwyN6cC&pg=PA178&lpg=PA178&dq=named+ritalin+after+his+wife  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=a4DuGVwyN6cC&pg=PA178&lpg=PA178&dq=named+ritalin+after+his+wife#v=onepage&q=named%20ritalin%20after%20his%20wife&f=false'" tppabs="https://books.google.com/books?id=a4DuGVwyN6cC&pg=PA178&lpg=PA178&dq=named+ritalin+after+his+wife#v=onepage&q=named%20ritalin%20after%20his%20wife&f=false" class="external text external"><i>The 100 Most Important Chemical Compounds: A Reference Guide</i></a>. ABC-CLIO. p.<span>&nbsp;</span>178. ISBN<span>&nbsp;</span><bdi>9780313337581</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170202064317/https://books.google.com/books?id=a4DuGVwyN6cC&pg=PA178&lpg=PA178&dq=named+ritalin+after+his+wife  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170202064317/https://books.google.com/books?id=a4DuGVwyN6cC&pg=PA178&lpg=PA178&dq=named+ritalin+after+his+wife#v=onepage&q=named%20ritalin%20after%20his%20wife&f=false'" tppabs="https://web.archive.org/web/20170202064317/https://books.google.com/books?id=a4DuGVwyN6cC&pg=PA178&lpg=PA178&dq=named+ritalin+after+his+wife#v=onepage&q=named%20ritalin%20after%20his%20wife&f=false" class="external text external">Archived</a> from the original on 2 February 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">24 September</span> 2016</span>.</cite></span></li><li id="cite_note-131"> <span id="mw-reference-text-cite_note-131" class="mw-reference-text">Leandro Panizzon et al <i>Pyridine and piperdjine compounds</i> <span><a href="javascript:if(confirm('https://www.google.com/patents/US2507631  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.google.com/patents/US2507631'" tppabs="https://www.google.com/patents/US2507631" class="external text external">U.S. Patent 2,507,631</a></span> Issue date: 16 May 1950</span></li><li id="cite_note-132"> <span id="mw-reference-text-cite_note-132" class="mw-reference-text">Rudolf Rouietscji et al <i>Process for the conversion of</i> <span><a href="javascript:if(confirm('https://www.google.com/patents/US2838519  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.google.com/patents/US2838519'" tppabs="https://www.google.com/patents/US2838519" class="external text external">U.S. Patent 2,838,519</a></span> Issue date: 10 June 1958</span></li><li id="cite_note-133"> <span id="mw-reference-text-cite_note-133" class="mw-reference-text">Rudolf Rouietscji et al<i>Process for the conversion of</i> <span><a href="javascript:if(confirm('https://www.google.com/patents/US2957880  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.google.com/patents/US2957880'" tppabs="https://www.google.com/patents/US2957880" class="external text external">U.S. Patent 2,957,880</a></span> Issue date: 25 October 1960</span></li><li id="cite_note-books.google.com-134"> <span id="mw-reference-text-cite_note-books.google.com-134" class="mw-reference-text"><cite class="citation book cs1">Myers RL (August 2007). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/100mostimportant0000myer  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/100mostimportant0000myer'" tppabs="https://archive.org/details/100mostimportant0000myer" class="external text external"><i>The 100 most important chemical compounds: a reference guide</i></a></span>. ABC-CLIO. p.<span>&nbsp;</span><a href="javascript:if(confirm('https://archive.org/details/100mostimportant0000myer/page/178  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/100mostimportant0000myer/page/178'" tppabs="https://archive.org/details/100mostimportant0000myer/page/178" class="external text external">178</a>. ISBN<span>&nbsp;</span><bdi>978-0-313-33758-1</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">10 September</span> 2010</span>. <q>named ritalin after his wife.</q></cite></span></li><li id="cite_note-135"> <span id="mw-reference-text-cite_note-135" class="mw-reference-text"><cite id="CITEREFStolerman2010" class="citation book cs1">Stolerman I (2010). <i>Encyclopedia of psychopharmacology</i>. Berlin London: Springer. p.<span>&nbsp;</span>763. ISBN<span>&nbsp;</span><bdi>978-3540686989</bdi>.</cite></span></li><li id="cite_note-136"> <span id="mw-reference-text-cite_note-136" class="mw-reference-text"><cite id="CITEREFMcCrossin1995" class="citation web cs1">McCrossin S (1995). <a href="javascript:if(confirm('https://web.archive.org/web/20120824105824/http://www.crossinology.com/pdf/RITALINus.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120824105824/http://www.crossinology.com/pdf/RITALINus.pdf'" tppabs="https://web.archive.org/web/20120824105824/http://www.crossinology.com/pdf/RITALINus.pdf" class="external text external">"Ritalin and Attention Deficit Disorder: History of its Use, Effects and Side Effects"</a> <span class="cs1-format">(PDF)</span>. Archived from <a href="javascript:if(confirm('http://www.crossinology.com/pdf/RITALINus.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.crossinology.com/pdf/RITALINus.pdf'" tppabs="http://www.crossinology.com/pdf/RITALINus.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 24 August 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">22 July</span> 2014</span>.</cite></span></li><li id="cite_note-137"> <span id="mw-reference-text-cite_note-137" class="mw-reference-text">Bradley, Charles. Benzedrine® and Dexedrine® in the Treatment of Children's Behavior Disorders. <i>Pediatrics</i> 1950; 5:1 24–37</span></li><li id="cite_note-138"> <span id="mw-reference-text-cite_note-138" class="mw-reference-text"><cite id="CITEREFWoodworth2000" class="citation web cs1">Woodworth T (16 May 2000). <a href="javascript:if(confirm('https://web.archive.org/web/20071012061712/http://www.dea.gov/pubs/cngrtest/ct051600.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20071012061712/http://www.dea.gov/pubs/cngrtest/ct051600.htm'" tppabs="https://web.archive.org/web/20071012061712/http://www.dea.gov/pubs/cngrtest/ct051600.htm" class="external text external">"DEA Congressional Testimony"</a>. Archived from <a href="javascript:if(confirm('http://www.dea.gov/pubs/cngrtest/ct051600.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.dea.gov/pubs/cngrtest/ct051600.htm'" tppabs="http://www.dea.gov/pubs/cngrtest/ct051600.htm" class="external text external">the original</a> on 12 October 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">2 November</span> 2007</span>.</cite></span></li><li id="cite_note-139"> <span id="mw-reference-text-cite_note-139" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.centerwatch.com/drug-information/fda-approvals/drug-details.aspx?DrugID=637  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.centerwatch.com/drug-information/fda-approvals/drug-details.aspx?DrugID=637'" tppabs="http://www.centerwatch.com/drug-information/fda-approvals/drug-details.aspx?DrugID=637" class="external text external">"Newly Approved Drug Therapies (637) Concerta, Alza"</a>. <i>CenterWatch</i><span class="reference-accessdate">. Retrieved <span class="nowrap">30 April</span> 2011</span>.</cite></span></li><li id="cite_note-:0-140"> <span id="mw-reference-text-cite_note-:0-140" class="mw-reference-text"><cite id="CITEREFMoscibrodzkiKatz2018" class="citation web cs1">Moscibrodzki P, Katz C (8 December 2018). <a href="javascript:if(confirm('https://www.who.int/selection_medicines/committees/expert/22/applications/s24_methylphenidate.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.who.int/selection_medicines/committees/expert/22/applications/s24_methylphenidate.pdf'" tppabs="https://www.who.int/selection_medicines/committees/expert/22/applications/s24_methylphenidate.pdf" class="external text external">"Application for Inclusion to the 22nd Expert Committee on the Selection and Use of Essential Medicines: METHYLPHENIDATE HYDROCHLORIDE"</a> <span class="cs1-format">(PDF)</span>. <i>World Health Organization</i><span class="reference-accessdate">. Retrieved <span class="nowrap">16 November</span> 2019</span>.</cite></span></li><li id="cite_note-141"> <span id="mw-reference-text-cite_note-141" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021121s038lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021121s038lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021121s038lbl.pdf" class="external text external">"Label for CONCERTA (methylphenidate HCI) Extended-Release Tablets"</a> <span class="cs1-format">(PDF)</span>. FDA. January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">18 June</span> 2020</span>.</cite></span></li><li id="cite_note-142"> <span id="mw-reference-text-cite_note-142" class="mw-reference-text"><cite id="CITEREFLehmannWojnowicz2016" class="citation journal cs1">Lehmann DF, Wojnowicz S (April 2016). "The Evergreening of Biopharmaceuticals: Time to Defoliate". <i>Journal of Clinical Pharmacology</i>. <b>56</b> (4): 383–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fjcph.642  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fjcph.642'" tppabs="https://doi.org/10.1002%2Fjcph.642" class="external text external">10.1002/jcph.642</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26388527  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26388527'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26388527" class="external text external">26388527</a>.</cite></span></li><li id="cite_note-DailyMed_2017-143"> <span id="mw-reference-text-cite_note-DailyMed_2017-143" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=effd952d-ac94-47bb-b107-589a4934dcca  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=effd952d-ac94-47bb-b107-589a4934dcca'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=effd952d-ac94-47bb-b107-589a4934dcca" class="external text external">"RITALIN LA- methylphenidate hydrochloride capsule, extended release"</a>. <i>DailyMed</i>. 5 January 2017. <a href="javascript:if(confirm('https://web.archive.org/web/20170326230529/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=effd952d-ac94-47bb-b107-589a4934dcca  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170326230529/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=effd952d-ac94-47bb-b107-589a4934dcca'" tppabs="https://web.archive.org/web/20170326230529/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=effd952d-ac94-47bb-b107-589a4934dcca" class="external text external">Archived</a> from the original on 26 March 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">10 September</span> 2018</span>.</cite></span></li><li id="cite_note-DailyMed_2018-144"> <span id="mw-reference-text-cite_note-DailyMed_2018-144" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd" class="external text external">"CONCERTA- methylphenidate hydrochloride tablet, extended release"</a>. <i>DailyMed</i>. 9 March 2018. <a href="javascript:if(confirm('https://web.archive.org/web/20170326230808/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170326230808/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd'" tppabs="https://web.archive.org/web/20170326230808/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd" class="external text external">Archived</a> from the original on 26 March 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">10 September</span> 2018</span>.</cite></span></li><li id="cite_note-145"> <span id="mw-reference-text-cite_note-145" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20130101125300/http://www.psych.uic.edu/docassist/ClinicalResources.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20130101125300/http://www.psych.uic.edu/docassist/ClinicalResources.html'" tppabs="https://web.archive.org/web/20130101125300/http://www.psych.uic.edu/docassist/ClinicalResources.html" class="external text external">"Education/Training<span>&nbsp;</span>» Clinical Resources"</a>. <i>Illinois DocAssist website</i>. University of Illinois at Chicago. Archived from <a href="javascript:if(confirm('http://www.psych.uic.edu/docassist/ClinicalResources.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.psych.uic.edu/docassist/ClinicalResources.html'" tppabs="http://www.psych.uic.edu/docassist/ClinicalResources.html" class="external text external">the original</a> on 1 January 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">26 July</span> 2012</span>. <q>Ritalin‑SR, methylphenidate<span>&nbsp;</span>SR, Methylin<span>&nbsp;</span>ER, and Metadate<span>&nbsp;</span>ER are the same formulation and have the same drug delivery system</q></cite></span></li><li id="cite_note-146"> <span id="mw-reference-text-cite_note-146" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://webprod3.hc-sc.gc.ca/dpd-bdpp/item-iteme.do?pm-mp=00001210  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://webprod3.hc-sc.gc.ca/dpd-bdpp/item-iteme.do?pm-mp=00001210'" tppabs="http://webprod3.hc-sc.gc.ca/dpd-bdpp/item-iteme.do?pm-mp=00001210" class="external text external">"Apo‑Methylphenidate<span>&nbsp;</span>SR product monograph"</a> <span class="cs1-format">(PDF)</span>. Apotex Inc. 31 March 2005. "Comparative Bioavailability" section<span class="reference-accessdate">. Retrieved <span class="nowrap">26 July</span> 2012</span>.</cite></span></li><li id="cite_note-147"> <span id="mw-reference-text-cite_note-147" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.rxbriefcase.com/rxNow/Archive/Sandoz/506_Methylphenidate%20SR%20launch%20Fax_EN.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rxbriefcase.com/rxNow/Archive/Sandoz/506_Methylphenidate%20SR%20launch%20Fax_EN.pdf'" tppabs="http://www.rxbriefcase.com/rxNow/Archive/Sandoz/506_Methylphenidate%20SR%20launch%20Fax_EN.pdf" class="external text external">"New product: Sandoz Methylphenidate<span>&nbsp;</span>SR 20 mg"</a> <span class="cs1-format">(PDF)</span>. Sandoz Canada Inc. 5 May 2009. <a href="javascript:if(confirm('https://web.archive.org/web/20121203062249/http://www.rxbriefcase.com/rxNow/Archive/Sandoz/506_Methylphenidate%20SR%20launch%20Fax_EN.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20121203062249/http://www.rxbriefcase.com/rxNow/Archive/Sandoz/506_Methylphenidate%20SR%20launch%20Fax_EN.pdf'" tppabs="https://web.archive.org/web/20121203062249/http://www.rxbriefcase.com/rxNow/Archive/Sandoz/506_Methylphenidate%20SR%20launch%20Fax_EN.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 3 December 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">26 July</span> 2012</span>. <q>An alternative to Ritalin‑SR from Novartis</q></cite></span></li><li id="cite_note-usfda-drugdb-148"> <span id="mw-reference-text-cite_note-usfda-drugdb-148" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm" class="external text external">"Drugs@FDA: FDA Approved Drug Products"</a>. <i>Drugs@FDA: FDA Approved Drug Products</i>. US Food and Drug Administration. <a href="javascript:if(confirm('https://web.archive.org/web/20161002201213/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161002201213/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm'" tppabs="https://web.archive.org/web/20161002201213/http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm" class="external text external">Archived</a> from the original on 2 October 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">1 October</span> 2016</span>.</cite></span></li><li id="cite_note-pmid19881943-150"> <span id="mw-reference-text-cite_note-pmid19881943-150" class="mw-reference-text"><cite id="CITEREFHosenbocusChahal2009" class="citation journal cs1">Hosenbocus S, Chahal R (November 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765387  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765387'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765387" class="external text external">"A review of long-acting medications for ADHD in Canada"</a>. <i>Journal of the Canadian Academy of Child and Adolescent Psychiatry</i>. <b>18</b> (4): 331–9. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765387  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765387'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765387" class="external text external">2765387</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19881943  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19881943'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19881943" class="external text external">19881943</a>.</cite></span></li><li id="cite_note-151"> <span id="mw-reference-text-cite_note-151" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.aptensioxr.com/resources/full-prescribing-information.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.aptensioxr.com/resources/full-prescribing-information.pdf'" tppabs="http://www.aptensioxr.com/resources/full-prescribing-information.pdf" class="external text external">"Aptensio XR Prescribing Information"</a> <span class="cs1-format">(PDF)</span>. <a href="javascript:if(confirm('https://web.archive.org/web/20170202000406/http://www.aptensioxr.com/resources/full-prescribing-information.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170202000406/http://www.aptensioxr.com/resources/full-prescribing-information.pdf'" tppabs="https://web.archive.org/web/20170202000406/http://www.aptensioxr.com/resources/full-prescribing-information.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2 February 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">15 April</span> 2017</span>.</cite></span></li><li id="cite_note-Moses-155"> <span id="mw-reference-text-cite_note-Moses-155" class="mw-reference-text"><cite id="CITEREFMoses2009" class="citation web cs1">Moses S (26 July 2009). <a href="javascript:if(confirm('http://www.fpnotebook.com/peds/Pharm/Mthylphndt.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.fpnotebook.com/peds/Pharm/Mthylphndt.htm'" tppabs="http://www.fpnotebook.com/peds/Pharm/Mthylphndt.htm" class="external text external">"Methylphenidate"</a>. <i>Family Practice Notebook</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20120914020554/http://www.fpnotebook.com/Peds/Pharm/Mthylphndt.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120914020554/http://www.fpnotebook.com/Peds/Pharm/Mthylphndt.htm'" tppabs="https://web.archive.org/web/20120914020554/http://www.fpnotebook.com/Peds/Pharm/Mthylphndt.htm" class="external text external">Archived</a> from the original on 14 September 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">7 August</span> 2012</span>.</cite></span></li><li id="cite_note-156"> <span id="mw-reference-text-cite_note-156" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.webmd.com/drugs/2/drug-144192/daytrana+transdermal/details  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.webmd.com/drugs/2/drug-144192/daytrana+transdermal/details'" tppabs="http://www.webmd.com/drugs/2/drug-144192/daytrana+transdermal/details" class="external text external">"Daytrana transdermal"</a>. WebMD. <a href="javascript:if(confirm('https://web.archive.org/web/20150611051920/http://www.webmd.com/drugs/2/drug-144192/daytrana+transdermal/details  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150611051920/http://www.webmd.com/drugs/2/drug-144192/daytrana+transdermal/details'" tppabs="https://web.archive.org/web/20150611051920/http://www.webmd.com/drugs/2/drug-144192/daytrana+transdermal/details" class="external text external">Archived</a> from the original on 11 June 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">11 June</span> 2015</span>.</cite></span></li><li id="cite_note-158"> <span id="mw-reference-text-cite_note-158" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20170416125833/https://www.pfizermedicalinformation.com/en-us/quillichew-er  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170416125833/https://www.pfizermedicalinformation.com/en-us/quillichew-er'" tppabs="https://web.archive.org/web/20170416125833/https://www.pfizermedicalinformation.com/en-us/quillichew-er" class="external text external">"QUILLICHEW ER™ (Methylphenidate HCl extended-release chewable tablets CII) | Pfizer Medical Information – US"</a>. <i>www.pfizermedicalinformation.com</i>. Pfizer. Archived from <a href="javascript:if(confirm('https://www.pfizermedicalinformation.com/en-us/quillichew-er  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pfizermedicalinformation.com/en-us/quillichew-er'" tppabs="https://www.pfizermedicalinformation.com/en-us/quillichew-er" class="external text external">the original</a> on 16 April 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">16 April</span> 2017</span>.</cite></span></li><li id="cite_note-163"> <span id="mw-reference-text-cite_note-163" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20110107153016/http://pediatrics.about.com/cs/adhd/a/concerta.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110107153016/http://pediatrics.about.com/cs/adhd/a/concerta.htm'" tppabs="https://web.archive.org/web/20110107153016/http://pediatrics.about.com/cs/adhd/a/concerta.htm" class="external text external">"Concerta for Kids with ADHD"</a>. <i>Pediatrics.about.com</i>. 1 April 2003. Archived from <a href="javascript:if(confirm('http://pediatrics.about.com/cs/adhd/a/concerta.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://pediatrics.about.com/cs/adhd/a/concerta.htm'" tppabs="http://pediatrics.about.com/cs/adhd/a/concerta.htm" class="external text external">the original</a> on 7 January 2011.</cite></span></li><li id="cite_note-164"> <span id="mw-reference-text-cite_note-164" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20110326160650/http://www.rxlist.com/concerta-drug.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110326160650/http://www.rxlist.com/concerta-drug.htm'" tppabs="https://web.archive.org/web/20110326160650/http://www.rxlist.com/concerta-drug.htm" class="external text external">"Concerta (Methylphenidate Extended-Release Tablets) Drug Information: User Reviews, Side Effects, Drug Interactions and Dosage"</a>. <i>RxList</i>. Archived from <a href="javascript:if(confirm('http://www.rxlist.com/concerta-drug.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rxlist.com/concerta-drug.htm'" tppabs="http://www.rxlist.com/concerta-drug.htm" class="external text external">the original</a> on 26 March 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">30 April</span> 2011</span>.</cite></span></li><li id="cite_note-165"> <span id="mw-reference-text-cite_note-165" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20110710185835/http://adhd.emedtv.com/metadate-cd/metadate-cd.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110710185835/http://adhd.emedtv.com/metadate-cd/metadate-cd.html'" tppabs="https://web.archive.org/web/20110710185835/http://adhd.emedtv.com/metadate-cd/metadate-cd.html" class="external text external">"Metadate<span>&nbsp;</span>CD"</a>. Archived from <a href="javascript:if(confirm('http://adhd.emedtv.com/metadate-cd/metadate-cd.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://adhd.emedtv.com/metadate-cd/metadate-cd.html'" tppabs="http://adhd.emedtv.com/metadate-cd/metadate-cd.html" class="external text external">the original</a> on 10 July 2011.</cite></span></li><li id="cite_note-166"> <span id="mw-reference-text-cite_note-166" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20141018052155/http://labeling.pfizer.com/ShowLabeling.aspx?id=965  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141018052155/http://labeling.pfizer.com/ShowLabeling.aspx?id=965'" tppabs="https://web.archive.org/web/20141018052155/http://labeling.pfizer.com/ShowLabeling.aspx?id=965" class="external text external">"QUILLIVANT XR- methylphenidate hydrochloride powder, for suspension NextWave Pharmaceuticals, Inc"</a>. <i>Quillivant PI Sheet</i>. Archived from <a href="javascript:if(confirm('http://labeling.pfizer.com/ShowLabeling.aspx?id=965  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://labeling.pfizer.com/ShowLabeling.aspx?id=965'" tppabs="http://labeling.pfizer.com/ShowLabeling.aspx?id=965" class="external text external">the original</a> on 18 October 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">13 October</span> 2014</span>.</cite></span></li><li id="cite_note-167"> <span id="mw-reference-text-cite_note-167" class="mw-reference-text"><a href="javascript:if(confirm('https://www.fda.gov/ohrms/dockets/AC/05/briefing/2005-4195B1_01_04-Noven-Appendix-3.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/ohrms/dockets/AC/05/briefing/2005-4195B1_01_04-Noven-Appendix-3.pdf'" tppabs="https://www.fda.gov/ohrms/dockets/AC/05/briefing/2005-4195B1_01_04-Noven-Appendix-3.pdf" class="external free external">https://www.fda.gov/ohrms/dockets/AC/05/briefing/2005-4195B1_01_04-Noven-Appendix-3.pdf</a></span></li><li id="cite_note-168"> <span id="mw-reference-text-cite_note-168" class="mw-reference-text"><cite class="citation journal cs1">Heal DJ, Pierce DM (2006). "Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system". <i>CNS Drugs</i>. <b>20</b> (9): 713–738 (Page:730). doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00023210-200620090-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00023210-200620090-00002'" tppabs="https://doi.org/10.2165%2F00023210-200620090-00002" class="external text external">10.2165/00023210-200620090-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16953648  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16953648'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16953648" class="external text external">16953648</a>.</cite><br>- <cite id="CITEREFAnderson_Vanessa_R.Lesley_J._Scott2006" class="citation journal cs1">Anderson Vanessa R.; Lesley J. Scott (2006). "Methylphenidate Transdermal System In Attention-Deficit Hyperactivity Disorder in Children". <i>Drugs</i>. <b>66</b> (8): 1117–1126. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200666080-00007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200666080-00007'" tppabs="https://doi.org/10.2165%2F00003495-200666080-00007" class="external text external">10.2165/00003495-200666080-00007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16789796  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16789796'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16789796" class="external text external">16789796</a>.</cite></span></li><li id="cite_note-insert-169"> <span id="mw-reference-text-cite_note-insert-169" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20140801210601/http://www.daytrana.com/Content/documents/daytrana-prescribing-information.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140801210601/http://www.daytrana.com/Content/documents/daytrana-prescribing-information.pdf'" tppabs="https://web.archive.org/web/20140801210601/http://www.daytrana.com/Content/documents/daytrana-prescribing-information.pdf" class="external text external">"Product Information: DAYTRANA(R) transdermal patch, methylphenidate transdermal patch"</a> <span class="cs1-format">(PDF)</span>. 2010. Archived from <a href="javascript:if(confirm('http://www.daytrana.com/Content/documents/daytrana-prescribing-information.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.daytrana.com/Content/documents/daytrana-prescribing-information.pdf'" tppabs="http://www.daytrana.com/Content/documents/daytrana-prescribing-information.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 1 August 2014.</cite></span></li><li id="cite_note-170"> <span id="mw-reference-text-cite_note-170" class="mw-reference-text">The <a href="javascript:if(confirm('https://www.healthinfo.moh.gov.on.ca/formulary/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.healthinfo.moh.gov.on.ca/formulary/'" tppabs="https://www.healthinfo.moh.gov.on.ca/formulary/" class="external text external">Ontario Drug Benefit online formulary</a> indicates that, in Ontario, Canada, the local most-expensive methylphenidate product is probably Concerta. Drug prices in the US are often higher than in Canada. The GoodRx website correctly points out that short-term refills (e.g. 30 tablets) often cost more per tablet than longer-term refills (e.g. 90 tablets). For 30 tablets of brand-name Concerta 27 mg, the relevant <a href="javascript:if(confirm('http://www.goodrx.com/concerta?form=tablet&dosage=27mg&quantity=30&days_supply=&label_override=Concerta  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.goodrx.com/concerta?form=tablet&dosage=27mg&quantity=30&days_supply=&label_override=Concerta'" tppabs="http://www.goodrx.com/concerta?form=tablet&dosage=27mg&quantity=30&days_supply=&label_override=Concerta" class="external text external">GoodRx webpage</a> <a href="javascript:if(confirm('https://web.archive.org/web/20160605082649/http://www.goodrx.com/concerta?form=tablet&dosage=27mg&quantity=30&days_supply=&label_override=Concerta  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160605082649/http://www.goodrx.com/concerta?form=tablet&dosage=27mg&quantity=30&days_supply=&label_override=Concerta'" tppabs="https://web.archive.org/web/20160605082649/http://www.goodrx.com/concerta?form=tablet&dosage=27mg&quantity=30&days_supply=&label_override=Concerta" class="external text external">Archived</a><span> 5 June 2016 at the </span>Wayback Machine offers coupons. However, if a patient ignores the coupons, and if the patient does not shop around, the website indicates that it is possible to pay more than twelve US dollars per defined daily dose. Data retrieved 17 May 2016.</span></li><li id="cite_note-171"> <span id="mw-reference-text-cite_note-171" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20120831222336/http://www.incb.org/pdf/e/list/green.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120831222336/http://www.incb.org/pdf/e/list/green.pdf'" tppabs="https://web.archive.org/web/20120831222336/http://www.incb.org/pdf/e/list/green.pdf" class="external text external">"Green List: Annex to the annual statistical report on psychotropic substances (form P)"</a> <span class="cs1-format">(PDF)</span>. Archived from <a href="javascript:if(confirm('http://www.incb.org/pdf/e/list/green.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.incb.org/pdf/e/list/green.pdf'" tppabs="http://www.incb.org/pdf/e/list/green.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 31 August 2012.</cite><span>&nbsp;</span><span style="font-size:85%;">(1.63<span>&nbsp;</span>MB)</span> 23rd edition. August 2003. International Narcotics Board, Vienna International Centre. Retrieved 2 March 2006.</span></li><li id="cite_note-ABC-172"> <span id="mw-reference-text-cite_note-ABC-172" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.statutelaw.gov.uk/content.aspx?LegType=All+Legislation&title=The+Misuse+of+Drugs+Act+1971&searchEnacted=0&extentMatchOnly=0&confersPower=0&blanketAmendment=0&sortAlpha=0&TYPE=QS&PageNumber=1&NavFrom=0&parentActiveTextDocId=1367412&ActiveTextDocId=1367471&filesize=1699  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.statutelaw.gov.uk/content.aspx?LegType=All+Legislation&title=The+Misuse+of+Drugs+Act+1971&searchEnacted=0&extentMatchOnly=0&confersPower=0&blanketAmendment=0&sortAlpha=0&TYPE=QS&PageNumber=1&NavFrom=0&parentActiveTextDocId=1367412&ActiveTextDocId=1367471&filesize=1699'" tppabs="http://www.statutelaw.gov.uk/content.aspx?LegType=All+Legislation&title=The+Misuse+of+Drugs+Act+1971&searchEnacted=0&extentMatchOnly=0&confersPower=0&blanketAmendment=0&sortAlpha=0&TYPE=QS&PageNumber=1&NavFrom=0&parentActiveTextDocId=1367412&ActiveTextDocId=1367471&filesize=1699" class="external text external">"Misuse of Drugs Act 1971 (c. 38): SCHEDULE 2: Controlled Drugs"</a>. Office of Public Sector Information<span class="reference-accessdate">. Retrieved <span class="nowrap">15 June</span> 2009</span>.</cite></span></li><li id="cite_note-173"> <span id="mw-reference-text-cite_note-173" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://laws-lois.justice.gc.ca/eng/acts/C-38.8/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://laws-lois.justice.gc.ca/eng/acts/C-38.8/'" tppabs="http://laws-lois.justice.gc.ca/eng/acts/C-38.8/" class="external text external">"Controlled Drugs and Substances Act (S.C. 1996, c. 19)"</a>. 25 April 2017. <a href="javascript:if(confirm('https://web.archive.org/web/20110403004630/http://laws-lois.justice.gc.ca/eng/acts/C-38.8/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110403004630/http://laws-lois.justice.gc.ca/eng/acts/C-38.8/'" tppabs="https://web.archive.org/web/20110403004630/http://laws-lois.justice.gc.ca/eng/acts/C-38.8/" class="external text external">Archived</a> from the original on 3 April 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">26 April</span> 2017</span>.</cite></span></li><li id="cite_note-174"> <span id="mw-reference-text-cite_note-174" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.comlaw.gov.au/Details/F2015C00043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.comlaw.gov.au/Details/F2015C00043'" tppabs="https://www.comlaw.gov.au/Details/F2015C00043" class="external text external">"Poisons Standard 2012 as amended made under paragraph 52D(2)(a) of the Therapeutic Goods Act 1989"</a>. Therapeutic Goods Administration. 27 November 2014. <a href="javascript:if(confirm('https://web.archive.org/web/20150701012941/https://www.comlaw.gov.au/Details/F2015C00043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150701012941/https://www.comlaw.gov.au/Details/F2015C00043'" tppabs="https://web.archive.org/web/20150701012941/https://www.comlaw.gov.au/Details/F2015C00043" class="external text external">Archived</a> from the original on 1 July 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">28 June</span> 2015</span>.</cite></span></li><li id="cite_note-175"> <span id="mw-reference-text-cite_note-175" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://government.ru/media/files/AXPVbdY3sc4.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://government.ru/media/files/AXPVbdY3sc4.pdf'" tppabs="http://government.ru/media/files/AXPVbdY3sc4.pdf" class="external text external">"Decree of the Government of Russian Federation on 25 October 2014 № 1102"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">17 October</span> 2019</span>.</cite></span></li><li id="cite_note-Narkotikastrafflag-176"> <span id="mw-reference-text-cite_note-Narkotikastrafflag-176" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://lagen.nu/1968:64  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://lagen.nu/1968:64'" tppabs="https://lagen.nu/1968:64" class="external text external">"Narkotikastrafflag (1968:64)"</a>. Ministry of Justice. <a href="javascript:if(confirm('https://web.archive.org/web/20131006112822/https://lagen.nu/1968:64  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20131006112822/https://lagen.nu/1968:64'" tppabs="https://web.archive.org/web/20131006112822/https://lagen.nu/1968:64" class="external text external">Archived</a> from the original on 6 October 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">15 January</span> 2014</span>.</cite></span></li><li id="cite_note-pmid14678352-177"> <span id="mw-reference-text-cite_note-pmid14678352-177" class="mw-reference-text"><cite id="CITEREFFrancesHoizeyMillartTrenque2004" class="citation journal cs1">Frances C, Hoizey G, Millart H, Trenque T (January 2004). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884413  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884413'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884413" class="external text external">"Paediatric methylphenidate (Ritalin) restrictive conditions of prescription in France"</a>. <i>Br J Clin Pharmacol</i>. <b>57</b> (1): 115–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1365-2125.2003.01943.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1365-2125.2003.01943.x'" tppabs="https://doi.org/10.1046%2Fj.1365-2125.2003.01943.x" class="external text external">10.1046/j.1365-2125.2003.01943.x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884413  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884413'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884413" class="external text external">1884413</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14678352  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14678352'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14678352" class="external text external">14678352</a>.</cite></span></li><li id="cite_note-178"> <span id="mw-reference-text-cite_note-178" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.mohfw.nic.in/showfile.php?lid=3036  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.mohfw.nic.in/showfile.php?lid=3036'" tppabs="http://www.mohfw.nic.in/showfile.php?lid=3036" class="external text external">"The Drugs and Cosmetics Rules, 1945"</a>. <i>Ministry of Health &amp; Family Welfare</i>. Government of India. 15 August 2013. pp.<span>&nbsp;</span>729–730. <a href="javascript:if(confirm('https://web.archive.org/web/20160808040545/http://mohfw.nic.in/showfile.php?lid=3036  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160808040545/http://mohfw.nic.in/showfile.php?lid=3036'" tppabs="https://web.archive.org/web/20160808040545/http://mohfw.nic.in/showfile.php?lid=3036" class="external text external">Archived</a> from the original on 8 August 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">5 December</span> 2016</span>.</cite></span></li><li id="cite_note-NCB-179"> <span id="mw-reference-text-cite_note-NCB-179" class="mw-reference-text"><cite id="CITEREFMehtaNarcotics_Control_Bureau" class="citation web cs1">Mehta R, Narcotics Control Bureau. <a href="javascript:if(confirm('http://narcoticsindia.nic.in/upload/download/document_idd8a4e572d866aa45da78418d9d2ff9f9.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://narcoticsindia.nic.in/upload/download/document_idd8a4e572d866aa45da78418d9d2ff9f9.pdf'" tppabs="http://narcoticsindia.nic.in/upload/download/document_idd8a4e572d866aa45da78418d9d2ff9f9.pdf" class="external text external">"Drug Law Enforcement Field Officers' Hand Book"</a> <span class="cs1-format">(PDF)</span>. Ministry of Home Affairs, Government of India. p.<span>&nbsp;</span>145. <a href="javascript:if(confirm('https://web.archive.org/web/20170305004634/http://narcoticsindia.nic.in/upload/download/document_idd8a4e572d866aa45da78418d9d2ff9f9.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170305004634/http://narcoticsindia.nic.in/upload/download/document_idd8a4e572d866aa45da78418d9d2ff9f9.pdf'" tppabs="https://web.archive.org/web/20170305004634/http://narcoticsindia.nic.in/upload/download/document_idd8a4e572d866aa45da78418d9d2ff9f9.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 5 March 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">5 December</span> 2016</span>.</cite></span></li><li id="cite_note-180"> <span id="mw-reference-text-cite_note-180" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.elegislation.gov.hk/hk/cap134?xpid=ID_1438402701417_001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.elegislation.gov.hk/hk/cap134?xpid=ID_1438402701417_001'" tppabs="https://www.elegislation.gov.hk/hk/cap134?xpid=ID_1438402701417_001" class="external text external">"Hong Kong e-Legislation"</a>.</cite></span></li><li id="cite_note-pmid17949504-181"> <span id="mw-reference-text-cite_note-pmid17949504-181" class="mw-reference-text"><cite id="CITEREFLakhanHagger-Johnson2007" class="citation journal cs1">Lakhan SE, Hagger-Johnson GE (2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100041  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100041'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100041" class="external text external">"The impact of prescribed psychotropics on youth"</a>. <i>Clin Pract Epidemiol Ment Health</i>. <b>3</b> (1): 21. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1745-0179-3-21  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1745-0179-3-21'" tppabs="https://doi.org/10.1186%2F1745-0179-3-21" class="external text external">10.1186/1745-0179-3-21</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100041  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100041'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100041" class="external text external">2100041</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17949504  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17949504'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17949504" class="external text external">17949504</a>.</cite></span></li><li id="cite_note-nih.gov-nida-29.htm-182"> <span id="mw-reference-text-cite_note-nih.gov-nida-29.htm-182" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20100528060023/http://www.nih.gov/news/pr/sept98/nida-29.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100528060023/http://www.nih.gov/news/pr/sept98/nida-29.htm'" tppabs="https://web.archive.org/web/20100528060023/http://www.nih.gov/news/pr/sept98/nida-29.htm" class="external text external">"New Research Helps Explain Ritalin's Low Abuse Potential When Taken As Prescribed"</a>. <i>NIH.gov</i>. 29 September 1998. Archived from <a href="javascript:if(confirm('http://www.nih.gov/news/pr/sept98/nida-29.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nih.gov/news/pr/sept98/nida-29.htm'" tppabs="http://www.nih.gov/news/pr/sept98/nida-29.htm" class="external text external">the original</a> on 28 May 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">30 April</span> 2011</span>.</cite></span></li><li id="cite_note-drugabuse.gov-ADHDFacts-183"> <span id="mw-reference-text-cite_note-drugabuse.gov-ADHDFacts-183" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20100326223023/http://www.drugabuse.gov/infofacts/ADHD.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100326223023/http://www.drugabuse.gov/infofacts/ADHD.html'" tppabs="https://web.archive.org/web/20100326223023/http://www.drugabuse.gov/infofacts/ADHD.html" class="external text external">"Stimulant ADHD Medications: Methylphenidate and Amphetamines"</a>. NIDA InfoFacts. <i>Drugabuse.gov</i>. Archived from <a href="javascript:if(confirm('http://www.drugabuse.gov/InfoFacts/ADHD.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.drugabuse.gov/InfoFacts/ADHD.html'" tppabs="http://www.drugabuse.gov/InfoFacts/ADHD.html" class="external text external">the original</a> on 26 March 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">30 April</span> 2011</span>.</cite></span></li><li id="cite_note-184"> <span id="mw-reference-text-cite_note-184" class="mw-reference-text"><cite id="CITEREFSchoenfelderFaraoneKollins2014" class="citation journal cs1">Schoenfelder EN, Faraone SV, Kollins SH (June 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531271  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531271'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531271" class="external text external">"Stimulant treatment of ADHD and cigarette smoking: a meta-analysis"</a>. <i>Pediatrics</i>. <b>133</b> (6): 1070–80. doi:<a href="javascript:if(confirm('https://doi.org/10.1542%2Fpeds.2014-0179  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1542%2Fpeds.2014-0179'" tppabs="https://doi.org/10.1542%2Fpeds.2014-0179" class="external text external">10.1542/peds.2014-0179</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531271  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531271'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531271" class="external text external">4531271</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24819571  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24819571'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24819571" class="external text external">24819571</a>.</cite></span></li><li id="cite_note-185"> <span id="mw-reference-text-cite_note-185" class="mw-reference-text"><cite id="CITEREFKarlstadZoëgaFuruBahmanyar2016" class="citation journal cs1">Karlstad Ø, Zoëga H, Furu K, Bahmanyar S, Martikainen JE, Kieler H, Pottegård A (December 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110707  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110707'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110707" class="external text external">"Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries"</a>. <i>European Journal of Clinical Pharmacology</i>. <b>72</b> (12): 1507–1514. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00228-016-2125-y  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00228-016-2125-y'" tppabs="https://doi.org/10.1007%2Fs00228-016-2125-y" class="external text external">10.1007/s00228-016-2125-y</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110707  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110707'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110707" class="external text external">5110707</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27586399  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27586399'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27586399" class="external text external">27586399</a>.</cite></span></li><li id="cite_note-186"> <span id="mw-reference-text-cite_note-186" class="mw-reference-text"><cite id="CITEREFBjarnadottirHaraldssonRafnarSigurdsson2016" class="citation journal cs1">Bjarnadottir GD, Haraldsson HM, Rafnar BO, Sigurdsson E, Steingrimsson S, Johannsson M,  et al. (29 November 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450903  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450903'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450903" class="external text external">"Prevalent intravenous abuse of methylphenidate among treatment-seeking patients with substance abuse disorders: a descriptive population-based study"</a>. <i>Journal of Addiction Medicine</i>. <b>9</b> (3): 188–94. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FADM.0000000000000115  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FADM.0000000000000115'" tppabs="https://doi.org/10.1097%2FADM.0000000000000115" class="external text external">10.1097/ADM.0000000000000115</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450903  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450903'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450903" class="external text external">4450903</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25748561  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25748561'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25748561" class="external text external">25748561</a>.</cite></span></li><li id="cite_note-187"> <span id="mw-reference-text-cite_note-187" class="mw-reference-text"><cite id="CITEREFOuellette1991" class="citation journal cs1">Ouellette EM (1991). "Legal issues in the treatment of children with attention deficit hyperactivity disorder". <i>Journal of Child Neurology</i>. 6 Suppl: S68-75. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0883073891006001S08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0883073891006001S08'" tppabs="https://doi.org/10.1177%2F0883073891006001S08" class="external text external">10.1177/0883073891006001S08</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2002217  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2002217'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2002217" class="external text external">2002217</a>.</cite></span></li><li id="cite_note-188"> <span id="mw-reference-text-cite_note-188" class="mw-reference-text"><cite id="CITEREFTheleritisSiarkosKatirtzoglouPolitis2017" class="citation journal cs1">Theleritis C, Siarkos K, Katirtzoglou E, Politis A (January 2017). "Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease<span>&nbsp;</span>: A systematic review across modalities". <i>Journal of Geriatric Psychiatry and Neurology</i>. <b>30</b> (1): 26–49. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F0891988716678684  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F0891988716678684'" tppabs="https://doi.org/10.1177%2F0891988716678684" class="external text external">10.1177/0891988716678684</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28248559  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28248559'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28248559" class="external text external">28248559</a>.</cite></span></li><li id="cite_note-pmid14981214-189"> <span id="mw-reference-text-cite_note-pmid14981214-189" class="mw-reference-text"><cite id="CITEREFLeddyEpsteinJaroniRoemmich2004" class="citation journal cs1">Leddy JJ, Epstein LH, Jaroni JL, Roemmich JN, Paluch RA, Goldfield GS, Lerman C (February 2004). "Influence of methylphenidate on eating in obese men". <i>Obesity Research</i>. <b>12</b> (2): 224–32. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Foby.2004.29  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Foby.2004.29'" tppabs="https://doi.org/10.1038%2Foby.2004.29" class="external text external">10.1038/oby.2004.29</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14981214  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14981214'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14981214" class="external text external">14981214</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<table role="presentation" class="mbox-small  sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000">
<tbody><tr>
<td class="mbox-image"><figure-inline class="noviewer"><span><img src="../I/m/Commons-logo.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Commons-logo.svg.png" data-file-width="1024" data-file-height="1376" data-file-type="drawing" height="40" width="30"></span></figure-inline></td>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="javascript:if(confirm('https://commons.wikimedia.org/wiki/Category:Methylphenidate  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://commons.wikimedia.org/wiki/Category:Methylphenidate'" tppabs="https://commons.wikimedia.org/wiki/Category:Methylphenidate" title="commons:Category:Methylphenidate" class="external"><span style=" ">Methylphenidate</span></a></b></i>.</td></tr>
</tbody></table>
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/rn/113-45-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/rn/113-45-1'" tppabs="https://druginfo.nlm.nih.gov/drugportal/rn/113-45-1" class="external text external">"Methylphenidate"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Stimulants" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Stimulants" style="font-size:114%;margin:0 4em">Stimulants</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Adamantane.htm" tppabs="https://ptable.com/wiki/compounds/A/Adamantane" title="Adamantane">Adamantanes</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Adapromine</li>
<li><a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">Amantadine</a></li>
<li>Bromantane</li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li><a href="Rimantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimantadine" title="Rimantadine">Rimantadine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Adenosine antagonists</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="8-Chlorotheophylline-1.htm" tppabs="https://ptable.com/wiki/compounds/A/8-Chlorotheophylline" title="8-Chlorotheophylline">8-Chlorotheophylline</a></li>
<li>8-Cyclopentyltheophylline</li>
<li>8-Phenyltheophylline</li>
<li><a href="Aminophylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminophylline" title="Aminophylline">Aminophylline</a></li>
<li><a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">Caffeine</a></li>
<li>CGS-15943</li>
<li>Dimethazan</li>
<li><a href="Paraxanthine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paraxanthine" title="Paraxanthine">Paraxanthine</a></li>
<li>SCH-58261</li>
<li><a href="Theobromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Theobromine" title="Theobromine">Theobromine</a></li>
<li><a href="Theophylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Theophylline" title="Theophylline">Theophylline</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Alkylamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cyclopentamine</li>
<li>Cypenamine</li>
<li>Cyprodenate</li>
<li><a href="Heptaminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Heptaminol" title="Heptaminol">Heptaminol</a></li>
<li>Isometheptene</li>
<li>Levopropylhexedrine</li>
<li>Methylhexaneamine</li>
<li><a href="Octodrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Octodrine" title="Octodrine">Octodrine</a></li>
<li>Propylhexedrine</li>
<li><a href="Tuaminoheptane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tuaminoheptane" title="Tuaminoheptane">Tuaminoheptane</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ampakines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CX-516</li>
<li>CX-546</li>
<li>CX-614</li>
<li>CX-691</li>
<li>CX-717</li>
<li>IDRA-21</li>
<li>LY-404,187</li>
<li>LY-503,430</li>
<li>Nooglutyl</li>
<li>Org 26576</li>
<li>PEPA</li>
<li>S-18986</li>
<li>Sunifiram</li>
<li>Unifiram</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Arylcyclohexylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arylcyclohexylamine" title="Arylcyclohexylamine">Arylcyclohexylamines</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Benocyclidine</li>
<li>Dieticyclidine</li>
<li>Esketamine</li>
<li>Eticyclidine</li>
<li>Gacyclidine</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Phencyclamine</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li><a href="Rolicyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rolicyclidine" title="Rolicyclidine">Rolicyclidine</a></li>
<li><a href="Tenocyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenocyclidine" title="Tenocyclidine">Tenocyclidine</a></li>
<li>Tiletamine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Benzazepines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>6-Br-APB</li>
<li>SKF-77434</li>
<li>SKF-81297</li>
<li>SKF-82958</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cathinones</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>3-Fluoromethcathinone</li>
<li>3,4-DMMC</li>
<li>4-BMC</li>
<li>4-CMC</li>
<li>4-Methylbuphedrone</li>
<li>4-Methylcathinone</li>
<li>4-MEAP</li>
<li>4-Methylpentedrone</li>
<li><a href="Amfepramone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amfepramone" title="Amfepramone">Amfepramone</a></li>
<li>Benzedrone</li>
<li>Buphedrone</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li>Butylone</li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a></li>
<li>Dimethylcathinone</li>
<li>Ethcathinone</li>
<li>Ethylone</li>
<li>Flephedrone</li>
<li>Hexedrone</li>
<li>Isoethcathinone</li>
<li>Mephedrone</li>
<li>Methcathinone</li>
<li>Methedrone</li>
<li>Methylenedioxycathinone</li>
<li>Methylone</li>
<li>Mexedrone</li>
<li>N-Ethylbuphedrone</li>
<li>N-Ethylhexedrone</li>
<li>Pentedrone</li>
<li>Pentylone</li>
<li>Phthalimidopropiophenone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Acetylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcholine" title="Acetylcholine">Cholinergics</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>A-84,543</li>
<li>A-366,833</li>
<li>ABT-202</li>
<li>ABT-418</li>
<li>AR-R17779</li>
<li>Altinicline</li>
<li><a href="Anabasine.htm" tppabs="https://ptable.com/wiki/compounds/A/Anabasine" title="Anabasine">Anabasine</a></li>
<li><a href="Arecoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Arecoline" title="Arecoline">Arecoline</a></li>
<li>Bradanicline</li>
<li><a href="Cotinine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cotinine" title="Cotinine">Cotinine</a></li>
<li><a href="Cytisine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytisine" title="Cytisine">Cytisine</a></li>
<li>Dianicline</li>
<li>Epibatidine</li>
<li>Epiboxidine</li>
<li>GTS-21</li>
<li>Ispronicline</li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li>PHA-543,613</li>
<li>PNU-120,596</li>
<li>PNU-282,987</li>
<li>Pozanicline</li>
<li>Rivanicline</li>
<li>Sazetidine A</li>
<li>SIB-1553A</li>
<li>SSR-180,711</li>
<li>TC-1698</li>
<li>TC-1827</li>
<li>TC-2216</li>
<li>Tebanicline</li>
<li>UB-165</li>
<li><a href="Varenicline.htm" tppabs="https://ptable.com/wiki/compounds/A/Varenicline" title="Varenicline">Varenicline</a></li>
<li>WAY-317,538</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Convulsants</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Anatoxin-a.htm" tppabs="https://ptable.com/wiki/compounds/A/Anatoxin-a" title="Anatoxin-a">Anatoxin-a</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Bicuculline  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Bicuculline'" tppabs="https://ptable.com/wiki/compounds/A/Bicuculline" title="Bicuculline">Bicuculline</a></li>
<li>DMCM</li>
<li><a href="Flurothyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Flurothyl" title="Flurothyl">Flurothyl</a></li>
<li>Gabazine</li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haldol" title="Haldol" class="mw-redirect">Haldol</a></li>
<li><a href="Pentylenetetrazol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentylenetetrazol" title="Pentylenetetrazol">Pentetrazol</a></li>
<li><a href="Picrotoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Picrotoxin" title="Picrotoxin">Picrotoxin</a></li>
<li><a href="Strychnine.htm" tppabs="https://ptable.com/wiki/compounds/A/Strychnine" title="Strychnine">Strychnine</a></li>
<li>Thujone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Eugeroics</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Adrafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrafinil" title="Adrafinil">Adrafinil</a></li>
<li>Armodafinil</li>
<li>CRL-40,940</li>
<li>CRL-40,941</li>
<li>Fluorenol</li>
<li><a href="Modafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Modafinil" title="Modafinil">Modafinil</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Oxazolines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="4-Methylaminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Methylaminorex" title="4-Methylaminorex">4-Methylaminorex</a></li>
<li><a href="Aminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminorex" title="Aminorex">Aminorex</a></li>
<li>Clominorex</li>
<li>Cyclazodone</li>
<li>Fenozolone</li>
<li>Fluminorex</li>
<li><a href="Pemoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Pemoline" title="Pemoline">Pemoline</a></li>
<li>Thozalinone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenethylamines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1-(4-Methylphenyl)-2-aminobutane</li>
<li>1-Methylamino-1-(3,4-methylenedioxyphenyl)propane</li>
<li>2-Fluoroamphetamine</li>
<li>2-Fluoromethamphetamine</li>
<li><a href="2-Hydroxyphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Hydroxyphenethylamine" title="2-Hydroxyphenethylamine" class="mw-redirect">2-OH-PEA</a></li>
<li>2-Phenyl-3-aminobutane</li>
<li>2,3-MDA</li>
<li>3-Fluoroamphetamine</li>
<li>3-Fluoroethamphetamine</li>
<li>3-Methoxyamphetamine</li>
<li>3-Methylamphetamine</li>
<li>4-Fluoroamphetamine</li>
<li>4-Fluoromethamphetamine</li>
<li>4-MA</li>
<li>4-MMA</li>
<li>4-MTA</li>
<li>6-FNE</li>
<li>AL-1095</li>
<li>Alfetamine</li>
<li>a-Ethylphenethylamine</li>
<li>Amfecloral</li>
<li>Amfepentorex</li>
<li>Amidephrine</li>
<li>2-Amino-1,2-dihydronaphthalene</li>
<li>2-Aminoindane</li>
<li>5-(2-Aminopropyl)indole</li>
<li><a href="2-Aminotetralin.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Aminotetralin" title="2-Aminotetralin">2-Aminotetralin</a></li>
<li>Acridorex</li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a> (<a href="Dextroamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a>, <a href="Levoamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levoamphetamine" title="Levoamphetamine">Levoamphetamine</a>)</li>
<li>Amphetaminil</li>
<li><a href="Arbutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arbutamine" title="Arbutamine">Arbutamine</a></li>
<li><a href="Β-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%92-Methylphenethylamine" title="Β-Methylphenethylamine">β-Methylphenethylamine</a></li>
<li>β-Phenylmethamphetamine</li>
<li>Benfluorex</li>
<li><a href="Benzphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzphetamine" title="Benzphetamine">Benzphetamine</a></li>
<li>BDB</li>
<li>BOH</li>
<li>3-Benzhydrylmorpholine</li>
<li>BPAP</li>
<li>Camfetamine</li>
<li><a href="Cathine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathine" title="Cathine">Cathine</a></li>
<li><a href="Chlorphentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphentermine" title="Chlorphentermine">Chlorphentermine</a></li>
<li>Cilobamine</li>
<li>Cinnamedrine</li>
<li><a href="Clenbuterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Clenbuterol" title="Clenbuterol">Clenbuterol</a></li>
<li>Clobenzorex</li>
<li>Cloforex</li>
<li><a href="Clortermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clortermine" title="Clortermine">Clortermine</a></li>
<li>Cypenamine</li>
<li><small>D</small>-Deprenyl</li>
<li>Denopamine</li>
<li><a href="Dimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethoxyamphetamine" title="Dimethoxyamphetamine">Dimethoxyamphetamine</a></li>
<li>Dimethylamphetamine</li>
<li><a href="Dobutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dobutamine" title="Dobutamine">Dobutamine</a></li>
<li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA">DOPA</a> (Dextrodopa, <a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA">Levodopa</a>)</li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li>Dopexamine</li>
<li><a href="L-DOPS.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPS" title="L-DOPS" class="mw-redirect">Droxidopa</a></li>
<li>EBDB</li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li><a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine</a></li>
<li>Epinine</li>
<li>Etafedrine</li>
<li>Ethylnorepinephrine</li>
<li>Etilamfetamine</li>
<li>Etilefrine</li>
<li>Famprofazone</li>
<li>Fencamfamin</li>
<li>Fencamine</li>
<li><a href="Fenethylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenethylline" title="Fenethylline">Fenethylline</a></li>
<li><a href="Fenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenfluramine" title="Fenfluramine">Fenfluramine</a> (<a href="Dexfenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexfenfluramine" title="Dexfenfluramine">Dexfenfluramine</a>, Levofenfluramine)</li>
<li><a href="Fenproporex.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenproporex" title="Fenproporex">Fenproporex</a></li>
<li>Feprosidnine</li>
<li>Fludorex</li>
<li>Formetorex</li>
<li>Furfenorex</li>
<li>Gepefrine</li>
<li>Hexapradol</li>
<li>HMMA</li>
<li>Hordenine</li>
<li>4-Hydroxyamphetamine</li>
<li>5-Iodo-2-aminoindane</li>
<li>Ibopamine</li>
<li>Indanylamphetamine</li>
<li>Iofetamine</li>
<li><a href="Isoetarine.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoetarine" title="Isoetarine">Isoetarine</a></li>
<li><a href="Isoprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoprenaline" title="Isoprenaline">Isoprenaline</a></li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline"><small>L</small>-Deprenyl</a> (Selegiline)</li>
<li>Lefetamine</li>
<li><a href="Lisdexamfetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisdexamfetamine" title="Lisdexamfetamine">Lisdexamfetamine</a></li>
<li>Lophophine</li>
<li>MBDB</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a></li>
<li>MDBU</li>
<li>MDEA</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>MDMPEA</li>
<li>MDOH</li>
<li>MDPR</li>
<li>MDPEA</li>
<li>Mefenorex</li>
<li><a href="Mephentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mephentermine" title="Mephentermine">Mephentermine</a></li>
<li>Metanephrine</li>
<li><a href="Metaraminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li>Mesocarb</li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a> (<a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Dextromethamphetamine</a>, Levomethamphetamine)</li>
<li><a href="Methoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxamine" title="Methoxamine">Methoxamine</a></li>
<li>Methoxyphenamine</li>
<li>MMA</li>
<li>Methoxyphenamine</li>
<li>MMDA</li>
<li>MMDMA</li>
<li>MMMA</li>
<li>Morforex</li>
<li>N,alpha-Diethylphenylethylamine</li>
<li>N,N-Dimethylphenethylamine</li>
<li>Naphthylamphetamine</li>
<li>Nisoxetine</li>
<li>Norepinephrine</li>
<li><a href="Norfenefrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Norfenefrine" title="Norfenefrine">Norfenefrine</a></li>
<li>Norfenfluramine</li>
<li>Normetanephrine</li>
<li><a href="L-Norpseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-Norpseudoephedrine" title="L-Norpseudoephedrine"><small>L</small>-Norpseudoephedrine</a></li>
<li>Octopamine</li>
<li><a href="Orciprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Orciprenaline" title="Orciprenaline">Orciprenaline</a></li>
<li>Ortetamine</li>
<li>Oxifentorex</li>
<li>Oxilofrine</li>
<li>PBA</li>
<li>PCA</li>
<li>PCMA</li>
<li>PHA</li>
<li>Pentorex</li>
<li><span class="new">Phenatine</span></li>
<li>Phenpromethamine</li>
<li><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermine</a></li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine">Phenylalanine</a></li>
<li><a href="Phenylephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylephrine" title="Phenylephrine">Phenylephrine</a></li>
<li><a href="Phenylpropanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a></li>
<li><a href="Pholedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li>PIA</li>
<li><a href="Para-Methoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-Methoxyamphetamine" title="Para-Methoxyamphetamine">PMA</a></li>
<li>PMEA</li>
<li>PMMA</li>
<li>PPAP</li>
<li><a href="Prenylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li>Propylamphetamine</li>
<li><a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li><a href="Ropinirole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ropinirole" title="Ropinirole">Ropinirole</a></li>
<li><a href="Salbutamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Salbutamol" title="Salbutamol">Salbutamol</a> (Levosalbutamol)</li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Solriamfetol</li>
<li><a href="Synephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Synephrine" title="Synephrine">Synephrine</a></li>
<li>Theodrenaline</li>
<li>Tiflorex</li>
<li><a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li>
<li><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">Tyramine</a></li>
<li><a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">Tyrosine</a></li>
<li>Xylopropamine</li>
<li>Zylofuramine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenylmorpholines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>3-Fluorophenmetrazine</li>
<li>Fenbutrazate</li>
<li>Fenmetramide</li>
<li>G-130</li>
<li>Manifaxine</li>
<li>Morazone</li>
<li>Morforex</li>
<li>Oxaflozane</li>
<li>PD-128,907</li>
<li><a href="Phendimetrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phendimetrazine" title="Phendimetrazine">Phendimetrazine</a></li>
<li><a href="Phenmetrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a></li>
<li>2-Phenyl-3,6-dimethylmorpholine</li>
<li>Pseudophenmetrazine</li>
<li>Radafaxine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Piperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperazine" title="Piperazine">Piperazines</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2C-B-BZP</li>
<li>3C-PEP</li>
<li><a href="Benzylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpiperazine" title="Benzylpiperazine">BZP</a></li>
<li>CM156</li>
<li>DBL-583</li>
<li>GBR-12783</li>
<li>GBR-12935</li>
<li>GBR-13069</li>
<li>GBR-13098</li>
<li>GBR-13119</li>
<li>MeOPP</li>
<li>MBZP</li>
<li>oMPP</li>
<li><a href="Vanoxerine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanoxerine" title="Vanoxerine">Vanoxerine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Piperidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperidine" title="Piperidine">Piperidines</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1-Benzyl-4-(2-(diphenylmethoxy)ethyl)piperidine</li>
<li>2-Benzylpiperidine</li>
<li>2-Methyl-3-phenylpiperidine</li>
<li>3,4-Dichloromethylphenidate</li>
<li><a href="4-Benzylpiperidine.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Benzylpiperidine" title="4-Benzylpiperidine">4-Benzylpiperidine</a></li>
<li>4-Fluoromethylphenidate</li>
<li>4-Methylmethylphenidate</li>
<li>Desoxypipradrol</li>
<li>Difemetorex</li>
<li>Diphenylpyraline</li>
<li>Ethylnaphthidate</li>
<li>Ethylphenidate</li>
<li>Methylnaphthidate</li>
<li>Isopropylphenidate</li>
<li>JZ-IV-10</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a> (Dexmethylphenidate)</li>
<li>Nocaine</li>
<li>Phacetoperane</li>
<li>Pipradrol</li>
<li>Propylphenidate</li>
<li>SCH-5472</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Pyrrolidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyrrolidine" title="Pyrrolidine">Pyrrolidines</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2-Diphenylmethylpyrrolidine</li>
<li>4-Cl-PVP</li>
<li>5-DBFPV</li>
<li>α-PPP</li>
<li>α-PBP</li>
<li>α-PCYP</li>
<li>α-PHiP</li>
<li>α-PHP</li>
<li>α-PHPP</li>
<li>α-PVP</li>
<li>α-PVT</li>
<li>Diphenylprolinol</li>
<li>DMPVP</li>
<li>FPOP</li>
<li>FPVP</li>
<li>MDPPP</li>
<li>MDPBP</li>
<li>MPBP</li>
<li>MPHP</li>
<li>MPPP</li>
<li>MOPVP</li>
<li>MOPPP</li>
<li>Indapyrophenidone</li>
<li>MDPV</li>
<li>Naphyrone</li>
<li>PEP</li>
<li>Picilorex</li>
<li>Prolintane</li>
<li>Pyrovalerone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Racetams</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Oxiracetam.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxiracetam" title="Oxiracetam">Oxiracetam</a></li>
<li>Phenylpiracetam</li>
<li>Phenylpiracetam hydrazide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Tropane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropane" title="Tropane">Tropanes</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4-fluorotropacocaine</li>
<li>4'-Fluorococaine</li>
<li>Altropane (IACFT)</li>
<li>Brasofensine</li>
<li>CFT (WIN 35,428)</li>
<li>β-CIT (RTI-55)</li>
<li><a href="Cocaethylene.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaethylene" title="Cocaethylene">Cocaethylene</a></li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Dichloropane (RTI-111)</li>
<li>Difluoropine</li>
<li>FE-β-CPPIT</li>
<li>FP-β-CPPIT</li>
<li>Ioflupane (<sup>123</sup>I)</li>
<li>Norcocaine</li>
<li>PIT</li>
<li>PTT</li>
<li>RTI-31</li>
<li>RTI-32</li>
<li>RTI-51</li>
<li>RTI-112</li>
<li>RTI-113</li>
<li>RTI-120</li>
<li>RTI-121 (IPCIT)</li>
<li>RTI-126</li>
<li>RTI-150</li>
<li>RTI-177</li>
<li>RTI-229</li>
<li>RTI-336</li>
<li>RTI-354</li>
<li>RTI-371</li>
<li>RTI-386</li>
<li>Salicylmethylecgonine</li>
<li>Tesofensine</li>
<li>Troparil (β-CPT, WIN 35,065-2)</li>
<li>Tropoxane</li>
<li>WF-23</li>
<li>WF-33</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Tryptamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4-HO-αMT</li>
<li>4-Methyl-αET</li>
<li>4-Methyl-αMT</li>
<li>5-Chloro-αMT</li>
<li>5-Fluoro-αMT</li>
<li>5-MeO-αET</li>
<li>5-MeO-αMT</li>
<li>5-MeO-DIPT</li>
<li>6-Fluoro-αMT</li>
<li>7-Methyl-αET</li>
<li>αET</li>
<li>αMT</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2-MDP</li>
<li>3,3-Diphenylcyclobutanamine</li>
<li>Amfonelic acid</li>
<li><a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a></li>
<li><a href="Amiphenazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiphenazole" title="Amiphenazole">Amiphenazole</a></li>
<li>Atipamezole</li>
<li><a href="Atomoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atomoxetine" title="Atomoxetine">Atomoxetine</a></li>
<li><a href="Bemegride.htm" tppabs="https://ptable.com/wiki/compounds/A/Bemegride" title="Bemegride">Bemegride</a></li>
<li>Benzydamine</li>
<li>BTQ</li>
<li>BTS 74,398</li>
<li>Centanafadine</li>
<li>Ciclazindol</li>
<li>Clofenciclan</li>
<li>Cropropamide</li>
<li>Crotetamide</li>
<li>D-161</li>
<li>Desipramine</li>
<li>Diclofensine</li>
<li>Dimethocaine</li>
<li>Efaroxan</li>
<li><a href="Etamivan.htm" tppabs="https://ptable.com/wiki/compounds/A/Etamivan" title="Etamivan">Etamivan</a></li>
<li>Fenisorex</li>
<li>Fenpentadiol</li>
<li>Gamfexine</li>
<li>Gilutensin</li>
<li>GSK1360707F</li>
<li>GYKI-52895</li>
<li>Hexacyclonate</li>
<li>Idazoxan</li>
<li>Indanorex</li>
<li>Indatraline</li>
<li>JNJ-7925476</li>
<li>Lazabemide</li>
<li>Leptacline</li>
<li>Lomevactone</li>
<li>LR-5182</li>
<li><a href="Mazindol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mazindol" title="Mazindol">Mazindol</a></li>
<li>Meclofenoxate</li>
<li>Medifoxamine</li>
<li>Mefexamide</li>
<li>Methamnetamine</li>
<li>Methastyridone</li>
<li>Methiopropamine</li>
<li>Naphthylaminopropane</li>
<li>Nefopam</li>
<li><a href="Nikethamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nikethamide" title="Nikethamide">Nikethamide</a></li>
<li><a href="Nomifensine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nomifensine" title="Nomifensine">Nomifensine</a></li>
<li>O-2172</li>
<li>Oxaprotiline</li>
<li>PNU-99,194</li>
<li>PRC200-SS</li>
<li><a href="Rasagiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Rasagiline" title="Rasagiline">Rasagiline</a></li>
<li>Rauwolscine</li>
<li><a href="Rubidium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Rubidium_chloride" title="Rubidium chloride">Rubidium chloride</a></li>
<li>Setazindol</li>
<li>Tametraline</li>
<li>Tandamine</li>
<li>Thiopropamine</li>
<li>Thiothinone</li>
<li>Trazium</li>
<li>UH-232</li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="font-style:italic"><div>ATC code: N06B</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="ADHD_pharmacotherapies" style="padding:3px"><table class="nowraplinks mw-collapsible expanded navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="ADHD_pharmacotherapies" style="font-size:114%;margin:0 4em"><abbr>ADHD</abbr> pharmacotherapies</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center"><abbr>CNS</abbr> stimulants</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a> (Mixed amphetamine salts, <a href="Levoamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levoamphetamine" title="Levoamphetamine">Levoamphetamine</a>, <a href="Dextroamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a>, <a href="Lisdexamfetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisdexamfetamine" title="Lisdexamfetamine">Lisdexamfetamine</a>)</li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li>Dexmethylphenidate</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center">Non-classical<br><abbr>CNS</abbr> stimulants</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Armodafinil</li>
<li><a href="Atomoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atomoxetine" title="Atomoxetine">Atomoxetine</a></li>
<li><a href="Modafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Modafinil" title="Modafinil">Modafinil</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center">α<sub>2</sub>-adrenoceptor<br>agonists</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Clonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonidine" title="Clonidine">Clonidine</a></li>
<li><a href="Guanfacine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanfacine" title="Guanfacine">Guanfacine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center">Antidepressants</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">Amitriptyline</a></li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li><a href="Buspirone.htm" tppabs="https://ptable.com/wiki/compounds/A/Buspirone" title="Buspirone">Buspirone</a></li>
<li>Desipramine</li>
<li><a href="Duloxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Duloxetine" title="Duloxetine">Duloxetine</a></li>
<li><a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">Imipramine</a></li>
<li><a href="Milnacipran.htm" tppabs="https://ptable.com/wiki/compounds/A/Milnacipran" title="Milnacipran">Milnacipran</a></li>
<li><a href="Moclobemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Moclobemide" title="Moclobemide">Moclobemide</a></li>
<li><a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">Nortriptyline</a></li>
<li><a href="Reboxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reboxetine" title="Reboxetine">Reboxetine</a></li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center">Miscellaneous/others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">Amantadine</a></li>
<li><a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">Carbamazepine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center">Related articles</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Attention deficit hyperactivity disorder (ADHD)</li>
<li>Attention deficit hyperactivity disorder management</li>
<li>Monoamine releasing agent</li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a> (DA)</li>
<li>Dopamine transporter (DAT)</li>
<li>Dopamine reuptake inhibitor (DRI)</li>
<li>Norepinephrine (NE)</li>
<li>Norepinephrine transporter (NET)</li>
<li>Norepinephrine reuptake inhibitor (NRI)</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a> (5-HT)</li>
<li>Serotonin transporter (SERT)</li>
<li>Selective serotonin reuptake inhibitor (SSRI)</li>
<li>Serotonin-norepinephrine reuptake inhibitor (SNRI)</li>
<li>Norepinephrine-dopamine reuptake inhibitor (NDRI)</li>
<li>Serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI)</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Recreational_drug_use" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="text-align:center;"><div id="Recreational_drug_use" style="font-size:114%;margin:0 4em">Recreational drug use</div></th></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Major<br> recreational<br> drugs</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Depressants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">Barbiturates</a></li>
<li>Benzodiazepines</li>
<li>Carbamates</li>
<li>Ethanol (alcohol)
<ul><li>Alcoholic drinks</li>
<li>Beer</li>
<li>Wine</li></ul></li>
<li>Gabapentinoids</li>
<li><a href="Gamma-Hydroxybutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">GHB</a></li>
<li>Inhalants
<ul><li>Medical
<ul><li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li></ul></li>
<li>Hazardous solvents
<ul><li>contact adhesives</li>
<li>Gasoline</li>
<li>nail polish remover</li>
<li>Paint thinner</li></ul></li>
<li>Other
<ul><li>Freon</li></ul></li></ul></li>
<li><a href="Kava.htm" tppabs="https://ptable.com/wiki/compounds/A/Kava" title="Kava">Kava</a></li>
<li>Nonbenzodiazepines</li>
<li>Quinazolinones</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Opioids</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a>
<ul><li>Suboxone</li>
<li>Subutex</li></ul></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Codeine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Codeine'" tppabs="https://ptable.com/wiki/compounds/A/Codeine" title="Codeine">Codeine</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Desomorphine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Desomorphine'" tppabs="https://ptable.com/wiki/compounds/A/Desomorphine" title="Desomorphine">Desomorphine</a>
<ul><li>Krokodil</li></ul></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene</a>
<ul><li>Darvocet</li>
<li>Darvon</li></ul></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><a href="Heroin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heroin" title="Heroin">Diamorphine</a>
<ul><li>Heroin</li></ul></li>
<li><a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydromorphone" title="Hydromorphone">Hydromorphone</a>
<ul><li>Dilaudid</li></ul></li>
<li><a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">Methadone</a></li>
<li>Mitragyna speciosa
<ul><li>Kratom</li></ul></li>
<li><a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">Morphine</a>
<ul><li>Opium</li></ul></li>
<li><a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">Oxycodone</a>
<ul><li>/paracetamol</li></ul></li>
<li><a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">Tramadol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Stimulants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a></li>
<li><a href="Arecoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Arecoline" title="Arecoline">Arecoline</a>
<ul><li>Areca</li></ul></li>
<li>Betel</li>
<li><a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">Caffeine</a>
<ul><li>Coffee</li>
<li>Energy drinks</li>
<li>Tea</li></ul></li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a>
<ul><li>Khat</li></ul></li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a>
<ul><li>Coca</li>
<li>Crack</li></ul></li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a>
<ul><li><a href="Ephedra.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedra" title="Ephedra">Ephedra</a></li></ul></li>
<li>MDPV</li>
<li>Mephedrone</li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li>Methylone</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li><a href="Modafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Modafinil" title="Modafinil">Modafinil</a></li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a>
<ul><li>Tobacco</li></ul></li>
<li><a href="Theobromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Theobromine" title="Theobromine">Theobromine</a>
<ul><li>Cocoa</li>
<li>Chocolate</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Entactogens</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2C series</li>
<li>6-APB
<ul><li>Benzofury</li></ul></li>
<li><a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">AMT</a></li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA</a></li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a>
<ul><li>Ecstasy</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Hallucinogens</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Psychedelics</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Bufotenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufotenin" title="Bufotenin">Bufotenin</a>
<ul><li>Psychoactive toads</li>
<li>Vilca</li>
<li>Yopo</li></ul></li>
<li>DMT
<ul><li>Ayahuasca</li></ul></li>
<li>LSA</li>
<li><a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD-25</a></li>
<li>Mescaline
<ul><li>Peruvian torch</li>
<li>Peyote</li>
<li>San Pedro</li></ul></li>
<li>Psilocybin / <a href="Psilocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Psilocin" title="Psilocin">Psilocin</a>
<ul><li>Psilocybin mushrooms</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Dissociatives</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">DXM</a></li>
<li>Glaucine</li>
<li>Inhalants
<ul><li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li>
<li>alkyl nitrites</li>
<li>poppers</li>
<li><a href="Amyl_nitrite.htm" tppabs="https://ptable.com/wiki/compounds/A/Amyl_nitrite" title="Amyl nitrite">amyl nitrite</a></li></ul></li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>MXE</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Muscimol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Muscimol'" tppabs="https://ptable.com/wiki/compounds/A/Muscimol" title="Muscimol">Muscimol</a>
<ul><li>Amanita muscaria</li></ul></li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">PCP</a></li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a>
<ul><li><a href="Salvia_divinorum.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvia_divinorum" title="Salvia divinorum">Salvia divinorum</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Deliriants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">Atropine</a> and <a href="Scopolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Scopolamine" title="Scopolamine" class="mw-redirect">Scopolamine</a>
<ul><li>Atropa belladonna</li>
<li>Datura</li>
<li>Hyoscyamus niger</li>
<li>Mandragora officinarum</li></ul></li>
<li><a href="Dimenhydrinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenhydrinate" title="Dimenhydrinate">Dimenhydrinate</a></li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Cannabinoids</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>JWH-018</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">THC</a>
<ul><li>Cannabis</li>
<li>Hashish</li>
<li>Hash oil</li>
<li>Marijuana</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Oneirogens</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Calea zacatechichi</li>
<li>Silene capensis</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Club drugs</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Quaaludes</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a> (Ecstasy)</li>
<li><a href="Nitrous_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a></li>
<li>Poppers</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Drug culture</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Cannabis culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>420</li>
<li>Cannabis cultivation</li>
<li>Cannabis smoking</li>
<li>Head shop</li>
<li>Legal history of cannabis in the United States</li>
<li>Legality of cannabis</li>
<li>Marijuana Policy Project</li>
<li>Medical cannabis</li>
<li>NORML</li>
<li>Cannabis and religion</li>
<li>Stoner film</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Coffee culture</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Coffee break</li>
<li>Coffeehouse</li>
<li>Latte art</li>
<li>Tea house</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drinking culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bartending</li>
<li>Beer culture</li>
<li>Beer festival</li>
<li>Binge drinking</li>
<li><a href="Diethyl_ether.htm#Recreational_use" tppabs="https://ptable.com/wiki/compounds/A/Diethyl_ether#Recreational_use" title="Diethyl ether">Diethyl ether</a></li>
<li>Drinking games</li>
<li>Drinking song</li>
<li>Happy hour</li>
<li>Hip flask</li>
<li>Nightclub</li>
<li>Pub</li>
<li>Pub crawl</li>
<li>Sommelier</li>
<li>Sports bar</li>
<li>Tailgate party</li>
<li>Wine bar</li>
<li>Wine tasting</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Psychedelia</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Psychonautics</li>
<li>Art</li>
<li>Drug</li>
<li>Era</li>
<li>Experience</li>
<li>Literature</li>
<li>Music</li>
<li>Microdosing</li>
<li>Therapy</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Smoking culture</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cigarette card</li>
<li>Fashion cigarettes</li>
<li>Cloud-chasing</li>
<li>Loosie</li>
<li>Smokeasy</li>
<li>Smoking fetishism</li>
<li>Tobacco smoking</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Club drug</li>
<li>Counterculture of the 1960s</li>
<li>Dance party</li>
<li>Drug paraphernalia</li>
<li>Drug tourism</li>
<li>Entheogen</li>
<li>Hippie</li>
<li>Needle sharing</li>
<li>Nootropic</li>
<li>Party and play</li>
<li>Poly drug use</li>
<li>Rave</li>
<li>Religion and drugs</li>
<li>Self-medication</li>
<li>Sex and drugs</li>
<li>Whoonga</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Drug<br> production<br> and trade</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug<br> production</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Coca production in Colombia</li>
<li>Drug precursors</li>
<li>Opium production in Afghanistan</li>
<li>Rolling meth lab</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug trade</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Illegal drug trade
<ul><li>Colombia</li></ul></li>
<li>Darknet market</li>
<li>Drug distribution
<ul><li>Beer shop</li>
<li>Cannabis shop</li>
<li>Liquor store</li>
<li>Liquor license</li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Issues with<br> drug use</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Abuse</li>
<li>Date rape drug</li>
<li>Impaired driving</li>
<li>Drug harmfulness
<ul><li>Effects of cannabis</li></ul></li>
<li>Addiction</li>
<li>Dependence
<ul><li>Prevention</li>
<li>Opioid replacement therapy</li>
<li>Rehabilitation</li>
<li>Responsible use</li></ul></li>
<li>Drug-related crime</li>
<li>Fetal alcohol spectrum disorder</li>
<li>Long-term effects of cannabis</li>
<li>Neurotoxicity</li>
<li>Overdose</li>
<li>Passive smoking
<ul><li>of tobacco or other substances</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Legality of<br> drug use</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">International</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1961 Narcotic Drugs</li>
<li>1971 Psychotropic Substances</li>
<li>1988 Drug Trafficking</li>
<li>Council of the European Union decisions on designer drugs</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">State level</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Drug policy
<ul><li>Decriminalization</li>
<li>Prohibition</li>
<li>Supply reduction</li></ul></li>
<li>Policy reform
<ul><li>Demand reduction</li>
<li>Drug Policy Alliance</li>
<li>Harm reduction</li>
<li>Law Enforcement Action Partnership</li>
<li>Liberalization
<ul><li>Latin America</li></ul></li>
<li>Students for Sensible Drug Policy</li>
<li>Transform Drug Policy Foundation</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug policy<br>by country</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Australia</li>
<li>Canada</li>
<li>Germany</li>
<li>India</li>
<li>Netherlands</li>
<li>Portugal</li>
<li>Slovakia</li>
<li>Soviet Union</li>
<li>Sweden</li>
<li>Switzerland</li>
<li>United States
<ul><li>Just Say No</li>
<li>Office of National Drug Control Policy</li>
<li>School district drug policies</li>
<li>California</li>
<li>Colorado</li>
<li>Maryland</li>
<li>Virginia</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Arguments for and against drug prohibition</li>
<li>Capital punishment for drug trafficking</li>
<li>Cognitive liberty</li>
<li>Designer drug</li>
<li>Drug court</li>
<li>Drug possession</li>
<li>Drug test</li>
<li>Narc</li>
<li>Politics of drug abuse</li>
<li>War on Drugs
<ul><li>Mexican Drug War</li>
<li>Plan Colombia</li>
<li>Philippine Drug War</li></ul></li>
<li>Zero tolerance</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="text-align:center;;width:1%">Lists of<br> countries by...</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alcohol legality
<ul><li>Alcohol consumption</li></ul></li>
<li>Anabolic steroid legality</li>
<li>Cannabis legality
<ul><li>Annual use</li>
<li>Lifetime use</li></ul></li>
<li>Cigarette consumption</li>
<li>Cocaine legality
<ul><li>Cocaine use</li></ul></li>
<li>Methamphetamine legality</li>
<li>Opiates use</li>
<li>Psilocybin mushrooms legality</li>
<li>Salvia legality</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Monoamine_reuptake_inhibitors" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Monoamine_reuptake_inhibitors" style="font-size:114%;margin:0 4em">Monoamine reuptake inhibitors</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>DAT</abbr><br><small>(<abbr>DRIs</abbr>)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Piperazines:</i> DBL-583</li>
<li>GBR-12783</li>
<li>GBR-12935</li>
<li>GBR-13069</li>
<li>GBR-13098</li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li><a href="Vanoxerine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanoxerine" title="Vanoxerine">Vanoxerine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Piperidines:</i> 4-Fluoropethidine</li>
<li>Benocyclidine (BTCP)</li>
<li>Desoxypipradrol</li>
<li>Dexmethylphenidate</li>
<li>Difemetorex</li>
<li>Ethylphenidate</li>
<li>HDMP-28</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li>Pipradrol</li>
<li><a href="Tenocyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenocyclidine" title="Tenocyclidine">Tenocyclidine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Pyrrolidines:</i> Diphenylprolinol</li>
<li>MDPV</li>
<li>Naphyrone</li>
<li>Prolintane</li>
<li>Pyrovalerone</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Tropanes:</i> Altropane</li>
<li><a href="Benzatropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzatropine" title="Benzatropine">Benzatropine (benztropine)</a></li>
<li>Brasofensine</li>
<li>CFT</li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Dichloropane</li>
<li>Difluoropine</li>
<li>Etybenzatropine (ethybenztropine)</li>
<li>FE-β-CPPIT</li>
<li>FP-β-CPPIT</li>
<li>Ioflupane (<sup>123</sup>I)</li>
<li>RTI-55</li>
<li>RTI-112</li>
<li>RTI-113</li>
<li>RTI-121</li>
<li>RTI-126</li>
<li>RTI-150</li>
<li>RTI-177</li>
<li>RTI-229</li>
<li>RTI-336</li>
<li>Tesofensine</li>
<li>Troparil</li>
<li>Tropoxane</li>
<li>WF-11</li>
<li>WF-23</li>
<li>WF-31</li>
<li>WF-33</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Others:</i> <a href="Adrafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrafinil" title="Adrafinil">Adrafinil</a></li>
<li>Amifitadine</li>
<li>Armodafinil</li>
<li>Amfonelic acid</li>
<li><a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a></li>
<li>Ansofaxine</li>
<li>BTQ</li>
<li>BTS 74,398</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li><i>Chaenomeles speciosa</i></li>
<li>Ciclazindol</li>
<li>Dasotraline</li>
<li>Desmethylsertraline</li>
<li><span class="new">Desmethylsibutramine</span></li>
<li>Diclofensine</li>
<li><span class="new">Didesmethylsibutramine</span></li>
<li>Dimethocaine</li>
<li>Diphenylpyraline</li>
<li>Dizocilpine (MK-801)</li>
<li>DOV-102,677</li>
<li>DOV-216,303</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>Ephenidine</li>
<li>Esketamine</li>
<li>EXP-561</li>
<li>Fencamfamin</li>
<li>Fezolamine</li>
<li>Fluorenol</li>
<li>GYKI-52895</li>
<li>Indatraline</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Lefetamine</li>
<li>Levophacetoperane</li>
<li>Liafensine</li>
<li>LR-5182</li>
<li>Manifaxine</li>
<li><a href="Mazindol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mazindol" title="Mazindol">Mazindol</a></li>
<li>Medifoxamine</li>
<li>Mesocarb</li>
<li>Metaphit</li>
<li>MIN-117 (WF-516)</li>
<li><a href="Modafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Modafinil" title="Modafinil">Modafinil</a></li>
<li>Nefopam</li>
<li><a href="Nomifensine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nomifensine" title="Nomifensine">Nomifensine</a></li>
<li>NS-2359</li>
<li>O-2172</li>
<li>Oroxylin A</li>
<li>Perafensine</li>
<li>Pridefine</li>
<li>Radafaxine</li>
<li><a href="Rimcazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimcazole" title="Rimcazole">Rimcazole</a></li>
<li><a href="Sertraline.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertraline" title="Sertraline">Sertraline</a></li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Solriamfetol</li>
<li>Tametraline</li>
<li>Tedatioxetine</li>
<li><a href="Tripelennamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tripelennamine" title="Tripelennamine">Tripelennamine</a></li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>NET</abbr><br><small>(<abbr>NRIs</abbr>)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Selective norepinephrine reuptake inhibitors:</i> Amedalin</li>
<li><a href="Alseroxylon.htm" tppabs="https://ptable.com/wiki/compounds/A/Alseroxylon" title="Alseroxylon">Alseroxylon</a></li>
<li>Ciclazindol</li>
<li>Daledalin</li>
<li>Edivoxetine</li>
<li>Esreboxetine</li>
<li>Lortalamine</li>
<li><a href="Mazindol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mazindol" title="Mazindol">Mazindol</a></li>
<li>Nisoxetine</li>
<li><a href="Reboxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reboxetine" title="Reboxetine">Reboxetine</a></li>
<li>Talopram</li>
<li>Talsupram</li>
<li>Tandamine</li>
<li>Teniloxazine</li>
<li>Viloxazine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Norepinephrine–dopamine reuptake inhibitors:</i> <a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a></li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li>Fencamine</li>
<li>Fencamfamin</li>
<li>Hydroxybupropion</li>
<li>Lefetamine</li>
<li>Levophacetoperane</li>
<li>LR-5182</li>
<li>Manifaxine</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li><a href="Nomifensine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nomifensine" title="Nomifensine">Nomifensine</a></li>
<li>O-2172</li>
<li>Radafaxine</li>
<li>Solriamfetol</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Serotonin–norepinephrine reuptake inhibitors:</i> <a href="Atomoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atomoxetine" title="Atomoxetine">Atomoxetine (tomoxetine)</a></li>
<li><span class="new">BTS-54505</span></li>
<li>CP-39,332</li>
<li>Desvenlafaxine</li>
<li><a href="Duloxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Duloxetine" title="Duloxetine">Duloxetine</a></li>
<li>Eclanamine</li>
<li>Levomilnacipran</li>
<li><span class="new">McN-5652</span></li>
<li><a href="Milnacipran.htm" tppabs="https://ptable.com/wiki/compounds/A/Milnacipran" title="Milnacipran">Milnacipran</a></li>
<li>N-Methyl-PPPA</li>
<li><span class="new">Nafenodone</span></li>
<li>PPPA</li>
<li>Tofenacin</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li>
<li><span class="new">WY-45233</span></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Serotonin–norepinephrine–dopamine reuptake inhibitors:</i> 3,3-Diphenylcyclobutanamine</li>
<li>Amifitadine</li>
<li>Ansofaxine</li>
<li>Bicifadine</li>
<li>Brasofensine</li>
<li>Centanafadine</li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Dasotraline</li>
<li>Desmethylsertraline</li>
<li><span class="new">Desmethylsibutramine</span></li>
<li>Diclofensine</li>
<li><span class="new">Didesmethylsibutramine</span></li>
<li>DOV-102677</li>
<li>DOV-216303</li>
<li>EXP-561</li>
<li>Fezolamine</li>
<li>HDMP-28</li>
<li>Indatraline</li>
<li>JNJ-7925476</li>
<li>JZ-IV-10</li>
<li>Liafensine</li>
<li><a href="Mazindol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mazindol" title="Mazindol">Mazindol</a></li>
<li>Naphyrone</li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li>Nefopam</li>
<li>NS-2359</li>
<li>Perafensine</li>
<li>PRC200</li>
<li>Pridefine</li>
<li><span class="new">SEP-228431</span></li>
<li><span class="new">SEP-228432</span></li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Tedatioxetine</li>
<li>Tesofensine</li>
<li><a href="Tropane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropane" title="Tropane">Tropanes</a> (e.g., <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a>)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Tricyclic antidepressants:</i> <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">Amitriptyline</a></li>
<li>Butriptyline</li>
<li>Cianopramine</li>
<li><a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">Clomipramine</a></li>
<li>Desipramine</li>
<li>Dosulepin (dothiepin)</li>
<li><a href="Doxepin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxepin" title="Doxepin">Doxepin</a></li>
<li><a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">Imipramine</a></li>
<li>Lofepramine</li>
<li>Melitracen</li>
<li><a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">Nortriptyline</a></li>
<li><a href="Protriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Protriptyline" title="Protriptyline">Protriptyline</a></li>
<li><a href="Trimipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimipramine" title="Trimipramine">Trimipramine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Tetracyclic antidepressants:</i> <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li><a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">Maprotiline</a></li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li>Oxaprotiline</li>
<li>Setiptiline</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Others:</i> Antihistamines (e.g., <a href="Brompheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brompheniramine" title="Brompheniramine">brompheniramine</a>, <a href="Chlorphenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphenamine" title="Chlorphenamine">chlorphenamine</a>, <a href="Pheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pheniramine" title="Pheniramine">pheniramine</a>, <a href="Tripelennamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tripelennamine" title="Tripelennamine">tripelennamine</a>)</li>
<li>Antipsychotics (e.g., <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">ziprasidone</a>)</li>
<li><a href="Arylcyclohexylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arylcyclohexylamine" title="Arylcyclohexylamine">Arylcyclohexylamines</a> (e.g., <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a>, <a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">phencyclidine</a>)</li>
<li>Dopexamine</li>
<li>Ephenidine</li>
<li><i>Ginkgo biloba</i></li>
<li>Indeloxazine</li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li>Opioids (e.g., desmetramadol, <a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">methadone</a>, <a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">pethidine (meperidine)</a>, tapentadol, <a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">tramadol</a>, <a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">levorphanol</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>SERT</abbr><br><small>(<abbr>SRIs</abbr>)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Selective serotonin reuptake inhibitors:</i> Alaproclate</li>
<li><span class="new">Centpropazine</span></li>
<li>Cericlamine</li>
<li><a href="Citalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Citalopram" title="Citalopram">Citalopram</a></li>
<li>Dapoxetine</li>
<li>Desmethylcitalopram</li>
<li>Didesmethylcitalopram</li>
<li><a href="Escitalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Escitalopram" title="Escitalopram">Escitalopram</a></li>
<li>Femoxetine</li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li><a href="Fluvoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvoxamine" title="Fluvoxamine">Fluvoxamine</a></li>
<li>Indalpine</li>
<li>Ifoxetine</li>
<li>Norfluoxetine</li>
<li>Omiloxetine</li>
<li>Panuramine</li>
<li><a href="Paroxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paroxetine" title="Paroxetine">Paroxetine</a></li>
<li>PIM-35</li>
<li>Pirandamine</li>
<li>RTI-353</li>
<li>Seproxetine</li>
<li><a href="Sertraline.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertraline" title="Sertraline">Sertraline</a></li>
<li><a href="Zimelidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zimelidine" title="Zimelidine">Zimelidine</a></li></ul>

<ul><li><i>Selective serotonin reuptake inhibitors and serotonin receptor modulators:</i> Etoperidone</li>
<li>Litoxetine</li>
<li>Lubazodone</li>
<li><span class="new">LY-393558</span></li>
<li>SB-649915</li>
<li>TGBA01AD</li>
<li><a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">Trazodone</a></li>
<li>Vilazodone</li>
<li>Vortioxetine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Serotonin–norepinephrine reuptake inhibitors:</i> <a href="Atomoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atomoxetine" title="Atomoxetine">Atomoxetine (tomoxetine)</a></li>
<li>Bicifadine</li>
<li><span class="new">BTS-54505</span></li>
<li><span class="new">CP-39332</span></li>
<li>Desvenlafaxine</li>
<li><a href="Duloxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Duloxetine" title="Duloxetine">Duloxetine</a></li>
<li>Eclanamine</li>
<li>Levomilnacipran</li>
<li><span class="new">McN-5652</span></li>
<li><a href="Milnacipran.htm" tppabs="https://ptable.com/wiki/compounds/A/Milnacipran" title="Milnacipran">Milnacipran</a></li>
<li>N-Methyl-PPPA</li>
<li>PPPA</li>
<li>Tofenacin</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li>
<li><span class="new">WY-45233</span></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Serotonin–norepinephrine–dopamine reuptake inhibitors:</i> 3,3-Diphenylcyclobutanamine</li>
<li>Amifitadine</li>
<li>Ansofaxine</li>
<li>Bicifadine</li>
<li>Brasofensine</li>
<li>Centanafadine</li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Dasotraline</li>
<li>Desmethylsertraline</li>
<li><span class="new">Desmethylsibutramine</span></li>
<li>Diclofensine</li>
<li><span class="new">Didesmethylsibutramine</span></li>
<li>DOV-102677</li>
<li>DOV-216303</li>
<li>EXP-561</li>
<li>Fezolamine</li>
<li>HDMP-28</li>
<li>Indatraline</li>
<li>JNJ-7925476</li>
<li>JZ-IV-10</li>
<li>Liafensine</li>
<li><a href="Mazindol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mazindol" title="Mazindol">Mazindol</a></li>
<li>Naphyrone</li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li>Nefopam</li>
<li>NS-2359</li>
<li>Perafensine</li>
<li>PRC200</li>
<li>Pridefine</li>
<li><span class="new">SEP-228431</span></li>
<li><span class="new">SEP-228432</span></li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Tedatioxetine</li>
<li>Tesofensine</li>
<li><a href="Tropane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropane" title="Tropane">Tropanes</a> (e.g., <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a>)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Tricyclic antidepressants:</i> <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">Amitriptyline</a></li>
<li>Cianopramine</li>
<li><a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">Clomipramine</a></li>
<li>Cyanodothiepin</li>
<li>Desipramine</li>
<li>Dosulepin (dothiepin)</li>
<li><a href="Doxepin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxepin" title="Doxepin">Doxepin</a></li>
<li><a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">Imipramine</a></li>
<li>Lofepramine</li>
<li><a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">Nortriptyline</a></li>
<li>Pipofezine</li>
<li><a href="Protriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Protriptyline" title="Protriptyline">Protriptyline</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Others:</i> <span class="new">A-80426</span></li>
<li><a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li>Antihistamines (e.g., <a href="Brompheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brompheniramine" title="Brompheniramine">brompheniramine</a>, <a href="Chlorphenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphenamine" title="Chlorphenamine">chlorphenamine</a>, <a href="Dimenhydrinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenhydrinate" title="Dimenhydrinate">dimenhydrinate</a>, <a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">diphenhydramine</a>, <a href="Mepyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mepyramine" title="Mepyramine">mepyramine (pyrilamine)</a>, <a href="Pheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pheniramine" title="Pheniramine">pheniramine</a>, <a href="Tripelennamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tripelennamine" title="Tripelennamine">tripelennamine</a>)</li>
<li>Antipsychotics (e.g., <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">ziprasidone</a>)</li>
<li><a href="Arylcyclohexylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arylcyclohexylamine" title="Arylcyclohexylamine">Arylcyclohexylamines</a> (e.g., 3-MeO-PCP, esketamine, <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a>, methoxetamine, <a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">phencyclidine</a>)</li>
<li><a href="Cyclobenzaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclobenzaprine" title="Cyclobenzaprine">Cyclobenzaprine</a></li>
<li>Delucemine</li>
<li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">Dextromethorphan</a></li>
<li>Dextrorphan</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>Medifoxamine</li>
<li>Mesembrine</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li>MIN-117 (WF-516)</li>
<li>N-Me-5-HT</li>
<li>Opioids (e.g., <a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">dextropropoxyphene</a>, <a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">methadone</a>, <a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">pethidine (meperidine)</a>, <a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">levorphanol</a>, tapentadol, <a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">tramadol</a>)</li>
<li>Roxindole</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>VMATs</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li>Amphetamines (e.g., <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a>, <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a>, <a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a>)</li>
<li><span class="new">APP</span></li>
<li><span class="new">AZIK</span></li>
<li>Bietaserpine</li>
<li><a href="Deserpidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Deserpidine" title="Deserpidine">Deserpidine</a></li>
<li>Deutetrabenazine</li>
<li>Dihydrotetrabenazine</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>GBR-12935</li>
<li><span class="new">GZ-793A</span></li>
<li>Ibogaine</li>
<li><a href="Ketanserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketanserin" title="Ketanserin">Ketanserin</a></li>
<li>Lobeline</li>
<li><span class="new">Methoxytetrabenazine</span></li>
<li><a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">Reserpine</a></li>
<li><a href="Rose_bengal.htm" tppabs="https://ptable.com/wiki/compounds/A/Rose_bengal" title="Rose bengal">Rose bengal</a></li>
<li><a href="Tetrabenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrabenazine" title="Tetrabenazine">Tetrabenazine</a></li>
<li>Valbenazine</li>
<li><a href="Vanoxerine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanoxerine" title="Vanoxerine">Vanoxerine (GBR-12909)</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>DAT enhancers:</i> <a href="Luteolin.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteolin" title="Luteolin">Luteolin</a></li></ul>

<ul><li><i>DAT modulators:</i> <i>Agonist-like:</i> SoRI-9804</li>
<li><span class="new">SoRI-20040</span>; <i>Antagonist-like:</i> SoRI-20041</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><small><i><b>See also:</b> Receptor/signaling modulators • Monoamine releasing agents • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins</i></small></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Sigma_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Sigma_receptor_modulators" style="font-size:114%;margin:0 4em">Sigma receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">σ<sub>1</sub></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> 3-PPP</li>
<li>4-PPBP</li>
<li><a href="5-MeO-DMT.htm" tppabs="https://ptable.com/wiki/compounds/A/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a></li>
<li>Alazocine (SKF-10047)</li>
<li><a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">Amantadine</a></li>
<li>ANAVEX2-73</li>
<li>Arketamine</li>
<li><span class="new">BD-737</span></li>
<li>BD-1052</li>
<li>Captodiame</li>
<li><a href="Citalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Citalopram" title="Citalopram">Citalopram</a></li>
<li><abbr>CGRP</abbr></li>
<li>Cloperastine</li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Cutamesine (SA-4503)</li>
<li><a href="Cyclazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclazocine" title="Cyclazocine">Cyclazocine</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">Dehydroepiandrosterone (DHEA)</a> (prasterone)</li>
<li><a href="Dehydroepiandrosterone_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">Dehydroepiandrosterone sulfate (DHEA-S)</a> (prasterone sulfate)</li>
<li>Dextrallorphan</li>
<li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">Dextromethorphan (DXM)</a></li>
<li>Dextrorphan (DXO)</li>
<li>Dimemorfan</li>
<li><a href="Dimethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethyltryptamine" title="Dimethyltryptamine" class="mw-redirect">Dimethyltryptamine (DMT)</a></li>
<li>Ditolylguanidine (DTG)</li>
<li><a href="Donepezil.htm" tppabs="https://ptable.com/wiki/compounds/A/Donepezil" title="Donepezil">Donepezil</a></li>
<li>Eliprodil</li>
<li><a href="Escitalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Escitalopram" title="Escitalopram">Escitalopram</a></li>
<li>Fabomotizole (afobazole)</li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li><a href="Fluvoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvoxamine" title="Fluvoxamine">Fluvoxamine</a></li>
<li>Ifenprodil</li>
<li>Igmesine (JO-1784)</li>
<li><span class="new">IPAB</span></li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>L-687384</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA"><abbr>MDMA</abbr> (midomafetamine)</a></li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li>Methoxetamine</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li>Nepinalone</li>
<li>Neuropeptide Y</li>
<li><a href="Noscapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Noscapine" title="Noscapine">Noscapine</a></li>
<li><span class="new">OPC-14523</span></li>
<li>Opipramol</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li><a href="Pentoxyverine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentoxyverine" title="Pentoxyverine">Pentoxyverine (carbetapentane)</a></li>
<li>PRE-084</li>
<li><a href="Pregnenolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li>Pregnenolone sulfate</li>
<li>Pridopidine</li>
<li><a href="Methorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Racemethorphan" title="Racemethorphan" class="mw-redirect">Racemethorphan (methorphan)</a></li>
<li>Racemorphan (morphanol)</li>
<li><span class="new">UMB-23</span></li>
<li><span class="new">UMB-82</span></li></ul>

<ul><li><b>Antagonists:</b> 3-PPP</li>
<li>AC-927</li>
<li>BD-1008</li>
<li>BD-1031</li>
<li>BD-1047</li>
<li>BD-1060</li>
<li>BD-1063</li>
<li>BD-1067</li>
<li>BMY-14802 (BMS-181100)</li>
<li>CM-156</li>
<li><span class="new">Dup-734</span></li>
<li><span class="new">E-5842</span></li>
<li>E-52862 (S1RA)</li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li><span class="new">LR-132</span></li>
<li><span class="new">LR-172</span></li>
<li><span class="new">MS-377</span></li>
<li>NE-100</li>
<li><span class="new">NPC-16377</span></li>
<li>Panamesine (EMD-57455)</li>
<li><span class="new">PD-144418</span></li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li><a href="Rimcazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimcazole" title="Rimcazole">Rimcazole (BW-234U)</a></li>
<li><a href="Sertraline.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertraline" title="Sertraline">Sertraline</a></li>
<li><span class="new">SR-31742A</span></li></ul>

<ul><li><b>Allosteric modulators:</b> <a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a>; <i>Positive:</i> Methylphenylpiracetam</li>
<li><span class="new">SOMCL-668</span></li></ul>

<ul><li><b>Unknown/unsorted:</b> <span class="new">3-Methoxydextrallorphan</span></li>
<li>3-MeO-PCP</li>
<li>4C-T-2</li>
<li><span class="new">4-IBP</span></li>
<li><span class="new">4-IPBS</span></li>
<li>4-MeO-PCP</li>
<li>5-MeO-DALT</li>
<li>5-MeO-DiPT</li>
<li><a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">Amitriptyline</a></li>
<li><span class="new">Azidopamil</span></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Clemastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clemastine" title="Clemastine">Clemastine</a></li>
<li><a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">Clomipramine</a></li>
<li><a href="Clorgiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Clorgiline" title="Clorgiline">Clorgiline</a></li>
<li><small>D</small>-Deprenyl</li>
<li><abbr>DiPT</abbr></li>
<li><abbr>DPT</abbr></li>
<li>Ibogaine</li>
<li><a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">Imipramine</a></li>
<li><span class="new">KCR-12-83.1</span></li>
<li>Nemonapride</li>
<li>Noribogaine</li>
<li><span class="new">RHL-033</span></li>
<li>RS-67,333</li>
<li>RTI-55</li>
<li>Saffron</li>
<li>Safinamide</li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a></li>
<li><span class="new">Spipethiane</span></li>
<li><a href="Trifluoperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a></li>
<li>W-18</li>
<li>YKP10A</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">σ<sub>2</sub></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> 3-PPP</li>
<li>Arketamine</li>
<li>BD-1047</li>
<li>BD1063</li>
<li>Ditolylguanidine (DTG)</li>
<li><span class="new">DKR-1005</span></li>
<li><span class="new">DKR-1051</span></li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li>Ifenprodil</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA"><abbr>MDMA</abbr> (midomafetamine)</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li><span class="new">OPC-14523</span></li>
<li>Opipramol</li>
<li>PB-28</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li>Siramesine (Lu 28-179)</li>
<li><span class="new">UKH-1114</span></li></ul>

<ul><li><b>Antagonists:</b> AC-927</li>
<li>BD-1008</li>
<li>BD-1067</li>
<li>CM-156</li>
<li><span class="new">CT-1812</span></li>
<li><span class="new">LR-172</span></li>
<li>MIN-101</li>
<li>Panamesine (EMD-57455)</li>
<li><span class="new">SAS-0132</span></li></ul>

<ul><li><b>Unknown/unsorted:</b> <span class="new">3-Methoxydextrallorphan</span></li>
<li>3-MeO-PCE</li>
<li>4-MeO-PCP</li>
<li>5-MeO-DALT</li>
<li>5-MeO-DiPT</li>
<li><a href="Clemastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clemastine" title="Clemastine">Clemastine</a></li>
<li><abbr>DiPT</abbr></li>
<li><abbr>DPT</abbr></li>
<li>Ibogaine</li>
<li>Nemonapride</li>
<li>Nepinalone</li>
<li>Noribogaine</li>
<li><a href="Pentazocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentazocine" title="Pentazocine">Pentazocine</a></li>
<li>RS-67,333</li>
<li>Safinamide</li>
<li><a href="Trimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4%2C5-Trimethoxyamphetamine" title="3,4,5-Trimethoxyamphetamine" class="mw-redirect"><abbr>TMA</abbr></a></li>
<li><span class="new">UMB-23</span></li>
<li><span class="new">UMB-82</span></li>
<li>W-18</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Unsorted</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Agonists:</b> <a href="Berberine.htm" tppabs="https://ptable.com/wiki/compounds/A/Berberine" title="Berberine">Berberine</a></li>
<li>Ethylketazocine</li>
<li>Fourphit</li>
<li>Metaphit</li>
<li>Naluzotan</li>
<li>Tapentadol</li>
<li><a href="Tenocyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenocyclidine" title="Tenocyclidine">Tenocyclidine</a></li></ul>

<ul><li><b>Antagonists:</b> <span class="new">AHD1</span></li>
<li><span class="new">AZ66</span></li>
<li><a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">Lamotrigine</a></li>
<li><a href="Naloxone.htm" tppabs="https://ptable.com/wiki/compounds/A/Naloxone" title="Naloxone">Naloxone</a></li>
<li><span class="new">SM-21</span></li>
<li><span class="new">UMB-100</span></li>
<li><span class="new">UMB-101</span></li>
<li><span class="new">UMB-103</span></li>
<li><span class="new">UMB-116</span></li>
<li><span class="new">YZ-011</span></li>
<li><span class="new">YZ-069</span></li>
<li><span class="new">YZ-185</span></li></ul>

<ul><li><b>Allosteric modulators:</b> SKF-83959</li></ul>

<ul><li><b>Unknown/unsorted:</b> 18-Methoxycoronaridine</li>
<li><span class="new">BMY-13980</span></li>
<li>Butaclamol</li>
<li>Caramiphen</li>
<li><span class="new">Carvotroline</span></li>
<li><a href="Chlorphenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphenamine" title="Chlorphenamine">Chlorphenamine (chlorpheniramine)</a></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Cinnarizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cinnarizine" title="Cinnarizine">Cinnarizine</a></li>
<li><span class="new">Cinuperone</span></li>
<li>Clocapramine</li>
<li><a href="Dezocine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dezocine" title="Dezocine">Dezocine</a></li>
<li><span class="new">EMD-59983</span></li>
<li>Hypericin (St. John's wort)</li>
<li><a href="Fluphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluphenazine" title="Fluphenazine">Fluphenazine</a></li>
<li>Gevotroline (WY-47384)</li>
<li><a href="Mepyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mepyramine" title="Mepyramine">Mepyramine (pyrilamine)</a></li>
<li><a href="Molindone.htm" tppabs="https://ptable.com/wiki/compounds/A/Molindone" title="Molindone">Molindone</a></li>
<li><a href="Perphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Perphenazine" title="Perphenazine">Perphenazine</a></li>
<li><a href="Pimozide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimozide" title="Pimozide">Pimozide</a></li>
<li>Proadifen</li>
<li><a href="Promethazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Promethazine" title="Promethazine">Promethazine</a></li>
<li><a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">Propranolol</a></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li><a href="Remoxipride.htm" tppabs="https://ptable.com/wiki/compounds/A/Remoxipride" title="Remoxipride">Remoxipride</a></li>
<li><span class="new">SL 82.0715</span></li>
<li><span class="new">SR-31747A</span></li>
<li>Tiospirone (BMY-13859)</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators</i></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Phenethylamines" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Phenethylamines" style="font-size:114%;margin:0 4em">Phenethylamines</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenethylamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Psychedelics:</i> 25B-NBOMe</li>
<li>25C-NBOMe</li>
<li>25D-NBOMe</li>
<li>25I-NBOMe</li>
<li>25N-NBOMe</li></ul>

<ul><li><a href="2C-B.htm" tppabs="https://ptable.com/wiki/compounds/A/2C-B" title="2C-B">2C-B</a></li>
<li><span class="new">2C-B-AN</span></li>
<li><span class="new">2C-Bn</span></li>
<li><span class="new">2C-Bu</span></li>
<li>2C-C</li>
<li><span class="new">2C-CN</span></li>
<li><span class="new">2C-CP</span></li>
<li>2C-D</li>
<li>2C-E</li>
<li><span class="new">2C-EF</span></li>
<li>2C-F</li>
<li>2C-G</li>
<li>2C-G-1</li>
<li>2C-G-2</li>
<li>2C-G-3</li>
<li>2C-G-4</li>
<li>2C-G-5</li>
<li>2C-G-6</li>
<li>2C-G-N</li>
<li><a href="2C-H.htm" tppabs="https://ptable.com/wiki/compounds/A/2C-H" title="2C-H">2C-H</a></li>
<li>2C-I</li>
<li>2C-iP</li>
<li>2C-N</li>
<li><span class="new">2C-NH2</span></li>
<li>2C-O</li>
<li>2C-O-4</li>
<li>2C-P</li>
<li><span class="new">2C-Ph</span></li>
<li>2C-SE</li>
<li>2C-T</li>
<li>2C-T-2</li>
<li><span class="new">2C-T-3</span></li>
<li>2C-T-4</li>
<li><span class="new">2C-T-5</span></li>
<li><span class="new">2C-T-6</span></li>
<li>2C-T-7</li>
<li>2C-T-8</li>
<li>2C-T-9</li>
<li><span class="new">2C-T-10</span></li>
<li><span class="new">2C-T-11</span></li>
<li><span class="new">2C-T-12</span></li>
<li>2C-T-13</li>
<li><span class="new">2C-T-14</span></li>
<li>2C-T-15</li>
<li>2C-T-16</li>
<li>2C-T-17</li>
<li><span class="new">2C-T-18</span></li>
<li>2C-T-19</li>
<li><span class="new">2C-T-20</span></li>
<li>2C-T-21</li>
<li><span class="new">2C-T-22</span></li>
<li><span class="new">2C-T-22.5</span></li>
<li><span class="new">2C-T-23</span></li>
<li><span class="new">2C-T-24</span></li>
<li><span class="new">2C-T-25</span></li>
<li><span class="new">2C-T-27</span></li>
<li><span class="new">2C-T-28</span></li>
<li><span class="new">2C-T-30</span></li>
<li><span class="new">2C-T-31</span></li>
<li><span class="new">2C-T-32</span></li>
<li><span class="new">2C-T-33</span></li>
<li><span class="new">2C-TFE</span></li>
<li>2C-TFM</li>
<li>2C-YN</li>
<li><span class="new">2C-V</span></li></ul>

<ul><li>Allylescaline</li>
<li>DESOXY</li>
<li>Escaline</li>
<li>Isoproscaline</li>
<li>Jimscaline</li>
<li>Macromerine</li>
<li>MEPEA</li>
<li>Mescaline</li>
<li>Metaescaline</li>
<li>Methallylescaline</li>
<li>Proscaline</li>
<li>Psi-2C-T-4</li>
<li>TCB-2</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a><br><i>Stimulants:</i> Phenylethanolamine</li>
<li>Hordenine</li>
<li><a href="Phenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenethylamine" title="Phenethylamine">Phenethylamine</a></li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">α-Methylphenethylamine</a> (amphetamine)</li>
<li><a href="Β-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%92-Methylphenethylamine" title="Β-Methylphenethylamine">β-Methylphenethylamine</a></li>
<li><i>m</i>-Methylphenethylamine</li>
<li><a href="N-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methylphenethylamine" title="N-Methylphenethylamine"><i>N</i>-Methylphenethylamine</a></li>
<li><i>o</i>-Methylphenethylamine</li>
<li><i>p</i>-Methylphenethylamine</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li></ul>

<ul><li><i>Entactogens:</i> Lophophine</li>
<li>MDPEA</li>
<li>MDMPEA<br><i>Others:</i> BOH</li>
<li><a href="3,4-Dimethoxyphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Dimethoxyphenethylamine" title="3,4-Dimethoxyphenethylamine">DMPEA</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Amphetamines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Psychedelics:</i> 3C-BZ</li>
<li>3C-E</li>
<li>3C-P</li>
<li>Aleph</li>
<li>Beatrice</li>
<li>Bromo-DragonFLY</li>
<li>D-Deprenyl</li>
<li><a href="Dimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethoxyamphetamine" title="Dimethoxyamphetamine">DMA</a></li>
<li><span class="new">DMCPA</span></li>
<li>DMMDA</li>
<li>DOB</li>
<li>DOC</li>
<li>DOEF</li>
<li><a href="2,5-Dimethoxy-4-ethylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-ethylamphetamine" title="2,5-Dimethoxy-4-ethylamphetamine">DOET</a></li>
<li>DOI</li>
<li><a href="2,5-Dimethoxy-4-methylamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2%2C5-Dimethoxy-4-methylamphetamine" title="2,5-Dimethoxy-4-methylamphetamine">DOM</a></li>
<li>DON</li>
<li>DOPR</li>
<li>DOTFM</li>
<li>Ganesha</li>
<li>MMDA</li>
<li>MMDA-2</li>
<li>Psi-DOM</li>
<li><a href="Trimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethoxyamphetamine" title="Trimethoxyamphetamine">TMA</a></li>
<li>TeMA<br><i>Stimulants:</i> 2-FA</li>
<li>2-FMA</li>
<li>3-FA</li>
<li>3-FMA</li>
<li>Acridorex</li>
<li>Alfetamine</li>
<li>Amfecloral</li>
<li>Amfepentorex</li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a> (<a href="Dextroamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a>, <a href="Levoamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levoamphetamine" title="Levoamphetamine">Levoamphetamine</a>)</li>
<li>Amphetaminil</li>
<li>Benfluorex</li>
<li><a href="Benzphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzphetamine" title="Benzphetamine">Benzphetamine</a></li>
<li><a href="Cathine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathine" title="Cathine">Cathine</a></li>
<li>Clobenzorex</li>
<li>Dimethylamphetamine</li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li>Etilamfetamine</li>
<li>Fencamfamin</li>
<li>Fencamine</li>
<li><a href="Fenethylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenethylline" title="Fenethylline">Fenethylline</a></li>
<li><a href="Fenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenfluramine" title="Fenfluramine">Fenfluramine</a> (<a href="Dexfenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexfenfluramine" title="Dexfenfluramine">Dexfenfluramine</a>, Levofenfluramine)</li>
<li><a href="Fenproporex.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenproporex" title="Fenproporex">Fenproporex</a></li>
<li>Flucetorex</li>
<li>Fludorex</li>
<li>Formetorex</li>
<li>Furfenorex</li>
<li>Gepefrine</li>
<li>4-Hydroxyamphetamine</li>
<li>Iofetamine</li>
<li>Isopropylamphetamine</li>
<li>Lefetamine</li>
<li><a href="Lisdexamfetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisdexamfetamine" title="Lisdexamfetamine">Lisdexamfetamine</a></li>
<li>Mefenorex</li>
<li><a href="Metaraminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a> (Dextromethamphetamine, Levomethamphetamine)</li>
<li>Methoxyphenamine</li>
<li>MMA</li>
<li>Morforex</li>
<li>Norfenfluramine</li>
<li><a href="L-Norpseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-Norpseudoephedrine" title="L-Norpseudoephedrine"><span style="font-size:90%;">L </span>-Norpseudoephedrine</a></li>
<li>N,alpha-Diethylphenylethylamine</li>
<li>Oxifentorex</li>
<li>Oxilofrine</li>
<li>Ortetamine</li>
<li>PBA</li>
<li>PCA</li>
<li>Phenpromethamine</li>
<li>PFA</li>
<li>PFMA</li>
<li>PIA</li>
<li><a href="Para-Methoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-Methoxyamphetamine" title="Para-Methoxyamphetamine">PMA</a></li>
<li>PMEA</li>
<li>PMMA</li>
<li><a href="Phenylpropanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a></li>
<li><a href="Pholedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li><a href="Prenylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li>Propylamphetamine</li>
<li><a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Tiflorex</li>
<li><a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li>
<li>Xylopropamine</li>
<li>Zylofuramine<br><i>Entactogens:</i> 4-FA</li>
<li>4-FMA</li>
<li>4-MA</li>
<li>4-MMA</li>
<li>4-MTA</li>
<li>5-APB</li>
<li>5-APDB</li>
<li>5-EAPB</li>
<li>5-IT</li>
<li>5-MAPB</li>
<li>5-MAPDB</li>
<li>6-APB</li>
<li>6-APDB</li>
<li>6-Chloro-MDMA</li>
<li>6-EAPB</li>
<li>6-IT</li>
<li>6-MAPB</li>
<li>6-MAPDB</li>
<li>EDA</li>
<li>IAP</li>
<li>2,3-MDA</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">3,4-MDA (tenamfetamine)</a></li>
<li>MDEA</li>
<li>MDHMA</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>MDOH</li>
<li>Methamnetamine</li>
<li>MMDMA</li>
<li>Naphthylaminopropane</li>
<li>TAP<br><i>Others:</i> 3,4-DCA</li>
<li>Amiflamine</li>
<li>DiFMDA</li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline">Selegiline</a> (also <span style="font-size:90%;">D </span>-Deprenyl)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermines</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Stimulants:</i> <a href="Chlorphentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphentermine" title="Chlorphentermine">Chlorphentermine</a></li>
<li>Cloforex</li>
<li><a href="Clortermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clortermine" title="Clortermine">Clortermine</a></li>
<li>Etolorex</li>
<li><a href="Mephentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mephentermine" title="Mephentermine">Mephentermine</a></li>
<li>Pentorex</li>
<li><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermine</a><br><i>Entactogens:</i> MDPH</li>
<li>MDMPH<br><i>Others:</i> Cericlamine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cathinones</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Stimulants:</i> 3-FMC</li>
<li>4-MC</li>
<li>4-BMC</li>
<li>4-CMC</li>
<li>4-EMC</li>
<li>4-FMC</li>
<li>4-MEC</li>
<li>4-MeMABP</li>
<li>4-MPD</li>
<li><a href="Amfepramone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amfepramone" title="Amfepramone">Amfepramone</a></li>
<li>Benzedrone</li>
<li>Brephedrone</li>
<li>Buphedrone</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a></li>
<li>Dimethylcathinone</li>
<li>Ethcathinone</li>
<li>Eutylone</li>
<li>Hydroxybupropion</li>
<li>Methcathinone</li>
<li>Methedrone</li>
<li>NEB</li>
<li>N-Ethylhexedrone</li>
<li>N-Ethylpentedrone</li>
<li>Pentedrone</li>
<li>Pentylone</li>
<li>Radafaxine<br><i>Entactogens:</i> 3,4-DMMC</li>
<li>3-MMC</li>
<li>Butylone</li>
<li>Ethylone</li>
<li>Methylone</li>
<li>Methylenedioxycathinone</li>
<li>Mephedrone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenylisobutylamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Entactogens:</i> 4-CAB</li>
<li>4-MAB</li>
<li>Ariadne</li>
<li>BDB</li>
<li>Butylone</li>
<li>EBDB</li>
<li>Eutylone</li>
<li>MBDB<br><i>Stimulants:</i> Phenylisobutylamine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenylalkylpyrrolidines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Stimulants:</i> α-PBP</li>
<li>α-PHP</li>
<li>α-PPP</li>
<li>α-PVP</li>
<li>MDPBP</li>
<li>MDPPP</li>
<li>MDPV</li>
<li>4-MePBP</li>
<li>4-MePHP</li>
<li>4-MePPP</li>
<li>MOPPP</li>
<li>MOPVP</li>
<li>MPBP</li>
<li>MPHP</li>
<li>MPPP</li>
<li>Naphyrone</li>
<li>PEP</li>
<li>Prolintane</li>
<li>Pyrovalerone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Catecholamines<br><span style="font-size:90%;">(and close relatives) </span></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>6-FNE</li>
<li><a href="Oxidopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/6-Hydroxydopamine" title="6-Hydroxydopamine" class="mw-redirect">6-OHDA</a></li>
<li><a href="Alpha-Methyldopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyldopamine" title="Alpha-Methyldopamine">a-Me-DA</a></li>
<li>a-Me-TRA</li>
<li>Adrenochrome</li>
<li>Ciladopa</li>
<li><span style="font-size:90%;">D </span>-DOPA (Dextrodopa)</li>
<li>Dimetofrine</li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li>Epinephrine</li>
<li>Epinine</li>
<li>Etilefrine</li>
<li>Ethylnorepinephrine</li>
<li><a href="Fenclonine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenclonine" title="Fenclonine">Fenclonine</a></li>
<li>Ibopamine</li>
<li><a href="Isoprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoprenaline" title="Isoprenaline">Isoprenaline</a></li>
<li><a href="Isoetarine.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoetarine" title="Isoetarine">Isoetarine</a></li>
<li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><span style="font-size:90%;">L </span>-DOPA</a> (Levodopa)</li>
<li><a href="L-DOPS.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPS" title="L-DOPS" class="mw-redirect"><span style="font-size:90%;">L </span>-DOPS</a> (Droxidopa)</li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-Phenylalanine" title="L-Phenylalanine" class="mw-redirect"><span style="font-size:90%;">L </span>-Phenylalanine</a></li>
<li><span style="font-size:90%;">L </span>-Tyrosine</li>
<li><i>m</i>-Tyramine</li>
<li>Metanephrine</li>
<li><a href="Metaraminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li>Metaterol</li>
<li><a href="Metirosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Metirosine" title="Metirosine">Metirosine</a></li>
<li><a href="Methyldopa.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyldopa" title="Methyldopa">Methyldopa</a></li>
<li>N,N-Dimethyldopamine</li>
<li>Nordefrin (Levonordefrin)</li>
<li>Norepinephrine</li>
<li><a href="Norfenefrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Norfenefrine" title="Norfenefrine">Norfenefrine</a> (<i>m</i>-Octopamine)</li>
<li>Normetanephrine</li>
<li><a href="Orciprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Orciprenaline" title="Orciprenaline">Orciprenaline</a></li>
<li><i>p</i>-Octopamine</li>
<li><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine"><i>p</i>-Tyramine</a></li>
<li><a href="Phenylephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylephrine" title="Phenylephrine">Phenylephrine</a></li>
<li><a href="Synephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Synephrine" title="Synephrine">Synephrine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Miscellaneous</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>AL-LAD</li>
<li>Amidephrine</li>
<li><a href="Arbutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arbutamine" title="Arbutamine">Arbutamine</a></li>
<li>Cafedrine</li>
<li>Denopamine</li>
<li>Desvenlafaxine</li>
<li>Diphenidine</li>
<li>Dizocilpine</li>
<li><a href="Dobutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dobutamine" title="Dobutamine">Dobutamine</a></li>
<li>Dopexamine</li>
<li>Ephenidine</li>
<li>Etafedrine</li>
<li>ETH-LAD</li>
<li>Famprofazone</li>
<li>Fluorolintane</li>
<li>Hexapradol</li>
<li>IP-LAD</li>
<li>Lysergic acid amide</li>
<li>Lysergic acid 2-butyl amide</li>
<li>Lysergic acid 2,4-dimethylazetidide</li>
<li><a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">Lysergic acid diethylamide</a></li>
<li><a href="Methoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxamine" title="Methoxamine">Methoxamine</a></li>
<li>Methoxphenidine</li>
<li>MT-45</li>
<li>PARGY-LAD</li>
<li>Phenibut</li>
<li>PRO-LAD</li>
<li>Pronethalol</li>
<li><a href="Salbutamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Salbutamol" title="Salbutamol">Salbutamol</a> (Levosalbutamol)</li>
<li>Solriamfetol</li>
<li>Theodrenaline</li>
<li><a href="Thiamphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiamphenicol" title="Thiamphenicol">Thiamphenicol</a></li>
<li>UWA-101</li></ul>
</div></td></tr></tbody></table></div>



















<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>